
<html lang="en"     class="pb-page"  data-request-id="7a566e90-14a4-453b-aa2e-63cec51c5ad7"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.6b00028;issue:issue:10.1021/jmcmar.2016.59.issue-13;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Trisubstituted Pyrimidines as Efficacious and Fast-Acting Antimalarials" /></meta><meta name="dc.Creator" content="Neil R.  Norcross" /></meta><meta name="dc.Creator" content="Beatriz  Baragaña" /></meta><meta name="dc.Creator" content="Caroline  Wilson" /></meta><meta name="dc.Creator" content="Irene  Hallyburton" /></meta><meta name="dc.Creator" content="Maria  Osuna-Cabello" /></meta><meta name="dc.Creator" content="Suzanne  Norval" /></meta><meta name="dc.Creator" content="Jennifer  Riley" /></meta><meta name="dc.Creator" content="Laste  Stojanovski" /></meta><meta name="dc.Creator" content="Frederick R. C.  Simeons" /></meta><meta name="dc.Creator" content="Achim  Porzelle" /></meta><meta name="dc.Creator" content="Raffaella  Grimaldi" /></meta><meta name="dc.Creator" content="Sergio  Wittlin" /></meta><meta name="dc.Creator" content="Sandra  Duffy" /></meta><meta name="dc.Creator" content="Vicky M.  Avery" /></meta><meta name="dc.Creator" content="Stephan  Meister" /></meta><meta name="dc.Creator" content="Laura  Sanz" /></meta><meta name="dc.Creator" content="Belén  Jiménez-Díaz" /></meta><meta name="dc.Creator" content="Iñigo  Angulo-Barturen" /></meta><meta name="dc.Creator" content="Santiago  Ferrer" /></meta><meta name="dc.Creator" content="María Santos  Martínez" /></meta><meta name="dc.Creator" content="Francisco Javier  Gamo" /></meta><meta name="dc.Creator" content="Julie A.  Frearson" /></meta><meta name="dc.Creator" content="David W.  Gray" /></meta><meta name="dc.Creator" content="Alan H.  Fairlamb" /></meta><meta name="dc.Creator" content="Elizabeth A.  Winzeler" /></meta><meta name="dc.Creator" content="David  Waterson" /></meta><meta name="dc.Creator" content="Simon F.  Campbell" /></meta><meta name="dc.Creator" content="Paul  Willis" /></meta><meta name="dc.Creator" content="Kevin D.  Read" /></meta><meta name="dc.Creator" content="Ian H.  Gilbert" /></meta><meta name="dc.Description" content="In this paper we describe the optimization of a phenotypic hit against Plasmodium falciparum, based on a trisubstituted pyrimidine scaffold. This led to compounds with good pharmacokinetics and ora..." /></meta><meta name="Description" content="In this paper we describe the optimization of a phenotypic hit against Plasmodium falciparum, based on a trisubstituted pyrimidine scaffold. This led to compounds with good pharmacokinetics and ora..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 17, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00028" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00028" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00028" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00028" /></link>
        
    
    

<title>Trisubstituted Pyrimidines as Efficacious and Fast-Acting Antimalarials | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00028" /></meta><meta property="og:title" content="Trisubstituted Pyrimidines as Efficacious and Fast-Acting Antimalarials" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/large/jm-2016-00028z_0020.jpeg" /></meta><meta property="og:description" content="In this paper we describe the optimization of a phenotypic hit against Plasmodium falciparum, based on a trisubstituted pyrimidine scaffold. This led to compounds with good pharmacokinetics and oral activity in a P. berghei mouse model of malaria. The most promising compound (13) showed a reduction in parasitemia of 96% when dosed at 30 mg/kg orally once a day for 4 days in the P. berghei mouse model of malaria. It also demonstrated a rapid rate of clearance of the erythrocytic stage of P. falciparum in the SCID mouse model with an ED90 of 11.7 mg/kg when dosed orally. Unfortunately, the compound is a potent inhibitor of cytochrome P450 enzymes, probably due to a 4-pyridyl substituent. Nevertheless, this is a lead molecule with a potentially useful antimalarial profile, which could either be further optimized or be used for target hunting." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00028"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00028">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00028&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00028&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00028&amp;href=/doi/10.1021/acs.jmedchem.6b00028" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 6101-6120</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00459" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00035" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Trisubstituted Pyrimidines as Efficacious and Fast-Acting Antimalarials</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Neil+R.++Norcross">Neil R. Norcross</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Beatriz++Baraga%C3%B1a">Beatriz Baragaña</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Caroline++Wilson">Caroline Wilson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Irene++Hallyburton">Irene Hallyburton</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria++Osuna-Cabello">Maria Osuna-Cabello</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Suzanne++Norval">Suzanne Norval</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer++Riley">Jennifer Riley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laste++Stojanovski">Laste Stojanovski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frederick+R.+C.++Simeons">Frederick R. C. Simeons</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Achim++Porzelle">Achim Porzelle</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Raffaella++Grimaldi">Raffaella Grimaldi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sergio++Wittlin">Sergio Wittlin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sandra++Duffy">Sandra Duffy</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vicky+M.++Avery">Vicky M. Avery</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephan++Meister">Stephan Meister</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laura++Sanz">Laura Sanz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bel%C3%A9n++Jim%C3%A9nez-D%C3%ADaz">Belén Jiménez-Díaz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=I%C3%B1igo++Angulo-Barturen">Iñigo Angulo-Barturen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Santiago++Ferrer">Santiago Ferrer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mar%C3%ADa+Santos++Mart%C3%ADnez">María Santos Martínez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francisco+Javier++Gamo">Francisco Javier Gamo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Julie+A.++Frearson">Julie A. Frearson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+W.++Gray">David W. Gray</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan+H.++Fairlamb">Alan H. Fairlamb</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elizabeth+A.++Winzeler">Elizabeth A. Winzeler</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Waterson">David Waterson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Simon+F.++Campbell">Simon F. Campbell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Willis">Paul Willis</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+D.++Read">Kevin D. Read</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ian+H.++Gilbert">Ian H. Gilbert</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, DD1 5EH, U.K.</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Swiss Tropical and Public Health Institute (Swiss TPH), Socinstrasse 57, 4051 Basel, Switzerland</span></div><div class="aff-info" id="aff2.2"><span class="aff-symbol">§</span> <span class="aff-text">University of Basel, CH-4003 Basel, Switzerland</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">∥</span> <span class="aff-text">Discovery Biology, Eskitis Institute for Drug Discovery, Griffith University, Nathan, Queensland 4111, Australia</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">⊥</span> <span class="aff-text">Department of Pediatrics, University of California, San Diego School of Medicine, 9500 Gilman Drive, 0741, La Jolla, California 92093, United States</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">#</span> <span class="aff-text">Diseases of the Developing World-Tres Cantos Medicines Development Campus, GlaxoSmithKline, c/Severo Ochoa, 2, Tres Cantos, 28760, Madrid, Spain</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">∇</span> <span class="aff-text">Medicines for Malaria Venture, International Center Cointrin, Entrance G, 3rd Floor, Route de Pré-Bois 20, P.O. Box 1826, CH-1215, Geneva 15, Switzerland</span></div><div class="corresp-info"><strong>*</strong>K.D.R.: phone, +44 1382 388 688; e-mail, <a href="/cdn-cgi/l/email-protection#85eeabf7e0e4e1c5e1f0ebe1e0e0abe4e6abf0ee"><span class="__cf_email__" data-cfemail="6e05401c0b0f0a2e0a1b000a0b0b400f0d401b05">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>I.H.G.: phone, +44 1382 386 240; e-mail, <a href="/cdn-cgi/l/email-protection#31581f591f56585d535443457155445f5554541f50521f445a"><span class="__cf_email__" data-cfemail="eb82c583c58c8287898e999fab8f9e858f8e8ec58a88c59e80">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00028&amp;href=/doi/10.1021%2Facs.jmedchem.6b00028" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 6101–6120</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 17, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>7 January 2016</li><li><span class="item_label"><b>Published</b> online</span>17 June 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 July 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00028" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00028</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice/index.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by text">with CC-BY<a href="/page/policy/authorchoice_ccby_termsofuse.html" title="License">license</a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00028"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2521</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">6</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00028" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Trisubstituted Pyrimidines as Efficacious and Fast-Acting Antimalarials&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Neil&quot;,&quot;last_name&quot;:&quot;R. Norcross&quot;},{&quot;first_name&quot;:&quot;Beatriz&quot;,&quot;last_name&quot;:&quot;Baragaña&quot;},{&quot;first_name&quot;:&quot;Caroline&quot;,&quot;last_name&quot;:&quot;Wilson&quot;},{&quot;first_name&quot;:&quot;Irene&quot;,&quot;last_name&quot;:&quot;Hallyburton&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Osuna-Cabello&quot;},{&quot;first_name&quot;:&quot;Suzanne&quot;,&quot;last_name&quot;:&quot;Norval&quot;},{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;Riley&quot;},{&quot;first_name&quot;:&quot;Laste&quot;,&quot;last_name&quot;:&quot;Stojanovski&quot;},{&quot;first_name&quot;:&quot;Frederick&quot;,&quot;last_name&quot;:&quot;R. C. Simeons&quot;},{&quot;first_name&quot;:&quot;Achim&quot;,&quot;last_name&quot;:&quot;Porzelle&quot;},{&quot;first_name&quot;:&quot;Raffaella&quot;,&quot;last_name&quot;:&quot;Grimaldi&quot;},{&quot;first_name&quot;:&quot;Sergio&quot;,&quot;last_name&quot;:&quot;Wittlin&quot;},{&quot;first_name&quot;:&quot;Sandra&quot;,&quot;last_name&quot;:&quot;Duffy&quot;},{&quot;first_name&quot;:&quot;Vicky&quot;,&quot;last_name&quot;:&quot;M. Avery&quot;},{&quot;first_name&quot;:&quot;Stephan&quot;,&quot;last_name&quot;:&quot;Meister&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;Sanz&quot;},{&quot;first_name&quot;:&quot;Belén&quot;,&quot;last_name&quot;:&quot;Jiménez-Díaz&quot;},{&quot;first_name&quot;:&quot;Iñigo&quot;,&quot;last_name&quot;:&quot;Angulo-Barturen&quot;},{&quot;first_name&quot;:&quot;Santiago&quot;,&quot;last_name&quot;:&quot;Ferrer&quot;},{&quot;first_name&quot;:&quot;María&quot;,&quot;last_name&quot;:&quot;Santos Martínez&quot;},{&quot;first_name&quot;:&quot;Francisco&quot;,&quot;last_name&quot;:&quot;Javier Gamo&quot;},{&quot;first_name&quot;:&quot;Julie&quot;,&quot;last_name&quot;:&quot;A. Frearson&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;W. Gray&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;H. Fairlamb&quot;},{&quot;first_name&quot;:&quot;Elizabeth&quot;,&quot;last_name&quot;:&quot;A. Winzeler&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Waterson&quot;},{&quot;first_name&quot;:&quot;Simon&quot;,&quot;last_name&quot;:&quot;F. Campbell&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Willis&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;D. Read&quot;},{&quot;first_name&quot;:&quot;Ian&quot;,&quot;last_name&quot;:&quot;H. Gilbert&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;6101-6120&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00028&quot;},&quot;abstract&quot;:&quot;In this paper we describe the optimization of a phenotypic hit against Plasmodium falciparum, based on a trisubstituted pyrimidine scaffold. This led to compounds with good pharmacokinetics and oral activity in a P. berghei mouse model of malaria. The most promising compound (13) showed a reduction in parasitemia of 96% when dosed at 30 mg/kg orally once a day for 4 days in the P. berghei mouse model of malaria. It also demonstrated a rapid rate of clearance of the erythrocytic stage of P. falciparum in the SCID mouse model with an ED90 of 11.7 mg/kg when dosed orally. Unfortunately, the compound is a potent inhibitor of cytochrome P450 enzymes, probably due to a 4-pyridyl substituent. Nevertheless, this is a lead molecule with a potentially useful antimalarial profile, which could either be further optimized or be used for target hunting.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00028&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00028" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00028&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00028" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00028&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00028" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00028&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00028&amp;href=/doi/10.1021/acs.jmedchem.6b00028" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00028" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00028" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00028%26sid%3Dliteratum%253Aachs%26pmid%3D27314305%26genre%3Darticle%26aulast%3DNorcross%26date%3D2016%26atitle%3DTrisubstituted%2BPyrimidines%2Bas%2BEfficacious%2Band%2BFast-Acting%2BAntimalarials%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D13%26spage%3D6101%26epage%3D6120%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291917" title="Pyrimidine">Pyrimidine</a>,</li><li><a href="/action/doSearch?ConceptID=291528" title="Parasites">Parasites</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291454" title="Solubility">Solubility</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/jmcmar.2016.59.issue-13/20160714/jmcmar.2016.59.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/medium/jm-2016-00028z_0020.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/large/jm-2016-00028z_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00028&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In this paper we describe the optimization of a phenotypic hit against <i>Plasmodium falciparum</i>, based on a trisubstituted pyrimidine scaffold. This led to compounds with good pharmacokinetics and oral activity in a <i>P. berghei</i> mouse model of malaria. The most promising compound (<b>13</b>) showed a reduction in parasitemia of 96% when dosed at 30 mg/kg orally once a day for 4 days in the <i>P. berghei</i> mouse model of malaria. It also demonstrated a rapid rate of clearance of the erythrocytic stage of <i>P. falciparum</i> in the SCID mouse model with an ED<sub>90</sub> of 11.7 mg/kg when dosed orally. Unfortunately, the compound is a potent inhibitor of cytochrome P450 enzymes, probably due to a 4-pyridyl substituent. Nevertheless, this is a lead molecule with a potentially useful antimalarial profile, which could either be further optimized or be used for target hunting.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07428" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07428" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Malaria is a devastating parasitic disease causing widespread mortality and morbidity across many parts of the developing world. Human malaria is caused by five <i>Plasmodium</i> species: <i>P. falciparum</i>, <i>P. vivax</i>, <i>P. ovale, P. malariae</i>, and <i>P. knowlesi</i>. <i>P. falciparum</i> causes the most mortality and is found in high levels in Africa, whereas <i>P. vivax</i> causes the most morbidity and is more commonly found across Asia and the Americas.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In 2013, there were an estimated 198 million cases of malaria worldwide and 584 000 deaths, of which 453 000 were of children under 5 years, with 90% of all malaria deaths in the African region.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Many medicines for the treatment of malaria such as chloroquine and pyrimethamine are failing due to increasing development of resistance. Furthermore, there are now cases of drug resistance to artemisinin-based combination therapies (ACTs), which are the mainstays for the World Health Organization (WHO) campaign against malaria.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Currently, primaquine is the only drug in general use for radical cure of malaria due to <i>P. vivax</i>, preventing relapse, but this medicine has a prolonged dosing schedule and is toxic to individuals with glucose 6-phosphate deficiency.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Therefore, new therapies for both treatment and prevention of this deadly disease across all of its life cycle stages are urgently needed. Efforts from academic groups and pharmaceutical companies to identify novel antimalarials are now beginning to bear fruit as novel therapies for the treatment of malaria are in clinical trials.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> However, the discovery of potential new antimalarials remains vital, given the high attrition rates in clinical development,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> the propensity of the parasite to develop resistance, and the need for additional indications (such as transmission blocking, chemoprevention, and radical cure of vivax malaria).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Here, we report the design, synthesis, and biological evaluation of fast-acting and highly efficacious antimalarials, based on trisubstituted pyrimidines, which were discovered using a whole cell-based screening approach.</div></div><div id="secy" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36364" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36364" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Project Initiation</h3><div class="NLM_p">A drug discovery program for the identification of novel antimalarials was initiated with the high throughput phenotypic screening (HTS) of an in-house library of protein kinase scaffolds (4731 compounds).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> This effort identified multiple structurally diverse chemical series that blocked asexual blood stage parasite viability, as measured by a SYBR green assay.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> In this paper, we describe a chemistry program based around one of these series, a trisubstituted pyrimidine, which displayed chemical tractability, nanomolar potency against <i>P. falciparum</i> cell line 3D7, and excellent selectivity over a mammalian cell line MRC-5 (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). An initial example of this series was inactive against a panel of mammalian kinases up to a concentration of 10 μM.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Hit Series Identified from Phenotypic Screening of Kinase-like Library</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/medium/jm-2016-00028z_0012.gif" alt="" id="fx1" /></img><div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Lead Identification</h3><div class="NLM_p">The initial hit from the screen, <b>1</b>, was followed up by hit expansion through commercially available analogues. Systematic changes of functional groups at R<sup>1</sup>, R<sup>2</sup>, and R<sup>3</sup> were carried out to try to improve potency and physicochemical properties. Analogues of our original screening hit (<b>1</b>) were also identified from published data from GSK<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and Novartis<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Following resynthesis and screening in-house, compound <b>2</b> (reported by GSK and Novartis) provided a suitable chemical start point for further synthetic modifications. However, due to poor solubility (5 μM), compound <b>2</b> was not progressed any further than assessment at the in vitro (cellular) level for potency and absorption, distribution, metabolism, excretion, and toxicology (ADMET). Analogue design was then directed toward improving potency and solubility and reducing the number of aromatic rings, which can have a beneficial impact on overall development characteristics including solubility.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> Compound <b>2</b> has a high degree of planarity, so we sought further improvement by increasing the proportion of sp<sup>3</sup> to sp<sup>2</sup> carbon atoms, which is reported to increase the solubility.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/medium/jm-2016-00028z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/large/jm-2016-00028z_0002.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Published analogue compound <b>2</b>, codes TCMDC-125419 (GSK) and GNF-Pf-1034/GNF-Pf-1447 (Novartis).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/large/jm-2016-00028z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00028&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We were concerned about the inhibition of cytochrome P450 isoform CYP3A4, which we believed to be due to the 4-pyridyl group (see later for further discussion). Initial attempts to replace the 4-pyridyl functional group at R<sup>1</sup> resulted in a significant loss of antimalarial activity (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Removal of the pyridine nitrogen at R<sup>1</sup> or simply moving the nitrogen from the 4- to the 3-position resulted in >30-fold drop in potency. In addition, replacing the 4-pyridyl group with a morpholine group reduced potency by almost 60-fold, highlighting the importance of the pyridine nitrogen and suggesting that the vector of the lone pair donor was also crucial for activity. We decided therefore to investigate variations at R<sup>2</sup> and R<sup>3</sup> for improvements in potency, which would render the interaction with the 4-pyridyl less critical.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Modifications at R<sup>1</sup> <a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/medium/jm-2016-00028z_0013.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">All parasite assays were run in duplicate.</p></div></div><div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Optimization of R<sup>2</sup></h3><div class="NLM_p">Removal of the tetrahydroisoquinoline (<b>2</b>) and replacement with an amino group (<b>6</b>) gave a 100-fold drop in activity, indicating the tetrahydroisoquinoline group has a significant effect on the potency. Replacement of the tetrahydroisoquinoline moiety of compound <b>2</b> with <i>N-</i>methylbenzylamine (<b>7</b>) resulted in a 10-fold loss of potency (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>), possibly suggesting that a degree of conformational restraint was necessary. Contracting the aliphatic ring size to a five-membered ring (<b>8</b>) led to a complete loss in activity. Replacing the phenyl ring in <b>2</b> with an imidazole (<b>9</b>) gave a 10-fold drop in activity (EC<sub>50</sub> = 1.7 μM). Interestingly, activity was retained when the phenyl was attached to a piperazine rather than being directly fused onto the piperidine ring (<b>10</b>, EC<sub>50</sub> = 0.3 μM), despite the different vector compared to compound <b>2</b>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Modifications at R<sup>2</sup> <a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/medium/jm-2016-00028z_0014.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">clogP was calculated using StarDrop from Optibrium. Sol is solubility in water for the free base.</p></div></div><div></div></div><div class="NLM_p last">Further work was undertaken to remove an aromatic ring, with a key aim being to increase solubility and improve the potential for clinical development. Replacing the phenyl ring found in <b>10</b> with piperidine gave a compound equipotent to the starting point (<b>11</b>, EC<sub>50</sub> = 0.1 μM). This compound had marginally improved aqueous solubility (56 μM, measured as the free base) and retained reasonably low microsomal turnover. Replacing the “terminal” piperidine with a morpholine gave a compound with similar activity (<b>12</b>, EC<sub>50</sub> = 0.3 μM) but with a significantly increased solubility (>100 μM), reduced clogP, and low microsomal turnover. It was also possible to add a flexible linker between the piperidine and the morpholine (<b>13</b>) with only a minimal effect on potency (EC<sub>50</sub> = 0.3 μM) and retaining low microsomal turnover but with a similar solubility (44 μM). It was possible to replace the piperidine of <b>13</b> with an alkyl linker to give <b>14</b>. This compound had the same activity as <b>13</b> (EC<sub>50</sub> = 0.3 μM), but despite a lower clogP, showed a significantly higher microsomal turnover. Finally, a bicyclic aliphatic system, <b>15</b>, also showed similar activity (EC<sub>50</sub> = 0.3 μM) and good solubility (>100 μM) but increased microsomal turnover. In summary, it is possible to reduce the number of aromatic rings and increase the proportion of sp<sup>3</sup> carbon atoms which improves solubility and clogP without compromising potency and microsomal turnover.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Optimization of R<sup>3</sup></h3><div class="NLM_p">Replacement of the planar aromatic 3-pyridyl unit at the R<sup>3</sup> position with aliphatic substituents was investigated to both reduce the aromatic ring count and increase the sp<sup>3</sup> nature.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Small aliphatic groups such as the cyclopropyl group of <b>16</b> were not tolerated and resulted in around a 30-fold drop in potency (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Furthermore, replacement of the 3-pyridyl by the flexible aminoalkylmorpholine (<b>17</b>) or aminoalkylamide (<b>18</b>) resulted in >90-fold drop in potency. In addition, the morpholine moiety <b>19</b> was completely inactive. Further examples are given in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00028/suppl_file/jm6b00028_si_001.pdf" class="ext-link">Supporting Information</a>. In summary, attempts to replace R<sup>3</sup> with an aliphatic group or heteroaromatics such as the oxazole (<b>20</b>) were unsuccessful. Attempts to replace the pyridyl nitrogen atom with groups such as 3-fluorophenyl (<b>21</b>) or 4-fluorophenyl (<b>22</b>) lost around 10-fold activity and led to an increase in clogP. Furthermore, the addition of another nitrogen atom into the pyridyl unit to afford the pyrimidine <b>23</b> was less well tolerated (10-fold loss in potency). In summary, despite extensive investigation, we were unable to find a suitable replacement for the 3-pyridyl moiety at R<sup>3</sup>, and further changes were focused on different substitutions on the 3-pyridyl ring to improve activity and physicochemical properties (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Modifications at R<sup>3</sup></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/medium/jm-2016-00028z_0015.gif" alt="" id="fx4" /></img><div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Modifications at R<sup>3</sup></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/medium/jm-2016-00028z_0016.gif" alt="" id="fx5" /></img><div></div></div><div class="NLM_p">A variety of modifications were made at different positions around the 3-pyridyl ring. Small electron withdrawing and electron donating substituents <i>meta</i> to pyridyl nitrogen were tolerated (methoxy, <b>24</b>; nitrile, <b>25</b>; fluoro, <b>26</b>). However, the aminomethyl analogue <b>27</b> had a 10-fold loss in activity, and the morpholine amide <b>28</b> was essentially inactive.</div><div class="NLM_p last">Small functional groups <i>ortho</i> to the pyridine nitrogen such as amino (<b>29</b>) or methoxy (<b>30</b>) were tolerated, with only a 3- to 6-fold loss in activity compared to <b>12</b>. However, larger groups at this position on the 3-pyridyl moiety, such as the methylamide (<b>31</b>) or morpholine (<b>32</b>), reduced activity by >10-fold. Furthermore, moving the methoxy from the <i>meta</i>-position of the pyridine (<b>24</b>) to the <i>para</i>-position (<b>33</b>) caused a 20-fold reduction in potency compared to <b>12</b>. In summary, there appear to be limited opportunities for synthetic modification to enhance activity at the R<sup>3</sup> position, based on the pyridyl moiety.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> In Vivo Efficacy</h3><div class="NLM_p">Compounds <b>12</b> and <b>13</b> were selected for in vivo pharmacokinetic (PK) and efficacy studies, based on their overall profile of properties. Both compounds displayed suitable predicted physicochemical properties consistent with that of an oral drug. In addition, <b>12</b> and <b>13</b> demonstrated submicromolar potency in vitro and good aqueous solubility, were reasonably stable when incubated with mouse liver microsomes, and displayed low plasma protein binding. Unfortunately, <b>13</b> displayed some binding to the hERG ion channel (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. In Vitro and in Vivo Profile of Key Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/medium/jm-2016-00028z_0017.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>Table a</sup><p class="last"><i>Pf</i>(K1) is a chloroquine and pyrimethamine resistant strain of <i>P. falciparum.</i></p></div><div class="footnote" id="t6fn2"><sup>Table b</sup><p class="last">Pharmacokinetic and efficacy studies were carried out using compound <b>12</b> as the HCl salt and compound <b>13</b> as the fumarate salt.</p></div></div><div></div></div><div class="NLM_p">In vivo PK studies with <b>12</b> showed rapid absorption after oral administration (10 mg/kg) but with limited exposure and a short half-life, whereas <b>13</b> displayed an improved half-life with a 7-fold increase in AUC. Subsequently, in vivo efficacy experiments were carried out and mice were subjected to oral dosing of compounds <b>12</b> and <b>13</b> up to 30 mg/kg once a day for 4 consecutive days using the <i>P. berghei</i> rodent model of infection (Peters’ test, <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). Compound <b>13</b> displayed superior efficacy compared with <b>12</b> with a 96% reduction in parasitemia (compared to 72% for <b>12</b>), when dosed at 30 mg/kg, q.d., po. The early lead criteria, stipulated by MMV, required compounds to display both suppression of parasitemia and an ED<sub>50</sub> < 50 mg/kg under this protocol.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> However, we were unable to obtain complete cures in the rodent model for either compound <b>12</b> or <b>13</b>. For efficacy experiments with compound <b>12</b>, all mice were euthanized by day 14. For compound <b>13</b>, all mice were euthanized by day 11.</div><div class="NLM_p">Compound <b>13</b> was also evaluated in vivo against <i>P. falciparum</i> parasites grown in the peripheral blood of NODscidIL2Rγ<sup>null</sup> mice (SCID), engrafted with human erythrocytes.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Three days after infection, mice were dosed orally once a day with <b>13</b> for 4 days at concentrations up to 100 mg/kg (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>a). The ED<sub>90</sub> measured at day 7 = 11.7 mg/kg, and its equivalent estimated daily exposure in blood AUC<sub>ED90</sub> = 1.4 μg·h/mL. In vivo there was a rapid reduction of parasitemia at doses of ≥20 mg/kg or >7.96 μg·h mL<sup>–1</sup> day<sup>–1</sup> in blood. With doses of ≥30 mg/kg, the parasites levels were reduced below detection limits within 2 days. The rate of parasite clearance in vivo was at least as fast as the artemisinins,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and only pyknotic parasites are observed in peripheral blood of mice 48 h after treatment at 100 mg/kg (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>c). Interestingly, the in vitro parasite reduction ratio (PRR) assay<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> identified <b>13</b> as a compound with a moderate rate of killing, displaying 99.9% clearance of parasites in 52 h, when tested at 10 × EC<sub>50</sub> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>b). It is possible that the PRR assay would show a faster killing rate at higher concentrations of compound, more in-line with what is seen in vivo.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/medium/jm-2016-00028z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/large/jm-2016-00028z_0003.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) In vivo efficacy data for compound <b>13</b> in <i>P. falciparum</i> infected SCID mice. (b) Levels of compound <b>13</b> in blood of the mice of the efficacy experiment during 23 h after the first oral dose. The symbols represent the same individuals depicted in plot a. (c) In vitro PRR data for compound <b>13</b> when parasites were treated at 10 × EC<sub>50</sub>. Comparator data for other standard drugs are included for reference (data previously reported<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a>). Compound <b>13</b> showed a similar rate of kill to pyrimethamine. (d) Comparison of morphology of parasitized human RBC in vehicle and compound <b>13</b> treated mice. Erythrocytes with only remnants of parasites showing nuclear condensation were seen following 2-day treatment with compound <b>13</b>. Compound dosed as the fumarate salt.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/large/jm-2016-00028z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00028&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To assess the mode of action, given that the compound contained a potential heme binding moiety in the 4-pyridyl, the ability of compound <b>13</b> to block hemozoin (β-hematin) formation was also tested. It displayed relatively comparable activity to chloroquine in this assay (27 μM for <b>13</b> vs 6.6 μM for chloroquine). It was not known if the primary mode of action is through the same mechanism of action as chloroquine. However, when assayed against the chloroquine/pyrimethamine resistant (K1) lines, compound <b>13</b> displayed similar activity to sensitive cell lines, so it has a different profile to chloroquine.</div></div><div id="sec7" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Reducing Affinity for Human CYP Isoforms</h3><div class="NLM_p">Although the antimalarial properties of the compound series had been demonstrated in mouse models of malaria, further development of the series required compounds that had markedly reduced inhibition of the major CYP enzymes. Subsequent elaboration of <b>13</b> focused on reducing inhibition of human CYP isoforms 3A4 and 2D6. Previous work had not been successful in distinguishing the antimalarial activity and the inhibition of human CYP isoforms (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), thought to be due to the 4-pyridyl group at the R<sup>1</sup> position. Therefore, two approaches were investigated to reduce CYP inhibition. One approach involved replacement of the 4-pyridyl unit with functional groups that could have similar steric and H-bond acceptor properties (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>). In parallel, the possibility of modifying the 4-pyridyl unit with the addition of functional groups adjacent to the pyridine nitrogen was also investigated, which could potentially reduce binding to human CYP isoforms while retaining suitable affinity for the unknown target of interest (<a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>). The R<sup>2</sup> and R<sup>3</sup> positions were fixed with piperidine-morpholine and 3-pyridyl, respectively, to use as a reference point for changes in activity and with the view that if it were possible to optimize R<sup>1</sup>, this should also work with other R<sup>2</sup> and R<sup>3</sup> substituents (e.g., as found in <b>13</b>). The key molecules prepared are summarized in the main text. Additional molecules prepared are presented in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00028/suppl_file/jm6b00028_si_001.pdf" class="ext-link">Supporting Information</a>.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Modifications at R<sup>1</sup></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/medium/jm-2016-00028z_0018.gif" alt="" id="fx7" /></img><div></div></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Modifications at R<sup>1</sup></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/medium/jm-2016-00028z_0019.gif" alt="" id="fx8" /></img><div></div></div></div><div id="sec8" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Optimization of R<sup>1</sup></h3><div class="NLM_p">The initial focus was on placing a hydrogen bond acceptor (HBA) at the 4-position of the phenyl ring to replace the 4-pyridyl moiety at the R<sup>1</sup> position (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>). Several nitrile derivatives were prepared. The 4-cyanophenyl (<b>34</b>) gave a 7-fold reduction in potency (EC<sub>50</sub> = 2.1 μM) from <b>12</b> (EC<sub>50</sub> = 0.3 μM). This would place the HBA further from the pyrimidine than the pyridine nitrogen in <b>12</b>. Therefore, it was decided to attach the nitrile directly onto the pyrimidine ring (<b>35</b>), which gave a similar level of potency (EC<sub>50</sub> = 5.3 μM) to the 4-cyanophenyl analogue. Other HBAs such as sulfones (<b>36</b>) gave significantly reduced activity (EC<sub>50</sub> = 49 μM). Direct attachment of a hydroxyl to the pyrimidine ring (<b>37</b>) also failed to increase activity (EC<sub>50</sub> = 24 μM), although this may be in a different tautomeric form. Amide <b>38</b> was also inactive (EC<sub>50</sub> = 50 μM). Finally, basic groups were investigated to determine if there was an interaction with an acidic group on the protein. None of these were active (e.g., <b>39</b>, EC<sub>50</sub> = 30 μM).</div><div class="NLM_p last">The original 4-pyridyl moiety at R<sup>1</sup> was then revisited with a focus on reducing binding to the human CYP450 isoforms with close analogues incorporating blocking groups adjacent to the pyridine nitrogen, to reduce the interaction with the heme iron (<a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>). Addition of two methyl groups in the 3- and 5-positions significantly reduced CYP inhibition across all five CYPs investigated (<b>40</b>), which confirmed involvement of the parent 4-pyridyl moiety. However, there was a 5-fold drop in activity (EC<sub>50</sub> = 1.5 μM). Interestingly having just one methyl group in the 3-position (<b>41</b>, EC<sub>50</sub> = 17 μM) led to a further 10-fold drop in potency compared to disubstitution. Other groups in the 3-position which would alter the electronics of the pyridine nitrogen were also inactive (e.g., the CF<sub>3</sub> group <b>42</b>, EC<sub>50</sub> = 50 μM). The effects of both electron-donating and electron-withdrawing substituents (<b>43</b> and <b>44</b>) were also investigated, where both gave a 5- to 10-fold reduction in potency compared to the substituted pyridine <b>12</b>. Changing the heterocycle to a pyrimidine, pyridone, or pyrazole (<b>45</b>–<b>47</b>) also led to a reduction in activity. Therefore, despite a variety of variations on the R<sup>1</sup> position, all modifications investigated led to a marked decrease in potency.</div></div></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Concluding Remarks and Future Work</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02060" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02060" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds <b>12</b> and <b>13</b> both display suitable physicochemical properties for an oral drug lead, good cellular activity in vitro against <i>P. falciparum</i> parasites, and good selectivity in a mammalian counterscreen. Compound <b>13</b> also demonstrated excellent oral efficacy in vivo with a 96% reduction in levels of parasitemia (<i>P. berghei</i>, 4 × 30 mg/kg, q.d., po) and a fast kill rate in the <i>P. falciparum</i> SCID mouse model. Compound <b>13</b> was also further profiled in the liver-stage schizont assay (EC<sub>50</sub> > 10 μM),<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and in a stage IV/V gametocyte assay (EC<sub>50</sub> = 2.4 μM).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Initial infection with malaria occurs when <i>Plasmodium</i> sporozites injected by the mosquito invade the liver cells. The parasites then undergo a liver-stage life cycle that involves formation of liver schizonts. Compounds that can prevent liver schizont formation may have potential for chemoprevention. The data for compound <b>13</b> suggest that this is not likely to have chemopreventative activity. Blood-stage infection gives rise to the clinical symptoms of malaria. Some of the parasites involved in blood-stage infection differentiate into gametocytes, which are the form of the parasite that can infect a mosquito, completing the life cycle. Compounds that kill the gametocytes may be able to block transmission of the parasite to mosquitos. The data for compound <b>13</b> suggest that these compounds may have transmission blocking activity. Additional studies would be required to assess this in detail.</div><div class="NLM_p last">Unfortunately, further development is hampered by the potent inhibition of major CYP enzymes, where involvement of the 4-pyridyl group has been demonstrated. Focus has now moved toward the identification of the biological target of <b>13</b> to see if this information can be used to scaffold-hop to compounds that do not inhibit human cytochrome P450s. Given the rapid development of parasite drug resistance to known antimalarials, the identification of an essential and druggable target associated with the rapid clearance of <i>P. falciparum</i> parasites would be significant.</div></div><div id="sec10" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03320" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03320" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Synthesis of 4-pyridylpyrimidines via a modified literature procedure<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> was initially undertaken by condensation of 4-pyridylamidine with dimethyl malonate using sodium methoxide as a base and refluxing in methanol for up to 3 days to afford 2-(pyridin-4-yl)pyrimidine-4,6-diol <b>48</b> in 55% yield. However, by employing experiment design software Modde and transferring the process to a microwave reactor, we were able to rapidly optimize the reaction conditions, improving the reaction yield to 70% and shortening the reaction time from 3 days to 1 h (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Chlorination of diol <b>48</b> with phosphorus trichloride at 90 °C gave rise to 4,6-dichloro-2-(pyridin-4-yl)pyrimidine <b>49</b> with 58% yield. Nucleophilic displacement of one chlorine atom by an amine followed by a Suzuki cross-coupling reaction with a boronic acid or ester afforded pyrimidines <b>51</b>, allowing us to investigate substituents at the R<sup>2</sup> and R<sup>3</sup> positions.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/medium/jm-2016-00028z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/large/jm-2016-00028z_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/large/jm-2016-00028z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00028&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) Dimethyl malonate (DMM), NaOMe, MeOH, reflux, 3 days, 55%; or DMM, NaOMe, <i>N</i>-methylpyrrolidinone, microwave, 1 h, 150 °C, 70%; (ii) POCl<sub>3</sub>, 90°C, 58%; (iii) amine, DIPEA, THF, rt ; (iv) boronic ester/acid, K<sub>3</sub>PO<sub>4</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DMF/water, microwave, 120 °C, 20 min.</p></p></figure><div class="NLM_p">The synthetic route outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> is not amenable to explore the influence of changes at the R<sup>1</sup> position on antimalarial activity. Therefore, a number of synthetic routes that allowed the introduction of a diverse array of substituents at C-2 position on the pyrimidine ring were explored. First, starting from commercially available 2,4,6-trichloropyrimidine <b>52</b>, nucleophilic displacement with the corresponding amine (1 equiv) at −5 °C in ethanol gave rise to <b>53</b>, with substitution at the 4-position as the major product, together with substitution at the 2-position as the minor product (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/medium/jm-2016-00028z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/large/jm-2016-00028z_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/large/jm-2016-00028z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00028&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) Amine, Et<sub>3</sub>N, ethanol, −5 °C, 4 h; (ii) boronic acid/ester, 2 M aq Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane/water, microwave at 120 °C, 20 min; (iii) amine, Et<sub>3</sub>N, acetonitrile, 40–70°C; (iv) 3-pyridyl boronic acid, K<sub>3</sub>PO<sub>4</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>,DMF/water 3/1, microwave at 120 °C, 20 min.</p></p></figure><div class="NLM_p">The two reaction products could be easily separated by column chromatography. Suzuki cross-coupling reaction at the 2-position allowed the introduction of aromatic R<sup>1</sup> substituents using commercially available boronic esters or acids. Alternatively, amino derivatives at C-2 were prepared by heating <b>53</b> in acetonitrile in the presence of the corresponding amine. Finally, the desired trisubstituted pyrimidines <b>55</b> were obtained by Suzuki cross-coupling with 3-pyridylboronic acid. An alternative route allowing the introduction of the R<sup>1</sup> substituent at C-2 as the last step is shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Starting from commercially available 4,6-dichloro-2-methylsulfanylpyrimidine <b>56</b>, reaction with 4-(4-piperidyl)morpholine in acetonitrile at room temperature gave rise to <b>57</b> in 56% yield. As above, a Suzuki cross-coupling with 3-pyridylboronic acid led to <b>58</b> in excellent yield. Finally, the introduction of the R<sup>1</sup> substituent was carried out following the palladium-catalyzed, copper(I) thiophene-2-carboxylate (CuTC) mediated coupling of boronic acids with heteroaromatic thioethers to yield compounds of type <b>55</b>, reported by Liebeskind and Srogl.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> However, this reaction is limited to boronic acids and the more commercially accessible boronic esters led to low yields or failed.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/medium/jm-2016-00028z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/large/jm-2016-00028z_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/large/jm-2016-00028z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00028&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) Amine, Et<sub>3</sub>N, ethanol, rt, 16 h, 56%; (ii) 3-pyridylboronic acid, K<sub>3</sub>PO<sub>4</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane/water 3/1, microwave at 130 °C, 20 min, 96%; (iii) boronic acid, thiophene-2-carbonyloxycopper, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane or THF, microwave at 130 °C, 1 h or 85 °C, 18 h.</p></p></figure><div class="NLM_p">To expand the diversity of substituents at R<sup>1</sup> allowing a comprehensive SAR study, we developed the synthetic route outlined in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Iodination of commercially available 2-aminopyrimidine <b>59</b> was performed in good yield using <i>tert</i>-butyl nitrate and diiodomethane as previously described.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Subsequent selective displacement of one of the chlorine atoms on intermediate <b>60</b> with amines such as 4-(4-piperidyl)morpholine was carried out to afford substituted pyrimidines as exemplified by <b>61</b>. Intermediate <b>61</b> proved to be a very versatile synthon, allowing the introduction of a diverse array of R<sup>1</sup> groups by a variety of synthetic methods. Pyrimidines bearing alkyl substituents were prepared by Sonogashira cross-coupling with a terminal alkyne followed by reduction of the resulting alkene. Aromatic and heteroaromatic substituents were introduced at C-2 by coupling with boronic acids or esters with good selectivity, and nucleophilic displacements of iodine with amines and copper cyanide were also selective. The final step to obtain trisubstituted pyrimidine <b>55</b> from intermediate <b>62</b> was by Suzuki cross-coupling with 3-pyridylboronic acid.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/medium/jm-2016-00028z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/large/jm-2016-00028z_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/large/jm-2016-00028z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00028&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) CH<sub>2</sub>I<sub>2</sub>, <i>t</i>-BuONO, acetonitrile, 80 °C, 3 h 30 min, 64%; (ii) amine, Et<sub>3</sub>N, ethanol, 0 °C, 3 h; (iii) acetylene, CuI, Et<sub>3</sub>N, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, acetonitrile, rt, 18 h; (iv) amine, DIPEA, NMP, microwave at 200 °C, 15 min; (v) boronic acid/ester, 2 M aq Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, DME, microwave at 200 °C, 20 min; (vi) 3-pyridylboronic acid, K<sub>3</sub>PO<sub>4</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DMF, microwave at 120 °C, 20 min.</p></p></figure></div><div id="sec11" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41711" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41711" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec11_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General</h3><div class="NLM_p last">Reactions using microwave irradiation were carried out in a Biotage Initiator microwave. Normal phase TLC was carried out on precoated silica plates (Kieselgel 60 F<sub>254</sub>, BDH) with visualization via UV light (UV 254/365 nm) and/or ninhydrin solution. Flash chromatography was performed using Combiflash Companion Rf (Teledyne ISCO) and prepacked silica gel columns purchased from Grace Davison Discovery Science or SiliCycle. Mass-directed preparative HPLC separations were performed using a Waters HPLC (2545 binary gradient pumps, 515 HPLC make-up pump, 2767 sample manager) connected to a Waters 2998 photodiode array and a Waters 3100 mass detector. Preparative HPLC separations were performed with a Gilson HPLC (321 pumps, 819 injection module, 215 liquid handler/injector) connected to a Gilson 155 UV/vis detector. On both intruments, HPLC chromatographic separations were conducted using Waters XBridge C18 columns, 19 mm × 100 mm, 5 μm particle size, using 0.1% ammonia in water (solvent A) and acetonitrile (solvent B) as mobile phase. <sup>1</sup>H NMR and <sup>19</sup>F NMR spectra were recorded on a Bruker Avance DPX 500 spectrometer (<sup>1</sup>H at 500.1 MHz, <sup>13</sup>C at 125 MHz, <sup>19</sup>F at 470.5 MHz) or a Bruker Avance DPX 300 (<sup>1</sup>H at 300 MHz). Chemical shifts (δ) are expressed in ppm recorded using the residual solvent as the internal reference in all cases. Signal splitting patterns are described as singlet (s), doublet (d), triplet (t), quartet (q), multiplet (m), broad (br), or a combination thereof. Coupling constants (<i>J</i>) are quoted to the nearest 0.5 Hz. Low resolution electrospray (ES) mass spectra were recorded on a Bruker MicroTof mass spectrometer, run in positive mode. High resolution mass spectrometry (HRMS) was performed using a Bruker MicroTof mass spectrometer. LCMS analysis and chromatographic separation were conducted with a Bruker MicrOTOf mass spectrometer or an Agilent Technologies 1200 series HPLC connected to an Agilent Technologies 6130 quadrupole LC/MS, where both instruments were connected to an Agilent diode array detector. The column used was a Waters XBridge column (50 mm × 2.1 mm, 3.5 μm particle size) and the compounds were eluted with a gradient of 5–95% acetonitrile/water + 0.1% ammonia. All compounds for in vitro and in vivo experiments displayed >95% purity by LCMS. Unless otherwise stated herein reactions have not been optimized. Solvents and reagents were purchased from commercial suppliers and used without further purification. Dry solvents were purchased in Sure/Seal bottles stored over molecular sieves.</div></div><div id="sec11_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Synthetic Routes</h3><div class="NLM_p last">See <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<a class="ref internalNav" href="#sch4" aria-label="4">4</a>.</div></div><div id="sec11_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Preparation of Compounds. 2-(2,6-Di(pyridine-3-yl)pyrimidin-4-yl)-1,2,3,4-tetrahydroisoquinoline (<b>3</b>)</h3><div class="NLM_p">To a solution of 2,4,6-trichloropyrimidine (<b>52</b>) (1 g, 5.45 mmol) in ethanol (12 mL) at 0 °C, a solution of 1,2,3,4-tetrahydroisoquinoline (0.68 mL, 5.45 mmol) in ethanol (5 mL) was added dropwise followed by triethylamine (1.14 mL, 8.19 mmol). Reaction mixture was stirred at 0 °C for 1.5 h. Solvents were removed under vacuum, and the reaction crude was partitioned between DCM (150 mL) and a saturated aqueous solution of NaHCO<sub>3</sub> (2 × 100 mL). The organic phase was dried over MgSO<sub>4</sub>, filtered, and solvents were removed under reduced pressure. The product was purified by column chromatography (25 g silica cartridge) using (A) hexane and (B) ethyl acetate as eluents and the following gradient: 3 min hold to 100% A, 10 min ramp to 40% B, 1 min hold to 40% B. Fractions containing pure product were pooled together and solvents were removed to obtain 2-(2,6-dichloropyrimidin-4-yl)-1,2,3,4-tetrahydroisoquinoline as a yellow solid (0.98 g, 64% yield). Purity by LCMS (UV chromatogram, 190–450 nm) 98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.29–7.22 (m, 4H), 6.49 (s, 1H), 4.76 (broad peak, 2H), 3.81 (broad peak, 4H), 3.01–2.99 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 281 [M + H]<sup>+</sup>.</div><div class="NLM_p last">To a stirred solution of 2-(2,6-dichloropyrimidin-4-yl)-1,2,3,4-tetrahydroisoquinoline (0.15 g, 0.54 mmol) and 3-pyridylboronic acid (0.15 g, 1.18 mmol) in 1,4-dioxane (4.5 mL), a solution of potassium phosphate (0.34 g, 1.61 mmol) in water (1.5 mL) was added. The reaction mixture was degassed by bubbling argon through for 5 min, and then Pd(PPh<sub>3</sub>)<sub>4</sub> (0.018 g, 0.02 mmol) was added. The reaction was heated at 120 °C under microwave irradiation for 30 min. The reaction crude was partitioned between DCM (2 × 50 mL) and saturated aqueous solution of NaHCO<sub>3</sub> (10 mL). The organics phase was dried over MgSO<sub>4</sub> before concentration to dryness. The product was purified by column chromatography (12 g silica cartridge) using (A) DCM and (B) 10% MeoH in DCM as eluents and the following gradient: 3 min hold to 100% A, 15 min ramp to 100% B, 3 min hold to 100% B. The fractions containing product were pooled together and solvents were removed to obtain <b>3</b> as an off-white solid (100 mg, 51% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.75 (dd, 1H, <i>J</i> = 0.8, 2.1 Hz), 9.31 (dd, 1H, <i>J</i> = 0.7, 2.2 Hz), 8.82–8.79 (m, 1H), 8.72–8.70 (m, 2H), 8.49–8.47 (m, 1H), 7.47–7.41 (m, 2H), 7.29–7.24 (m, 4H), 6.92 (s, 1H), 4.95 (broad m, 2H), 4.07 (broad m, 4H), 3.07–3.04 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 366 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 4-(4-(3,4-Dihydroisoquinolin-2(1<i>H</i>)-yl)-6-(pyridine-3-yl)pyrimidin-2-yl)morpholine (<b>5</b>)</h3><div class="NLM_p">To a solution of 2,4,6-trichloropyrimidine (<b>52</b>) (0.63 mL, 5.5 mmol) in ethanol (12 mL) at 0 °C, a solution of 1,2,3,4-tetrahydroisoquinoline (0.68 mL, 5.45 mmol) in ethanol (5 mL) was added dropwise followed by triethylamine (1.14 mL, 8.19 mmol). The white suspension was stirred at 0 °C for 3 h and then was allowed to reach room temperature. Morpholine (0.48 mL, 5.5 mmol) and acetonitrile (20 mL) were added to the reaction mixture. The clear suspension was stirred at 40 °C overnight. Solvents were removed under vacuum, and the reaction crude was partitioned between DCM (100 mL) and water (25 mL). The organic phase was washed with a saturated aqueous solution of NaHCO<sub>3</sub> (25 mL), dried over MgSO<sub>4</sub>, filtered, and solvents were removed under reduced pressure. The product was purified by column chromatography (24 g silica cartridge) using (A) hexane amd (B) ethyl acetate as eluents and the following gradient: 3 min hold to 100% A, 18 min ramp to 30% B, 2 min hold to 30% B. Fractions containing product were pooled together and solvents were removed to obtain 4-(4-chloro-6-(3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)pyrimidin-2-yl)morpholine as a white wax (1.25 g, 69% yield, 88% purity by LCMS) that was used for the next step without further purification.</div><div class="NLM_p last">To a stirred solution of 4-(4-chloro-6-(3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)pyrimidin-2-yl)morpholine (0.15 g, 0.45 mmol) and 3-pyridylboronic acid (0.17 g, 1.4 mmol) in DMF (6 mL), a solution of potassium phosphate (0.30 g, 1.4 mmol) in water (2 mL) was added. The reaction mixture was degassed by bubbling argon through for 5 min, and then Pd(PPh<sub>3</sub>)<sub>4</sub> (0.016 g, 0.01 mmol) was added. The reaction was heated at 120 °C under microwave irradiation for 30 min. The reaction crude was filtered through Celite and partitioned between DCM (2 × 50 mL) and saturated aqueous solution of NaHCO<sub>3</sub> (10 mL). The organics phase was dried over MgSO<sub>4</sub> before concentration to dryness. The product was purified by column chromatography (12 g silica cartridge) using (A) hexane and (B) ethyl acetate as eluents and the following gradient: 3 min hold to 100% A, 15 min ramp to 80% B, 2 min ramp to 100% B, 3 min hold to 100% B. The fractions containing product, first eluting peak, were pooled together and solvents were removed to obtain <b>5</b> as yellow solid (34 mg, 20% yield). Purity by LCMS (UV chromatogram, 190–450 nm) 95%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.19 (bs, 1H), 8.66–8.65 (m, 1H), 8.312–8.29 (m, 1H), 7.38–7.36 (m, 1H), 7.23–7.18 (m, 4H), 6.38 (s, 1H), 4.79 (broad peak, 2H), 3.93–3.87 (m, 6H), 3.81–3.79 (m, 4H), 2.97 (t, 2H, <i>J</i> = 5.9 Hz); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 374 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 6-(Pyridyl-3yl)-2-(pyridin-4-yl)pyrimidin-4-amine (<b>6</b>)</h3><div class="NLM_p">In a sealed tube a solution of 4,6-dichloro-2-(pyridin-4-yl)pyrimidine (<b>49</b>) (0.13 g, 0.58 mmol) and ammonium hydroxide (2 mL) in methanol (2 mL) was heated at 80 °C for 5h. Solvents were removed under reduced pressure, and the residue was partitioned between water (10 mL) and DCM (2 × 25 mL). The organic phases were combined, dried over magnesium sulfate, and solvents were removed under reduced pressure. The product was purified by column chromatography (12 g silica cartridge) using (A) DCM and (B) 20% MeOH in DCM as eluents and the following gradient: 2 min hold at 100% A, 18 min ramp to 100% B, 3 min hold at 100% B. The fractions containing product were pooled together and solvents were removed to obtain 6-chloro-2-(pyridin-4-yl)pyrimidin-4-amine as white solid (69 mg, 39% yield, 99% purity by LCMS). Product was used in the next step without further purification. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.74–8.72 (m, 2H), 8.10–8.08 (m, 2H), 7.50 (bs, 2H), 6.51 (m, 1H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 207 [M + H]<sup>+</sup>.</div><div class="NLM_p last">To a stirred solution of 6-chloro-2-(pyridin-4-yl)pyrimidin-4-amine (69 mg, 0.33 mmol) and 3-pyridylboronic acid (91 mg, 0.66 mmol) in DMF (3 mL), a solution of potassium phosphate (140 mg, 0.66 mmol) in water (1 mL) was added. The reaction mixture was degassed by bubbling argon through for 5 min, and then Pd(PPh<sub>3</sub>)<sub>4</sub> (20 mg, 0.017 mmol) was added. The reaction was heated at 120 °C under microwave irradiation for 30 min. Reaction crude was filtered through Celite, quenched with water (10 mL), and extracted with DCM (2 × 25 mL). The organic phases were combined, dried over magnesium sulfate, and solvents were removed under reduced pressure. The product was purified by column chromatography (4 g silica cartridge) using (A) DCM and (B) 20% MeOH in DCM as eluents and the following gradient: 3 min hold at 100% A, 18 min ramp to 50% B, 3 min hold at 50% B. The fractions containing product were pooled together and solvents were removed to obtain <b>6</b> as off-white solid (24 mg, 29% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >98%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.76–8.72 (m, 3H), 8.50–8.47 (m, 1H), 8.31–8.29(m, 2H), 7.59 (dd, 2H, <i>J</i> = 4.8, 7.4 Hz), 7.29 (m, 1H), 7.02 (m, 1H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 250 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>N</i>-Benzyl-<i>N</i>-methyl-6-(pyridine-3-yl)-2-(pyridin-4-yl)pyrimidin-4-amine (<b>7</b>)</h3><div class="NLM_p last"><b>7</b> was prepared in an analogous four-step procedure as that of compound <b>12</b>: To a stirred solution of <i>N</i>-benzyl-6-chloro-<i>N</i>-methyl-2-(pyridin-4-yl)pyrimidin-4-amine (0.18 g, 0.58 mmol) and 3-pyridylboronic acid (0.21 g, 1.74 mmol) in DMF (3 mL), a solution of potassium phosphate (0.36 g, 1.74 mmol) in water (1 mL) was added. The reaction mixture was degassed by bubbling argon through for 5 min, and then Pd(PPh<sub>3</sub>)<sub>4</sub> (0.02 g, 0.014 mmol) was added. The reaction was heated at 120 °C under microwave irradiation for 30 min. Reaction crude was filtered through Celite, quenched with water (10 mL), and extracted with DCM (2 × 25 mL). The organic phases were combined, dried over magnesium sulfate, and solvents were removed under reduced pressure. The product was purified by column chromatography (12 g silica cartridge) using (A) DCM and (B) 20% MeOH in DCM as eluents and the following gradient: 3 min hold at 100% A, 18 min ramp to 50% B, 3 min hold at 50% B. The fractions containing product were pooled together and solvents were removed to obtain <b>7</b> as a white solid (115 mg, 56% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.27 (s, 1H), 8.74–8.73 (m, 2H), 8.70–8.69 (m, 1H), 8.42–8.41 (m, 1H), 8.37–8.35 (m, 2H), 7.43–7.28 (m, 6H), 6.82 (s, 1H), 4.99 (bs, 2H), 3.20 (bs, 3H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 354 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 2-(6-(Pyridin-4-yl)-2-(pyridine-4-yl)pyrimidin-4-yl)isoindoline (<b>8</b>)</h3><div class="NLM_p last"><b>8</b> was prepared in an analogous four-step procedure as that of compound <b>12</b>: To a stirred solution of 2-(6-chloro-2-(pyridin-4-yl)pyrimidin-4-yl)isoindoline (0.21 g, 0.68 mmol) and 3-pyridylboronic acid (2.50 g, 2.04 mmol) in DMF (3 mL), a solution of potassium phosphate (0.63 g, 2.04 mmol) in water (1 mL) was added. The reaction mixture was degassed by bubbling argon through for 5 min, and then Pd(PPh<sub>3</sub>)<sub>4</sub> (0.03 g, 0.02 mmol) was added. The reaction was heated at 120 °C under microwave irradiation for 30 min. Reaction crude was filtered through Celite, quenched with water (10 mL), and extracted with DCM (2 × 25 mL). The organic phases were combined, dried over magnesium sulfate, and solvents were removed under reduced pressure. The product was purified by column chromatography (12 g silica cartridge) using (A) DCM and (B) 20% MeOH in DCM as eluents and the following gradient: 3 min hold at 100% A, 15 min ramp to 100% B, 3 min hold at 100% B. The fractions containing product were pooled together and solvents were removed to obtain <b>8</b> as off-white solid (90 mg, 38% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.35 (d, 1H, <i>J</i> = 1.7 Hz), 8.78–8.73 (m, 2H), 8.74 (dd, 1H, <i>J</i> = 1.5, 4.8 Hz), 8.53–8.50 (m, 1H), 8.44–8.43 (m, 2H), 7.47 (ddd, 1H, <i>J</i> = 0.7, 4.8, 8.0 Hz), 7.43–7.38 (m, 4H), 6.83 (s, 1H), 5.16 (s, 2H), 4.90 (s, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 352 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 7-(6-(Pyridine-4-yl)-2-(pyridine-4-yl)pyrimidin-4-yl)-5,6,7,8-tetrahydroimidazo[1,2-<i>a</i>]pyrazine (<b>9</b>)</h3><div class="NLM_p last"><b>9</b> was prepared in an analogous four-step procedure as that of compound <b>12</b>: To a stirred solution of 7-(6-chloro-2-(pyridine-4-yl)pyrimidin-4-yl)-5,6,7,8-tetrahydroimidazo[1,2-<i>a</i>]pyrazine (0.09 g, 0.29 mmol) and 3-pyridylboronic acid (0.71 g, 0.58 mmol) in DMF (3 mL), a solution of potassium phosphate (0.18 g, 0.86 mmol) in water (1 mL) was added. The reaction mixture was degassed by bubbling argon through for 5 min, and then Pd(PPh<sub>3</sub>)<sub>4</sub> (0.01 g, 0.008 mmol) was added. The reaction was heated at 120 °C under microwave irradiation for 30 min. Reaction crude was filtered through Celite, quenched with water (10 mL), and extracted with DCM (2 × 25 mL). The organic phases were combined, dried over magnesium sulfate, and solvents were removed under reduced pressure. The product was purified by column chromatography (12 g silica cartridge) using (A) DCM and (B) 20% MeOH in DCM as eluents and the following gradient: 3 min hold at 100% A, 15 min ramp to 100% B, 3 min hold at 100% B. The fractions containing product were pooled together and solvents were removed to obtain <b>9</b> as an off-white solid (79 mg, 77% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.30 (d, 1H, <i>J</i> = 1.7 Hz), 8.75–8.74 (m, 2H), 8.72 (dd, 1H, <i>J</i> = 1.6, 4.8 Hz), 8.43–8.40 (m, 1H), 8.33–8.32 (m, 2H), 7.44 (ddd, 1H, <i>J</i> = 0.7, 4.8, 8.0 Hz), 7.09 (s, 1H), 6.98 (s, 1H), 6.92 (s, 1H), 4.97 (s, 2H), 4.93(t, 2H, <i>J</i> = 5.3 Hz), 4.20–4.18 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 356 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 4-(4-Phenylpiperazin-1-yl)-6-(pyridin-3-yl)-2-(pyridin-4-yl)pyrimidine (<b>10</b>)</h3><div class="NLM_p last"><b>10</b> was prepared in an analogous four-step procedure as that of compound <b>12</b>: To a stirred solution of 4-chloro-6-(4-phenylpiperazin-1-yl)-2-(pyridin-4-yl)pyrimidine (0.18 g, 0.53 mmol) and 3-pyridylboronic acid (0.21 g, 1.69 mmol) in DMF (3 mL), a solution of potassium phosphate (0.35 g, 1.69 mmol) in water (1 mL) was added. The reaction mixture was degassed by bubbling argon through for 5 min, and then Pd(PPh<sub>3</sub>)<sub>4</sub> (0.02 g, 0.014 mmol) was added. The reaction was heated at 120 °C under microwave irradiation for 30 min. Reaction crude was filtered through Celite, quenched with water (10 mL), and extracted with DCM (2 × 25 mL). The organic phases were combined, dried over magnesium sulfate, and solvents were removed under reduced pressure. The product was purified by column chromatography (12 g silica cartridge) using (A) DCM and (B) 20% MeOH in DCM as eluents and the following gradient: 3 min hold at 100% A, 18 min ramp to 30% B, 3 min hold at 30% B. The fractions containing product were pooled together and solvents were removed to obtain <b>10</b> as off-white solid (28 mg, 13% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.30 (s, 1H), 8.77–8.74 (m, 3H), 8.47–8.45 (m, 1H), 8.37–8.36 (m, 2H), 7.46 (dd, 1H, <i>J</i> = 4.8, 7.7 Hz), 7.33–7.31 (m, 2H), 7.01–6.92 (s, 4H), 4.02 (broad peak, 4H), 3.37–3.35 (m, 4H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 395 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 1′-(6-(Pyridin-3-yl)-2-(pyridin-4-yl)pyrimidin-4-yl)-1,4′-bipiperidine (<b>11</b>)</h3><div class="NLM_p last"><b>11</b> was prepared in an analogous four-step procedure as that of compound <b>12</b>: To a stirred solution of 1′-(6-chloro-2-(pyridin-4-yl)pyrimidin-4-yl)-1,4′-bipiperidine (0.25 g, 0.71 mmol) and 3-pyridylboronic acid (0.17 g, 1.43 mmol) in DMF (9 mL), a solution of potassium phosphate (0.45 g, 2.14 mmol) in water (3 mL) was added. The reaction mixture was degassed by bubbling argon through for 5 min, and then Pd(PPh<sub>3</sub>)<sub>4</sub> (0.02 g, 0.014 mmol) was added. The reaction was heated at 120 °C under microwave irradiation for 30 min. Reaction crude was filtered through Celite, quenched with water (20 mL), and extracted with DCM (2 × 50 mL). The organic phases were combined, dried over magnesium sulfate, and solvents were removed under reduced pressure. The product was purified by column chromatography (12 g silica cartridge) using (A) DCM and (B) 20% MeOH in DCM as eluents and the following gradient: 3 min hold at 100% A, 18 min ramp to 100% B, 3 min hold at 100% B. The fractions containing product were pooled together and solvents were removed to obtain <b>11</b> as an off-white solid (261 mg, 91% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.21 (d, 1H, <i>J</i> = 1.8 Hz), 8.68–8.67 (m, 2H), 8.64 (dd, 1H, <i>J</i> = 1.6, 4.8 Hz), 8.36–8.34 (m, 1H), 8.27–8.26 (m, 2H), 7.36 (dd, 1H, <i>J</i> = 4.9, 7.8 Hz), 6.83 (s, 1H), 4.61 (broad peak, 2H), 3.95–3.90 (m, 2H), 2.59–2.49 (m, 5H), 1.96–1.93 (m, 2H), 1.57–1.49 (m, 6H), 1.40–1.39(m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 401 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 4-(1-(6-(Pyridin-3-yl)-2-(pyridin-4-yl)pyrimidin-4-yl)piperidin-4-yl)morpholine (<b>12</b>). <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> (Four-Step Procedure). Step 1: 2-(Pyridin-4-yl)pyrimidine-4,6-diol (<b>48</b>)</h3><div class="NLM_p last">A mixture of 4-amidinopyridine hydrochloride (0.5 g, 3.17 mmol) and <i>N</i>-methyl-2-pyrolidone (10 mL) was prepared at rt and dimethylmalonate (0.363 mL, 419 mg, 3.17 mmol) added followed by sodium methoxide (686 mg, 12.69 mmol) and the mixture heated in a microwave at 150 °C for 1 h. The mixture was then concentrated under reduced pressure, diluted with water (10 mL), and acidified to pH 6 with concentrated acetic acid. The resulting precipitate was then filtered and dried in vacuo to afford compound <b>48</b> (420 mg, 2.22 mmol, 70%) as an off-white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.10 (bs, 2H), 8.76–8.75 (m, 2H), 8.02–8.03 (m, 2H), 5.56 (s, 1H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 190 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Step 2: 4,6-Dichloro-2-(pyridin-4-yl)pyrimidine (<b>49</b>)</h3><div class="NLM_p last">A stirred solution of 2-(pyridin-4-yl)pyrimidine-4,6-diol (0.62 g, 3.28 mmol) in phosphorus oxychloride (6 mL) was heated at 90 °C for 3 h. The reaction mixture was slowly added to ice–water, and 2.5 M NaOH was added to adjust to pH 7. The white precipitate was filtered. The filtrate was extracted with ethyl acetate (2 × 50 mL), and the organic phases were combined, dried over magnesium sulfate, and solvents were removed under reduced pressure. Precipitate and extracted product were combined to obtain <b>49</b> as a brown solid (421 mg, 58% yield). Purity by LCMS (UV chromatogram, 190–450 nm) 90%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.81–8.80 (m, 2H), 8.27–8.26 (m, 2H), 7.41 (s, 1H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 225 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Step 3: 4-(1-(6-Chloro-2-(pyridin-4-yl)pyrimidin-4-yl)piperidin-4-yl)morpholine</h3><div class="NLM_p last">To a stirred solution of 4,6-dichloro-2-(pyridin-4-yl)pyrimidine (0.13 g, 0.58 mmol) in anhydrous THF (5 mL), 4-morpholinopiperidine (0.11 g, 0.63 mmol) and diisopropylethylamine (0.20 mL, 1.15 mmol) were added at room temperature, and the reaction mixture was stirred at room temperature overnight. Water (10 mL) was added, and the product was extracted with DCM (2 × 50 mL), the organic phases were combined, dried over magnesium sulfate, and solvents were removed under reduced pressure. The product was purified by column chromatography (12 g silica cartridge) using (A) DCM and (B) 10% MeOH in DCM as eluents and the following gradient: 3 min hold at 100% A, 18 min ramp to 50% B, 3 min hold at 50% B. The fractions containing product were pooled together and solvents were removed to obtain 4-(1-(6-chloro-2-(pyridin-4-yl)pyrimidin-4-yl)piperidin-4-yl)morpholine as white solid (151 mg, 73% yield). Purity by LCMS (UV chromatogram, 190–450 nm) 97%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.74–8.72 (m, 2H), 8.14–8.13 (m, 2H), 7.03 (s, 1H), 4.58 (broad peak, 2H), 3.57–3.55 (m, 4H), 3.06–3.02 (m, 2H), 2.48–2.46 (m, 4H), 1.90–1.87 (m, 2H), 1.39 (dddd, 2H, <i>J</i> = 4.2, 12.5, 12.6, 12.6 Hz); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 360 [M + H]<sup>+</sup>.</div></div><div id="secx" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Step 4</h3><div class="NLM_p last">To a stirred solution of 4-[1-[6-chloro-2-(4-pyridyl)pyrimidin-4-yl]-4-piperidyl]morpholine (<b>3x</b>) (0.141 g, 0.39 mmol) and 3-pyridylboronic acid (0.098 g, 0.78 mmol) in DMF (3 mL), a solution of potassium phosphate (0.249 g, 1.17 mmol) in water (1 mL) was added. The reaction mixture was degassed by bubbling argon through for 5 min, and then Pd(PPh<sub>3</sub>)<sub>4</sub> (0.018 g, 0.016 mmol) was added. The reaction was heated at 120 °C under microwave irradiation for 20 min. Reaction crude was diluted with methanol (10 mL) and applied to a SCX 5 g column, and product was eluted with 2 M NH<sub>3</sub> in MeOH. Solvents were removed. The product was further purified by preparative HPLC. The fractions containing product were pooled together, and solvents were removed to obtain compound <b>12</b> as off-white solid (38 mg, 24% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.28–9.27 (m, 1H), 8.76–8.75 (m, 2H), 8.72 (dd, 1H, <i>J</i> = 1.7, 4.8 Hz), 8.45–8.42 (m, 1H), 8.34–8.33 (m, 2H), 7.44 (ddd, 1H, <i>J</i> = 0.7, 4.8, 7.9 Hz), 6.93 (s, 1H), 4.65 (bs, 2H), 3.74–3.72 (m, 4H), 3.12–3.06 (m, 2H), 2.60–2.52 (m, 5H), 2.04–2.01 (m, 2H), 1.59 (ddd, 2H, <i>J</i> = 4.3, 12.3, 24.1 Hz); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 403 [M + H]<sup>+</sup>. HRMS (ES<sup>+</sup>) calculated for C<sub>23</sub>H<sub>27</sub>N<sub>6</sub>O <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 403.2241. Measured <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 403.2260.</div></div><div id="sec11_3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 4-((1-(6-(Pyridin-3-yl)-2-(pyridin-4-yl)pyrimidin-4-yl)piperidin-4-yl)methyl)morpholine Fumarate (<b>13</b>)</h3><div class="NLM_p last"><b>13</b> was prepared in an analogous four-step procedure to that of compound <b>12</b>: A mixture of 4-((1-(6-chloro-2-(pyridin-4-yl)pyrimidin-4-yl)piperidin-4-yl)methyl)morpholine (312 mg, 0.83 mmol) in DMF (4 mL) was prepared at rt, and to it were added 3-pyridylboronic acid (205 mg, 1.70 mmol), potassium phosphate (354 mg, 1.70 mmol) in water (1 mL), and Pd tetrakis (48 mg, 0.04 mmol). The mixture was then heated in a microwave at 130 °C for 1 h. The mixture was then diluted with DCM (10 mL) and filtered through a Celite column. Filtrate was then purified by SCX-2 column, column washed with methanol (2 × 10 mL) and then flushed with 7 M ammonia in methanol (2 × 10 mL), and the ammonia/methanol filtrate concentrated under reduced pressure. Mixture was then purified by column (0–10% 7 M ammonia in methanol/dichloromethane) to afford <b>13</b> as an off-white solid (276 mg, 0.66 mmol). A sample of <b>13</b> (free base) (100 mg, 0.24 mmol) was suspended in ethanol (20.0 mL) and refluxed for 5 min until dissolution occurred. Fumaric acid (13.9 mg, 0.12 mmol) was dissolved in ethanol (5 mL) and added to the mixture and stirred at rt for a further 24 h. The mixture was then concentrated under reduced pressure and triturated with ethyl acetate and the resulting precipitate filtered, washed with ethyl acetate (2 × 5 mL), and dried by vacuum filtration to afford compound <b>13</b> (82 mg, 0.15 mmol, 21% yield over two steps). Purity by LCMS (UV chromatogram, 190–450 nm) > 95%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.47 (1H, d, J = 1.6 Hz), 8.74 (2H, d, J = 6.0 Hz), 8.71 (1H, dd, J = 1.3, 4.7 Hz), 8.67–8.64 (1H, m), 8.33 (2H, d, J = 6.0 Hz), 7.57 (1H, dd, J = 4.8, 8.0 Hz), 7.49 (1H, s), 6.60 (1H, s), 4.73–4.73 (2H, m), 3.59 (4H, dd, <i>J</i> = 4.0, 4.0 Hz), 3.04 (2H, t, <i>J</i> = 12.5 Hz), 2.35 (4H, s), 2.16 (2H, d, <i>J</i> = 7.3 Hz), 1.95–1.89 (1H, m), 1.86 (2H, d, <i>J</i> = 13.0 Hz), 1.17–1.09 (2H, m); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 417 [M + H]<sup>+</sup></div></div><div id="sec11_3_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>N</i>-(4-Morpholinobutyl)-6-(pyridin-3-yl)-2-(pyridin-4-yl)pyrimidin-4-amine (<b>14</b>)</h3><div class="NLM_p last"><b>14</b> was prepared in an analogous four-step procedure to that of compound <b>12</b>: A mixture of 6-chloro-<i>N</i>-(4-morpholinobutyl)-2-(pyridin-4-yl)pyrimidin-4-amine (187 mg, 0.54 mmol) in DMF (4 mL) was prepared at rt and 3-pyridylboronic acid (132, 1.08 mmol) added followed by potassium phosphate (228 mg, 1.08 mmol) in water (2 mL). Pd tetrakis (31 mg, 0.03 mmol) was added and the mixture heated in a microwave to 130 °C for 1 h. The mixture was diluted with dichloromethane (10 mL) and filtered through an SCX-2 column, washed with methanol (2 × 10 mL), and flushed with 7 M ammonia in methanol (2 × 10 mL) and filtrate concentrated under reduced pressure. The mixture was then purified by mass directed autoprep to afford <b>14</b> (161 mg, 0.41 mmol, 77%) as a colorless solid. Purity by LCMS (UV chromatogram, 190–450 nm) > 95%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.27 (d, 1H, <i>J</i> = 1.8 Hz), 8.75 (dd, 2H, <i>J</i> = 1.6, 4.5 Hz), 8.72 (dd, 1H, <i>J</i> = 1.6, 4.8 Hz), 8.45 (dt, 1H, <i>J</i> = 2.0, 9.9 Hz), 8.32 (d, 2H, <i>J</i> = 8.3 Hz), 7.45 (dd, 1H, <i>J</i> = 3.1, 7.3 Hz), 6.70 (s, 1H), 6.04 (brs, 1H), 3.78 (t, 4H, <i>J</i> = 4.4 Hz), 3.52 (brs, 2H), 2.49 (brs, 4H), 2.43 (t, 2H, <i>J</i> = 7.1 Hz), 1.80 (p, 2H, <i>J</i> = 6.8 Hz), 1.69 (p, 2H, <i>J</i> = 7.1 Hz); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 389 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (<i>R</i>)-2-(6-(Pyridin-3-yl)-2-(pyridine-4-yl)pyrimidin-4-yl)octahydropyrrolo[1,2-<i>a</i>]pyrazine (<b>15</b>)</h3><div class="NLM_p last"><b>15</b> was prepared in an analogous four-step procedure as that of compound <b>12</b>: To a stirred solution of (<i>R</i>)-2-(6-chloro-2-(pyridin-4-yl)pyrimidin-4-yl)octahydropyrrolo[1,2-<i>a</i>]pyrazine (0.14 g, 0.44 mmol) and 3-pyridylboronic acid (0.16 g, 1.31 mmol) in DMF (4.5 mL), a solution of potassium phosphate (0.28 g, 1.31 mmol) in water (1.5 mL) was added. The reaction mixture was degassed by bubbling argon through for 5 min, and then Pd(PPh<sub>3</sub>)<sub>4</sub> (0.015 g, 0.013 mmol) was added. The reaction was heated at 120 °C under microwave irradiation for 30 min. Reaction crude was filtered through Celite, quenched with water (20 mL), and extracted with DCM (2 × 50 mL). The organic phases were combined, dried over magnesium sulfate, and solvents were removed under reduced pressure. The product was purified by column chromatography (12 g silica cartridge) using (A) DCM and (B) 20% MeOH in DCM as eluents and the following gradient: 3 min hold at 100% A, 18 min ramp to 45% B, 3 min hold at 45% B. The fractions containing product were pooled together and solvents were removed to obtain <b>15</b> as white solid (119 mg, 75% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.22 (s, 1H), 8.69–8.65 (m, 3H), 8.37–8.35 (m, 1H), 8.28–8.27 (m, 2H), 7.37 (dd, 1H, <i>J</i> = 4.8, 7.8 Hz), 6.84 (s, 1H), 4.56 (broad peak, 2H), 3.16–3.09 (m, 3H), 2.78–2.74 (m, 1H), 2.27–2.22 (m, 1H), 2.18–2.13 (m, 1), 2.04–1.98 (m, 1H) 1.94–1.82 (m, 2H), 1.78–1.70 (m, 1H), 1.54–1.45 (m, 1H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 359 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 4-(1-(6-Cyclopropyl-2-(pyridin-4-yl)pyrimidin-4-yl)piperidin-4-yl)morpholine (<b>16</b>)</h3><div class="NLM_p last"><b>16</b> was prepared in an analogous four-step procedure to that of compound <b>12</b>: A mixture of 4-[1-[6-chloro-2-(4-pyridyl)pyrimidin-4-yl]-4-piperidyl]morpholine (0.050 g, 0.14 mmol), potassium phosphate (0.088 g, 0.41 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (0.005 g, 0.004 mmol), cyclopropylboronic acid (0.012 g, 0.014 mmol) in 1,4-dioxane (1.6 mL) and water (0.4 mL) was heated at 120 °C under microwave irradiation for 30 min. The cooled reaction mixture was evaporated to dryness. The residue was dissolved in MeOH/DCM and purified by SCX 2 g column eluting with MeOH and then 2 M NH<sub>3</sub> in MeOH. The fraction containing product was evaporated to dryness. The residue was dissolved in DMF and purified by mass directed HPLC 5–95% MeCN, basic, to afford <b>16</b> as a white solid (15 mg, 28% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.68 (d, 2H, <i>J</i> = 5.5 Hz), 8.19 (d, 2H, <i>J</i> = 5.65 Hz), 6.42 (s, 1H), 4.59 (bs, 2H), 3.86–3.74 (broad peak, 4H), 2.96 (m, 2H), 2.76–2.51 (broad peak, 5H), 2.07–1.98 (broad peak, 2H), 1.88 (m, 1H), 1.65–1.52 (broad peak, 2H), 1.19 (m, 2H), 0.98 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 366 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 6-(4-Morpholinopiperidin-1-yl)-<i>N</i>-(3-morpholinopropyl)-2-(pyridin-4-yl)pyrimidin-4-amine (<b>17</b>)</h3><div class="NLM_p last">To a mixture of 4-[1-[6-chloro-2-(4-pyridyl)pyrimidin-4-yl]-4-piperidyl]morpholine (0.050 g, 0.14 mmol) in anhydrous NMP (1 mL) was added 3-morpholinopropan-1-amine (60 mg, 0.41 mmol), and the mixture was heated at 200 °C under microwave irradiation for 10 min. The cooled reaction mixture was purified by mass directed HPLC 5–95% MeCN, basic, to afford <b>17</b> as a yellow solid (38 mg, 55% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.69- 8.65 (m, 2H), 8.18–8.16 (m, 2H), 5.61 (bs, 1H), 5.43 (s, 1H), 4.50–4.45 (m, 2H), 3.80–3.70 (m, 8H), 3.44–3.38 (m, 2H), 2.90 (m, 2H), 2.62–2.44 (m, 11H), 1.97–1.94 (m, 2H), 1.87–1.80 (m, 2H), 1.58–1.48 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 468 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 3-((6-(4-Morpholinopiperidin-1-yl)-2-(pyridin-4-yl)pyrimidin-4-yl)amino)propanamide (<b>18</b>)</h3><div class="NLM_p last">A mixture of 4-[1-[6-chloro-2-(4-pyridyl)pyrimidin-4-yl]-4-piperidyl]morpholine (0.050 g, 0.14mmol), <i>N</i>,<i>N</i>-diisopropylethylamine (0.072ml, 0.41mmol), 3-aminopropanamide hydrochloride (0.052 g, 0.41mmol) in anhydrous NMP (1 mL) was heated at 200 °C under microwave irradiation for 10 min. The cooled reaction mixture was purified by mass directed HPLC 5–95% MeCN, basic, to afford <b>18</b> as a yellow solid (16 mg, 26% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >98%. <sup>1</sup>H NMR (500 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 8.67–8.64 (m, 2H), 8.15–8.12 (m, 2H), 7.33 (bs, 1H), 6.84–6.75 (broad peaks, 2H), 5.7 (s, 1H), 4.41–4.32 (m, 2H), 3.48–3.47 (m, 6H), 2.83 (m, 2H), 2.52–2.34 (m, 7H), 1.88–1.82 (m, 2H), 1.40–1.30 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 412 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 4-(1-(6-Morpholino-2-(pyridin-4-yl)pyrimidin-4-yl)piperidin-4-yl)morpholine (<b>19</b>)</h3><div class="NLM_p last">To a mixture of 4-[1-[6-chloro-2-(4-pyridyl)pyrimidin-4-yl]-4-piperidyl]morpholine (0.050 g, 0.14 mmol) in anhydrous NMP (1 mL) was added morpholine (36 mg, 0.41 mmol), and the mixture was heated at 200 °C under microwave irradiation for 10 min. The cooled reaction mixture was purified by mass directed HPLC 5–95% MeCN, basic, to afford <b>19</b> as a white solid (30 mg, 57% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.69–8.67 (m, 2H), 8.20–8.18 (m, 2H), 5.61 (s, 1H), 4.55–4.49 (m, 2H), 3.83–3.80 (m, 4H), 3.68–3.71 (broad peak, 4H), 3.66–3.63, (m, 4H), 2.92 (m, 2H), 2.62–2.57 (broad peak, 5H), 2.00–1.93 (m, 2H), 1.62–1.52 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 411 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 4-(1-(6-(3,5-Dimethylisoxazol-4-yl)-2-(pyridin-4-yl)pyrimidin-4-yl)piperidin-4-yl)morpholine (<b>20</b>)</h3><div class="NLM_p last"><b>20</b> was prepared in an analogous four-step procedure to that of compound <b>51</b>: A mixture of 4-[1-[6-chloro-2-(4-pyridyl)pyrimidin-4-yl]-4-piperidyl]morpholine (0.050 g, 0.14 mmol), potassium phosphate (0.088 g, 0.41 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (0.005 g, 0.004 mmol), 3,5-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoxazole (0.093 g, 0.41 mmol) in 1,4-dioxane (1.6 mL) and water (0.4 mL) was heated at 120 °C under microwave irradiation for 30 min. The cooled reaction mixture was filtered through a Celite cartridge (2.5 g), washing the cartridge with DCM. The filtrate was partitioned between saturated NaHC0<sub>3</sub> (5 mL) and DCM (10 mL). The DCM extract was evaporated to dryness. The residue was dissolved in MeOH and purified by SCX 2 g column eluting with MeOH and then 2 M NH<sub>3</sub> in MeOH. The fraction containing product was evaporated to dryness. The residue was dissolved in DMF and purified by mass directed HPLC 5–95% MeCN, basic, to afford <b>20</b> as a white solid (36 mg, 61% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.75–8.73 (m, 2H), 8.25–8.23 (m, 2H), 6.51 (s, 1H), 4.61 (bs, 2H), 3.92–3.67 (broad peak, 4H), 3.05 (m, 2H), 2.75–2.55 (m, 8H), 2.53 (s, 3H), 2.16–2.00 (broad peak, 2H), 1,72–1.49 (broad peak, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 421 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 4-(1-(6-(3-Fluorophenyl)-2-(pyridin-4-yl)pyrimidin-4-yl)piperidin-4-yl)morpholine (<b>21</b>)</h3><div class="NLM_p last"><b>21</b> was prepared in an analogous four-step procedure to that of compound <b>12</b>: A mixture of 4-[1-[6-chloro-2-(4-pyridyl)pyrimidin-4-yl]-4-piperidyl]morpholine (0.050 g, 0.14 mmol), potassium phosphate (0.088 g, 0.41 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (0.005 g, 0.004 mmol), (3-fluorophenyl)boronic acid (0.058 g, 0.41 mmol) in 1,4-dioxane (1.6 mL) and water (0.4 mL) was heated at 120 °C under microwave irradiation for 30 min. The cooled reaction mixture was evaporated to dryness. The residue was dissolved in MeOH/DCM and purified by SCX 2 g column eluting with MeOH and then 2 M NH<sub>3</sub> in MeOH. The fraction containing product was evaporated to dryness. The residue was dissolved in DMF and purified by mass directed HPLC 5–95% MeCN, basic, to afford <b>21</b> as a white solid (47 mg, 76% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.76–8.74 (m, 2H), 8.35–8.33 (m, 2H), 7.88–7.83 (m, 2H), 7.49–7.44 (m, 1H), 7.2–7.16 (m, 1H), 6.90 (s, 1H), 4.68 (bs, 2H), 3.85–3.73 (broad peak, 4H), 3.06 (m, 2H), 2.76–2.59 (broad peak, 5H), 2.14–2.04 (m, 2H), 1.69–1.54 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 420 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 4-(1-(6-(4-Fluorophenyl)-2-(pyridin-4-yl)pyrimidin-4-yl)piperidin-4-yl)morpholine (<b>22</b>)</h3><div class="NLM_p last"><b>22</b> was prepared in an analogous four-step procedure to that of compound <b>12</b>: A mixture of 4-[1-[6-chloro-2-(4-pyridyl)pyrimidin-4-yl]-4-piperidyl]morpholine (0.050 g, 0.1389 mmol), potassium phosphate (0.088 g, 0.41 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (0.005 g, 0.004 mmol), (4-fluorophenyl)boronic acid (0.058 g, 0.41 mmol) in 1,4-dioxane (1.6 mL) and water (0.4 mL) was heated at 120 °C under microwave irradiation for 30 min. The cooled reaction mixture was evaporated to dryness. The residue was dissolved in MeOH/DCM and purified by SCX 2 g column eluting with MeOH and then 2 M NH<sub>3</sub> in MeOH. The fraction containing product was evaporated to dryness. The residue was dissolved in DMF and purified by mass directed HPLC 5–95% MeCN, basic, to afford <b>22</b> as a white solid (38 mg, 61% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.74 (d, 2H, <i>J</i> = 5.35 Hz), 8.35–8.32 (m, 2H), 8.14–8.09 (m, 2H), 7.21–7.16 (m, 2H), 6.87 (s, 1H), 4.67 (broad peak, 2H), 3.84–3.7 (broad peak, 4H), 3.05 (m, 2H), 2.71–2.55 (broad peak, 5H), 2.10–2.00 (m, 2H), 1.67–1.52 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 420 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 4-(1-(2-(Pyridin-4-yl)[4,5′-bipyrimidin]-6-yl)piperidin-4-yl)morpholine (<b>23</b>)</h3><div class="NLM_p last"><b>23</b> was prepared in an analogous four-step procedure to that of compound <b>12</b>: A mixture of 4-[1-[6-chloro-2-(4-pyridyl)pyrimidin-4-yl]-4-piperidyl]morpholine (0.050 g, 0.14 mmol), potassium phosphate (0.088 g, 0.41 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (0.005 g, 0.004 mmol), 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine (0.085 g, 0.41 mmol) in 1,4-dioxane (1.6 mL) and water (0.4 mL) was heated at 120 °C under microwave irradiation for 30 min. The cooled reaction mixture was evaporated to dryness. The residue was dissolved in MeOH/DCM and purified by SCX 2 g column eluting with MeOH and then 2 M NH<sub>3</sub> in MeOH. The fraction containing product was evaporated to dryness. The residue was dissolved in DMF and purified by mass directed HPLC 5–95% MeCN, basic, to afford <b>23</b> as a white solid (26 mg, 44% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.41 (s, 2H), 9.32 (s, 1H), 8.78–8.75 (m, 2H), 8.33–8.31 (m, 2H), 6.92 (s, 1H) 4.70 (bs, 2H), 3.99–3.66 (broad peak, 4H), 3.11 (m, 2H), 2.82–2.52 (broad peak, 5H), 2.19–2.01 (broad peak, 2H), 1.77–1.49 (broad peak, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 404 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 4-(1-(6-(5-Methoxypyridin-3-yl)-2-(pyridin-4-yl)pyrimidin-4-yl)piperidin-4-yl)morpholine (<b>24</b>)</h3><div class="NLM_p last"><b>24</b> was prepared in an analogous four-step procedure to that of compound <b>12</b>: A mixture of 4-[1-[6-chloro-2-(4-pyridyl)pyrimidin-4-yl]-4-piperidyl]morpholine (0.050 g, 0.14 mmol), potassium phosphate (0.088 g, 0.41 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (0.005 g, 0.004 mmol), (5-methoxy-3-pyridyl)boronic acid (0.063 g, 0.41 mmol) in 1,4-dioxane (1.6 mL) and water (0.4 mL) was heated at 120 °C under microwave irradiation for 30 min. The cooled reaction mixture was evaporated to dryness. The residue was dissolved in MeOH/DCM and purified by SCX 2 g column eluting with MeOH and then 2 M NH<sub>3</sub> in MeOH. The fraction containing product was evaporated to dryness. The residue was dissolved in DMF and purified by mass directed HPLC 5–95% MeCN, basic, to afford <b>24</b> as a white solid (38 mg, 60% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.82 (d, 1H, <i>J</i> = 1.7 Hz), 8.76–8.74 (m, 2H), 8.41 (d, 1H, <i>J</i> = 2.85 Hz), 8.34–8.32 (m, 2H), 8.00–7.98 (m, 1H), 6.93 (s, IH), 4.71 (broad peak, 2H), 3.98 (s, 3H), 3.86–3.74 (broad peak, 4H), 3.13–3.04 (m, 2H), 2.76–2..04 (broad peak, 5H), 2.16–2.04 (broad peak, 2H), 1.7–1.56 (broad peak, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 433 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 5-(6-(4-Morpholinopiperidin-1-yl)-2-(pyridin-4-yl)pyrimidin-4-yl)nicotinonitrile (<b>25</b>)</h3><div class="NLM_p last"><b>25</b> was prepared in an analogous four-step procedure to that of compound <b>12</b>: A mixture of 4-[1-[6-chloro-2-(4-pyridyl)pyrimidin-4-yl]-4-piperidyl]morpholine (0.050 g, 0.14 mmol), potassium phosphate (0.088 g, 0.41 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (0.005 g, 0.004 mmol), (3-cyanophenyl)boronic acid (0.061 g, 0.41 mmol) in 1,4-dioxane (1.6 mL) and water (0.4 mL) was heated at 120 °C under microwave irradiation for 60 min. The cooled reaction mixture was evaporated to dryness. The residue was dissolved in MeOH/DCM and purified by SCX 2 g column eluting with MeOH and then 2 M NH<sub>3</sub> in MeOH. The fraction containing product was evaporated to dryness. The residue was dissolved in DMF and purified by mass directed HPLC 5–95% MeCN, basic, to afford <b>25</b> as a white solid (14 mg, 22% yield). Purity by LCMS (UV chromatogram, 190–450 nm) 97%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.45 (d, 1H, <i>J</i> = 2.09 Hz), 8.97 (d, 1H, <i>J</i> = 1.94 Hz), 8.79–8.72 (m, 3H), 8.34–8.29 (m, 2H), 6.94 (s, 1H), 4.69 (broad peak, 2H), 3.84–3.72 (broad peak, 4H), 3.12 (m, 2H), 2.70–2.58 (broad peak, 5H), 2.15–2.03 (m, 2H), 1.71–1.54 (broad peak, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 428 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 4-(1-(6-(5-Fluoropyridin-3-yl)-2-(pyridin-4-yl)pyrimidin-4-yl)piperidin-4-yl)morpholine (<b>26</b>)</h3><div class="NLM_p last"><b>26</b> was prepared in an analogous four-step procedure to that of compound <b>12</b>: A mixture of 4-[1-[6-chloro-2-(4-pyridyl)pyrimidin-4-yl]-4-piperidyl]morpholine (0.050 g, 0.14 mmol), potassium phosphate (0.088 g, 0.41 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (0.005 g, 0.004 mmol), (5-fluoropyridin-3-yl)boronic acid (0.058 g, 0.41 mmol) in 1,4-dioxane (1.6 mL) and water (0.4 mL) was heated at 120 °C under microwave irradiation for 30 min. The cooled reaction mixture was evaporated to dryness. The residue was dissolved in MeOH/DCM and purified by SCX 2 g column eluting with MeOH and then 2 M NH<sub>3</sub> in MeOH. The fraction containing product was evaporated to dryness. The residue was dissolved in DMF and purified by mass directed HPLC 5–95% MeCN, basic, to afford <b>26</b> as a yellow solid (13 mg, 21% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.07 (m, 1H), 8.76 (m, 2H), 8.58 (d, 1H, <i>J</i> = 2.8 Hz), 8.34 (m, 2H), 8.22–8.19 (m, 1H), 6.94 (s, IH), 4.67 (bs, 2H), 3.76–3.74 (m, 4H), 3.13–3.07 (m, 2H), 2.64–2.62 (m, 5H), 2.07–2.04 (m, 2H), 1.64–1.56 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 421 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 5-(6-(4-Morpholinopiperidin-1-yl)-2-(pyridin-4-yl)pyrimidin-4-yl)pyridin-3-yl)methanamine (<b>27</b>)</h3><div class="NLM_p last"><b>27</b> was prepared in an analogous four-step procedure to that of compound <b>12</b>: A solution of 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinaldehyde (0.100 g, 0.43 mmol) in ammonia (7 M in MeOH, 2 mL) was stirred at room temperature overnight. Sodium borohydride (0.035 g, 0.92 mmol) was added and the reaction mixture stirred at room temperature under argon for 5 h. Water (1 mL) was added and the reaction mixture evaporated to dryness. The residue was dissolved in MeOH and purified by SCX 2 g column eluted MeOH and then 2 M NH<sub>3</sub> in MeOH. The fractions containing product were evaporated to dryness to give impure (5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)methanamine (0.090 g) as a brown gum. A mixture of impure (5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)methanamine (0.090 g, 0.38 mmol), 4-[1-[6-chloro-2-(4-pyridyl)pyrimidin-4-yl]-4-piperidyl]morpholine (0.050 g, 0.14 mmol), potassium phosphate (0.088 g, 0.41 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (0.005 g, 0.004 mmol) in 1,4-dioxane (1.6 mL) and water (0.4 mL) was heated at 120 °C under microwave irradiation for 30 min. The cooled reaction mixture was evaporated to dryness. The residue was dissolved in MeOH/DCM and purified by SCX 2 g column eluting with MeOH and then 2 M NH<sub>3</sub> in MeOH. The fraction containing product was evaporated to dryness. The residue was dissolved in DMF and purified by mass directed HPLC 5–95% MeCN, basic, to afford <b>27</b> as a white solid (13 mg, 20% yield). Purity by LCMS (UV chromatogram, 190–450 nm) 95%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.16 (d, 1H, <i>J</i> = 1.9 Hz), 8.77–8.74 (m, 2H), 8.34 (d, 1H, <i>J</i> = 1.85 Hz), 8.47 (m, 1H), 8.35–8.33 (m, 2H), 6.95 (s, 1H), 4,65 (bs, 2H) 4.04 (s, 2H), 3.76–3.70 (m, 4H), 3.09 (m, 2H), 2.62–2.56 (m, 5H), 2.07–1.99 (m, 2H), 1.65–1.54 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 432 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 5-(6-(4-Morpholinopiperidin-1-yl)-2-(pyridin-4-yl)pyrimidin-4-yl)pyridin-3-yl)methanone (<b>28</b>)</h3><div class="NLM_p last"><b>28</b> was prepared in an analogous four-step procedure to that of compound <b>12</b>: A mixture of 4-[1-[6-chloro-2-(4-pyridyl)pyrimidin-4-yl]-4-piperidyl]morpholine (0.050 g, 0.14 mmol), potassium phosphate (0.088 g, 0.41 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (0.005 g, 0.004 mmol), morpholino(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)methanone (0.132 g, 0.41 mmol) in 1,4-dioxane (1.6 mL) and water (0.4 mL) was heated at 120 °C under microwave irradiation for 30 min. The cooled reaction mixture was evaporated to dryness. The residue was dissolved in MeOH/DCM and purified by SCX 2 g column eluting with MeOH and then 2 M NH<sub>3</sub> in MeOH. The fraction containing product was evaporated to dryness. The residue was dissolved in DMF and purified by mass directed HPLC 5–95% MeCN, basic, to afford <b>28</b> as a light brown solid (52 mg, 68% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.35 (d, 1H, <i>J</i> = 2.11 Hz), 8.77–8.73 (m, 3H), 8.51 (m, 1H), 8.33–8.30 (m, 2H), 6.95 (s, 1H), 4.70 (bs, 2H), 3.92–3.64 (broad peaks, 12H), 3.09 (m, 2H), 2.77–2.55 (broad peak, 5H), 2.17–2.03 (broad peak, 2H), 1.73–1.53, (broad peak, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 516 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 5-(6-(4-Morpholinopiperidin-1-yl)-2-(pyridin-4-yl)pyrimidin-4-yl)pyridin-2-amine (<b>29</b>)</h3><div class="NLM_p last">A mixture of 4-[1-[6-chloro-2-(4-pyridyl)pyrimidin-4-yl]-4-piperidyl]morpholine (0.050 g, 0.14 mmol), potassium phosphate (0.088 g, 0.41 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (0.005 g, 0.004 mmol), 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine (0.091 g, 0.41 mmol) in 1,4-dioxane (1.6 mL) and water (0.4 mL) was heated at 120 °C under microwave irradiation for 30 min. The cooled reaction mixture was evaporated to dryness. The residue was dissolved in MeOH/DCM and purified by SCX 2 g column eluting with MeOH and then picolinamide, 2 M NH<sub>3</sub> in MeOH. The fraction containing product was evaporated to dryness. The residue was dissolved in DMF and purified by mass directed HPLC 5–95% MeCN, basic, to afford <b>29</b> as a white solid (42 mg, 68% yield). Purity by LCMS (UV chromatogram, 190–450 nm) 96%. <sup>1</sup>H NMR (500 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 8.92 (d, 1H, <i>J</i> = 2.05 Hz), 8.74–8.72 (m, 2H), 8.32–8.28 (m, 3H), 7.23 (s, 1H), 6.54 (d, 1H, <i>J</i> = 8.75 Hz), 6.48 (bs, 2H), 4.70 (bs, 2H), 3.59–3.55 (m, 4H), 3.04–2.97 (m, 2H), 2.55–2.48 (m, 5H), 1.94–1.88 (m, 2H), 1.45–1.36 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 418 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 4-(1-(6-(6-Methoxypyridin-3-yl)-2-(pyridin-4-yl)pyrimidin-4-yl)piperidin-4-yl)morpholine (<b>30</b>)</h3><div class="NLM_p last"><b>30</b> was prepared in an analogous four-step procedure to that of compound <b>12</b>: A mixture of 4-[1-[6-chloro-2-(4-pyridyl)pyrimidin-4-yl]-4-piperidyl]morpholine (0.050 g, 0.14 mmol), potassium phosphate (0.088 g, 0.41 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (0.005 g, 0.004 mmol), (6-methoxypyridin-3-yl)boronic acid (0.063 g, 0.41 mmol) in 1,4-dioxane (1.6 mL) and water (0.4 mL) was heated at 120 °C under microwave irradiation for 30 min. The cooled reaction mixture was filtered through a Celite cartridge (2.5 g). The cartridge was washed with DCM. The filtrate was partitioned between saturated NaHCO<sub>3</sub> (5 mL) and DCM (10 mL). The DCM extract was evaporated to dryness. The residue was dissolved in MeOH and purified by SCX 2 g column eluting with MeOH and then 2 M NH<sub>3</sub> in MeOH. The fraction containing product was evaporated to dryness. The residue was dissolved in DMF and purified by mass directed HPLC 5–95% basic to afford impure product. The sample was dissolved in DMF and purified by mass directed HPLC 25–75% MeCN, basic, to afford <b>30</b> as a white solid (17 mg, 26% yield). Purity by LCMS (UV chromatogram, 190–450 nm) 96%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.9 (m, 1H), 8.75–8.73 (m, 2H), 8.34–8.31 (m, 3H), 6.88–6.85 (m, 1H), 6.84 (s, 1H), 4.67 (broad peak, 2H), 4.01 (s, 3H), 3.87–3.79 (broad peak, 4H), 3.06 (m, 2H), 2.76–2.58 (broad peak, 5H), 2.14–2.08 (broad peak 2H), 1.69–1.55 (broad peak 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 433 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> <i>N</i>-Methyl-5-(6-(4-morpholinopiperidin-1-yl)-2-(pyridin-4-yl)pyrimidin-4-yl)picolinamide (<b>31</b>)</h3><div class="NLM_p last"><b>31</b> was prepared in an analogous four-step procedure to that of compound <b>12</b>: A mixture of 4-[1-[6-chloro-2-(4-pyridyl)pyrimidin-4-yl]-4-piperidyl]morpholine (0.050 g, 0.14 mmol), potassium phosphate (0.088 g, 0.41 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (0.005 g, 0.004 mmol), <i>N</i>-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinamide (0.109 g, 0.41 mmol) in 1,4-dioxane (1.6 mL) and water (0.4 mL) was heated at 120 °C under microwave irradiation for 30 min. The cooled reaction mixture was evaporated to dryness. The residue was dissolved in MeOH/DCM and purified by SCX 2 g column eluting with MeOH and then 2 M NH<sub>3</sub> in MeOH. The fraction containing product was evaporated to dryness. The residue was dissolved in DMF and purified by mass directed HPLC 5–95% MeCN, basic, to afford <b>31</b> as a white solid (22 mg, 32% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.25 (m, 1H), 8.77 (bs, 2H), 8.53–8.49 (m, 1H), 8.36–8.30 (m, 3H), 8.10–8.04 (m, 1H), 6.95 (s, 1H), 4.72 (bs, 2H), 3.96–3.67 (broad peak, 4H), 3.013–3.04 (m, 5H), 2.75–2.60 (broad peak, 5H), 2.16–2.03 (broad peak, 2H), 1.75–1.55 (broad peak, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 460 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 4-(5-(6-(4-Morpholinopiperidin-1-yl)-2-(pyridin-4-yl)pyrimidin-4-yl)pyridin-2-yl)morpholine (<b>32</b>)</h3><div class="NLM_p last"><b>32</b> was prepared in an analogous four-step procedure to that of compound <b>12</b>: A mixture of 4-[1-[6-chloro-2-(4-pyridyl)pyrimidin-4-yl]-4-piperidyl]morpholine (0.050 g, 0.14 mmol), potassium phosphate (0.088 g, 0.41 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (0.005 g, 0.004 mmol), 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)morpholine (0.121 g, 0.41 mmol) in 1,4-dioxane (1.6 mL) and water (0.4 mL) was heated at 120 °C under microwave irradiation for 30 min. The cooled reaction mixture was filtered through a Celite cartridge (2.5 g), washing the cartridge with DCM. The filtrate was partitioned between saturated NaHC0<sub>3</sub> (5 mL) and DCM (10 mL). The DCM extract was evaporated to dryness. The residue was dissolved in MeOH and purified by SCX 2 g column eluting with MeOH and then 2 M NH<sub>3</sub> in MeOH. The fraction containing product was evaporated to dryness. The residue was dissolved in DMF and purified by mass directed HPLC 5–95% MeCN, basic, to afford impure product. The sample was dissolved in DMF and purified by mass directed HPLC 25–75%, basic, to afford <b>32</b> as a white solid (40 mg, 56% yield). Purity by LCMS (UV chromatogram, 190–450 nm) 95%. <sup>1</sup>H NMR (500 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 9.12–9.09 (m, 1H), 8.72 (d, 2H, <i>J</i> = 5.78 Hz), 8.48–8.42 (m, 1H), 8.30 (d, 2H, <i>J</i> = 5.93 Hz), 7.3 (s, 1H), 6.95 (d, 1H, <i>J</i> = 9.08 Hz), 4.65 (bs, 2H), 3.78–3.50 (m, 12H), 3.01 (m, 2H), 2.58–2.38 (m, 5H), 1.97–1.84 (m, 2H), 1.50–1.29 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 488 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 4-(1-(6-(4-Methoxypyridin-3-yl)-2-(pyridin-4-yl)pyrimidin-4-yl)piperidin-4-yl)morpholine (<b>33</b>)</h3><div class="NLM_p last"><b>33</b> was prepared in an analogous four-step procedure to that of compound <b>12</b>: A mixture of 4-[1-[6-chloro-2-(4-pyridyl)pyrimidin-4-yl]-4-piperidyl]morpholine (0.050 g, 0.14 mmol), potassium phosphate (0.088 g, 0.41 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (0.005 g, 0.004 mmol), (4-methoxypyridin-3-yl)boronic acid (0.068 g, 0.41 mmol) in 1,4-dioxane (1.6 mL) and water (0.4 mL) was heated at 120 °C under microwave irradiation for 30 min. The cooled reaction mixture was evaporated to dryness. The residue was dissolved in MeOH/DCM and purified by SCX 2 g column eluting with MeOH and then 2 M NH<sub>3</sub> in MeOH. The fraction containing product was evaporated to dryness. The residue was dissolved in DMF and purified by mass directed HPLC 5–95% MeCN, basic, to afford <b>33</b> as a white solid (46 mg, 72% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.16 (s, 1H), 8.75–8.71 (m, 2H), 8.56 (d, 1H, <i>J</i> = 5.75 Hz), 8.32–8.29 (m, 2H), 7.13 (s, 1H), 6.94 (d, 1H, <i>J</i> = 5.80 Hz), 4.65 (bs, 2H), 3.97 (s, 3H), 3.85–3.76 (broad peak, 4H), 3.04 (m, 2H), 2.72–2.65 (broad peak, 5H), 2.15–2.02 (m, 2H), 1.67–1.54 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 433 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 4-(4-(4-Morpholinopiperidin-1-yl)-6-(pyridin-3-yl)pyrimidin-2-yl)benzonitrile (<b>34</b>)</h3><div class="NLM_p last"><b>34</b> was prepared in an analogous three-step procedure to that of compound <b>43</b>: In a sealed 5 mL microwave vial, a solution of 4-[1-[2-methylsulfanyl-6-(3-pyridyl)pyrimidin-4-yl]-4-piperidyl]morpholine (0.075 g, 0.20 mmol) in THF (4 mL) was degassed by bubbling argon through for 5 min. (4-Cyanophenyl)boronic acid (0.030 g, 0.20 mmol), thiophene-2-carbonyloxycopper (0.058 g, 0.30 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (0.023 g,0.02 mmol) were added at room temperature. The reaction was heated in the sealed tube at 85 °C for 18 h. Reaction was filtered through Celite and partitioned between DCM (10 mL) and NH<sub>3</sub> aq (5 mL). The organic phase was dried over magnesium sulfate, and solvents were removed under reduced pressure. The product was purified by mass directed autopreparative HPLC under basic conditions. The fractions containing product were pooled together and solvents were removed to obtain <b>34</b> as off-white solid (12 mg, 14% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.27 (d, 1H, <i>J</i> = 1.7 Hz), 8.72 (dd, 1H, <i>J</i> = 1.6z, 4.8 Hz), 8.64–8.61 (m, 2H), 8.44–8.42 (m, 1H), 7.78–7.76 (m, 2H), 7.45 (ddd, 1H, <i>J</i> = 0.7, 4.8, 7.9 Hz), 6.92(s, 1H), 4.74–4.61 (m, 2H), 3.79–3.72 (m, 4H), 3.49 (d, 2H, <i>J</i> = 5.2 Hz), 3.11–3.06 (m, 2H), 2.69–2.52 (m, 5H), 2.08–2.03 (m, 2H), 1.63–1.54 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 427 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 4-(4-Morpholinopiperidin-1-yl)-6-(pyridin-3-yl)pyrimidine-2-carbonitrile (<b>35</b>)</h3><div class="NLM_p">In a stirred sealed tube a solution of 4-[1-(6-chloro-2-iodo-pyrimidin-4-yl)-4-piperidyl]morpholine (0.29 g, 0.72 mmol) and copper cyanide (0.077 g, 0.86 mmol) in NMP (3 mL) was heated at 120 °C for 5 h. Reaction crude was applied to a SCX cartridge (5 g), and the product was diluted with a solution of 2 N NH<sub>3</sub> in methanol. The product was further purified by column chromatography (12 g silica cartridge) using (A) DCM, (B) 10% MeOH in DCM as eluents and the following gradient: 1 min hold at 100% A, 10 min ramp to 50% B, and 3 min hold at 50% B. The fractions containing product were pooled together and solvents were removed to obtain 4-chloro-6-(4-morpholinopiperidin-1-yl)pyrimidine-2-carbonitrile as an off-white solid (139 mg, 62% yield). Purity by LCMS (UV chromatogram, 190–450 nm) 90%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 6.44 (s, 1H), 3.73–3.71 (m, 4H), 3.06–3.01 (m, 2H), 2.56–2.48 (m, 5H), 1.99–1.96 (m, 2H), 1.55–1.47 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 308 [M + H]<sup>+</sup>.</div><div class="NLM_p last">To a stirred solution of 6-chloro-4-(4-morpholino-1-piperidyl)-1,6-dihydropyrimidine-2-carbonitrile (0.128 g, 0.41 mmol) and 3-pyridylboronic acid (0.103 g, 0.83 mmol) in DME (4 mL), an aqueous solution of sodium carbonate (2 M, 0.26 g, 1.24 mmol) and PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (0.014 g, 0.02 mmol) were added. The reaction was heated at 120 °C for 20 min under microwave irradiation. The reaction crude was diluted with methanol (5 mL) and applied to a SCX column (5 g), and the product was eluted with 2 M NH<sub>3</sub> in MeOH. The product was further purified by preparative HLPC under acidic conditions. The fractions containing product were pooled together and solvents were removed to obtain <b>35</b> as off-white solid (47 mg, 31% yield). Purity by LCMS (UV chromatogram, 190–450 nm) 98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.14–9.13 (m, 1H), 8.72 (dd, 1H, <i>J</i> = 1.7, 4.8 Hz), 8.36–8.34 (m, 1H), 7.45 (ddd, 1H, <i>J</i> = 0.8, 4.8, 8.0 Hz), 6.97 (s, 1H), 4.59–4.56 (m, 2H), 3.76–3.74 (m, 4H), 3.10–3.05 (m, 2H), 2.63–2.57 (m, 5H), 2.04–2.02 (m, 2H), 1.60–1.52 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 351 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 1-(4-(4-Morpholinopiperidin-1-yl)-6-(pyridine-3-yl)pyrimidin-2-yl)thiomorpholine 1,1-Dioxide (<b>36</b>)</h3><div class="NLM_p"><b>36</b> was prepared in an analogous three-step procedure to that of compound <b>74</b>: A solution of 4-[1-(6-chloro-2-iodo-pyrimidin-4-yl)-4-piperidyl]morpholine (0.15 g, 0.37 mmol), thiomorpholine 1,1-dioxide (0.06 mg, 0.40 mmol), and DIPEA (0.13 mL, 040 mmol) in NMP (2 mL) was heated at 200 °C for 15 min under microwaved irradiation. Reaction crude was diluted with MeOH (5 mL) and applied to a SCX cartridge (5 g), and the product was diluted with a solution of 2 N NH<sub>3</sub> in methanol. Solvents were removed under reduced pressure and the product was further purified by column chromatography (12 g silica cartridge) using (A) DCM, (B) 10% MeOH in DCM as eluents and the following gradient: 1 min hold at 100% A, 18 min ramp to 50% B, and 3 min hold at 50% B. The fractions containing product were pooled together and solvents were removed to obtain 1-(4-chloro-6-(4-morpholinopiperidin-1-yl)pyrimidin-2-yl)thiomorpholine 1,1-dioxide as an off-white solid (149 mg, 98%, 91% purity by LCMS). The product was used for the next step without further purification.</div><div class="NLM_p last">To a stirred solution of 1-(4-chloro-6-(4-morpholinopiperidin-1-yl)pyrimidin-2-yl)thiomorpholine 1,1-dioxide (0.15 g, 0.36 mmol) and 3-pyridylboronic acid (0.09 g, 0.76 mmol) in DMF (3 mL), Pd(PPh<sub>3</sub>)<sub>4</sub> (0.015 g, 0.01 mmol) and an aqueous solution of potassium carbonate (2 M, 0.5 mL) were added. The reaction was heated at 120 °C for 20 min under microwave irradiation. The reaction crude was diluted with methanol (10 mL) and applied to a SCX column (2 g), and the product was eluted with 2 M NH<sub>3</sub> in MeOH. The product was further purified by preparative HLPC under basic conditions. The fractions containing product were pooled together, and solvents were removed to obtain <b>36</b> as off-white solid (67 mg, 41% yield). Purity by LCMS (UV chromatogram, 190–450 nm) 98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.13 (dd, 1H, <i>J</i> = 0.7, 2.2 Hz), 8.66 (dd, 1H, <i>J</i> = 1.7, 4.8 Hz), 8.22–8.20 (m, 1H), 7.37 (ddd, 1H, <i>J</i> = 0.8, 4.8, 8.0 Hz), 6.42 (s, 1H), 4.45–4.40 (m, 6H), 3.73–3.71 (m, 4H), 3.07–3.05 (m, 4H), 2.53–2.93 (m, 2H), 2.58–2.56 (m, 4H), 2.52–2.47 (m, 1H), 1.97–1.94 (m, 2H), 1.55–1.47 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 459 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 4-(4-Morpholinopiperidin-1yl)-6-(pyridin-3-yl)pyrimidin-2-ol (<b>37</b>)</h3><div class="NLM_p">To a stirred solution of 4-[1-(2,6-dichloropyrimidin-4-yl)-4-piperidyl]morpholine (0.60 g, 1.89 mmol) in THF (10 mL) in a 20 mL microwave vial, a solution of NaOH (1M, 9.8 mL) was added at room temperature. The reaction mixture was heated 150 °C for 1 h under microwave irradiation. The reaction crude was washed with ethyl acetate (2 × 100 mL). The pH of the aqueous layer was adjusted to pH 6 with 10% HCl, and then MeOH (40 mL) added. The water/methanol mixture was applied onto an SCX column (20 g) and the compound was eluted from the column with 2 M NH<sub>3</sub> in methanol. Solvents were removed under reduced pressure to obtain 4-chloro-6-(4-morpholinopiperidin-1-yl)pyrimidin-2-ol as a white solid (256 mg, 45% yield). Purity by LCMS (UV chromatogram, 190–450 nm) 86%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 5.86 (s, 1H), 4.26 (broad peak, 2H), 3.69 (broad peak, 4H), 2.94–2.89 (m, 2H), 2.51–2.40 (m, 5H), 1.90–1.87 (m, 2H), 1.46–1.40 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 299 [M + H]<sup>+</sup>.</div><div class="NLM_p last">To a stirred suspension of 4-chloro-6-(4-morpholinopiperidin-1-yl)pyrimidin-2-ol (0.26 g, 0.86 mmol) and 3-pyridylboronic acid (0.32 g, 2.57 mmol) in DMF (3 mL), a solution of potassium phosphate (0.55 g, 2.57 mmol) in water (1 mL) was added. The reaction mixture was degassed by bubbling argon through for 5 min, and then Pd(PPh<sub>3</sub>)<sub>4</sub> (0.049 g, 0.04 mmol) was added. The reaction was heated at 130 °C under microwave irradiation for 20 min. Reaction was filtered through Celite and partitioned between DCM (50 mL) and a saturated aqueous solution of NaHCO<sub>3</sub> (15 mL). The organics phase was dried over MgSO<sub>4</sub> before concentration to dryness. The crude was then purified by column chromatography (12 g silica cartridge) using (A) DCM and (B) MeOH as eluents and the following gradient: 1 min hold at 100% A, 20 min ramp to 20% B, 5 min hold to 10% B. The fractions containing product were pooled together and solvents were removed to obtain <b>37</b> as a white solid (50 mg, 17% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >98%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.02 (bs, 1H), 9.07 (d, 1H, <i>J</i> = 2.0 Hz), 8.77 (dd, 1H, <i>J</i> = 1.5, 4.8 Hz), 8.28–8.25 (m, 1H), 7.61 (dd, 1H, <i>J</i> = 4.8, 8.0 Hz), 6.58(s, 1H), 4.84–4.32 (broad peak, 2H), 3.65–3.63 (m, 4H), 3.02 (broad peak, 2H), 2.54 (broad peak, 5H), 1.93–1.91 (m, 2H), 1.45–1.33 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 342 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 4(4-(4-Morpholinopiperidin-1-yl)-6-(pyridine-3-yl)pyrimidin-2yl)piperazine-2-one (<b>38</b>)</h3><div class="NLM_p last"><b>38</b> was prepared in an analogous three-step procedure to that of compound <b>74</b>: A solution of 4-[1-(6-chloro-2-iodo-pyrimidin-4-yl)-4-piperidyl]morpholine (0.15 g, 0.37 mmol), piperazine-2-one (0. 04 mg, 0.40 mmol), and DIPEA (0.13 mL, 0.40 mmol) in NMP (2 mL) was heated at 200 °C for 15 min under microwave irradiation. Reaction crude was diluted with MeOH (5 mL) and applied to a SCX cartridge (5 g), and the product was diluted with a solution of 2 N NH<sub>3</sub> in methanol. Solvents were removed under reduced pressure, and the product was further purified by column chromatography (12 g silica cartridge) using (A) DCM, (B) 10% MeOH in DCM as eluents and the following gradient: 1 min hold at 100% A, 18 min ramp to 50% B, and 3 min hold at 50% B. The fractions containing product were pooled together and solvents were removed to obtain 4-chloro-<i>N</i>-(2-morpholinoethyl)-6-(4-morpholinopiperidin-1-yl)pyrimidin-2-amine as an off-white solid (159 mg, quantitiative yield, 83% purity by LCMS). The product was used for the next step without further purification. To a stirred solution of 4-chloro-<i>N</i>-(2-morpholinoethyl)-6-(4-morpholinopiperidin-1-yl)pyrimidin-2-amine (0.16 g, 0.41 mmol) and 3-pyridylboronic acid (0.10 g, 0.82 mmol) in DMF (3 mL), Pd(PPh<sub>3</sub>)<sub>4</sub> (0.015 g, 0.01 mmol) and an aqueous solution of potassium carbonate (2 M, 0.5 mL) were added. The reaction was heated at 120 °C for 20 min under microwave irradiation. The reaction crude was diluted with methanol (10 mL) and applied to a SCX column (2 g), and the product was eluted with 2 M NH<sub>3</sub> in MeOH. The product was further purified by preparative HLPC under basic conditions. The fractions containing product were pooled together and solvents were removed to obtain <b>38</b> as off-white solid (70 mg, 40% yield). Purity by LCMS (UV chromatogram, 190–450 nm) 98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.17 (dd, 1H, <i>J</i> = 0.7, 2.2 Hz), 8.67 (dd, 1H, <i>J</i> = 1.7, 4.8 Hz), 8.31–8.29 (m, 1H), 7.38 (ddd, 1H, <i>J</i> = 0.8, 4.8, 8.0 Hz), 6.47 (bs, 1H), 6.41 (s,1H), 4.52–4.49 (m, 4H), 4.16–4.13 (m, 2H), 3.16–3.74 (m, 4H), 3.53–3.50 (m, 2H), 2.99–2.94 (m, 2H), 2.60–2.59 (m, 4H), 2.54–2.48 (m, 1H), 1.98–1.95 (m, 2H), 1.57–1.49 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 425 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> <i>N</i><sup>1</sup>,<i>N</i><sup>1</sup>-Dimethyl-<i>N</i><sup>2</sup>-(4-(4-morpholinopiperidin-1-yl)-6-(pyridine-3-yl)pyrimidin-2-yl)ethane-1,2-diamine (<b>39</b>)</h3><div class="NLM_p last"><b>39</b> was prepared in an analogous three-step procedure to that of compound <b>5</b>: To a stirred suspension of <i>N</i><sup>1</sup>-(4-chloro-6-(4-morpholinopiperidin-1-yl)pyrimidin-2-yl)-<i>N</i><sup>2</sup>,<i>N</i><sup>2</sup>-dimethylethane-1,2-diamine (0.04 g, 0.11 mmol) and 3-pyridylboronic acid (0.41 g, 0.33 mmol) in DMF (3 mL), a solution of potassium phosphate (0.07 g, 0.33 mmol) in water (1 mL) was added. The reaction mixture was degassed by bubbling argon through for 5 min, and then Pd(PPh<sub>3</sub>)<sub>4</sub> (0.004 g, 0.003 mmol) was added. The reaction was heated at 130 °C under microwave irradiation for 20 min. Reaction was filtered through Celite and partitioned between DCM (10 mL) and a saturated aqueous solution of NaHCO<sub>3</sub> (5 mL). The organics phase was dried over MgSO<sub>4</sub> before concentration to dryness. The crude was then purified by preparative mass directed autopreparative HPLC (method: 5–95 basic). The fractions containing product were pooled together and solvents were removed to obtain <b>39</b> as a white solid (18 mg, 39% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >98%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.11 (s, 1H), 8.63 (dd, 1H, <i>J</i> = 1.6, 4.8 Hz), 8.24 (d, 1H, <i>J</i> = 7.9 Hz), 7.35 (dd, 1H, <i>J</i> = 4.8, 7.9 Hz), 6.32 (s, 1H), 4.51–4.48 (m, 2H), 3.73–3.55 (m, 4H), 3.55–3.52 (m, 2H), 2.90 (t, 1H, <i>J</i> = 12.7 Hz), 2.58–2.54 (m, 4H), 2.53–2.51 (m, 2H), 2.49–2.44 (m, 1H), 2.27 (s, 6H), 1.94–1.91 (m, 2H), 1.54–1.45 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 412 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 4-(1-(2-(2,6-Dimethylpyridin-4-yl)-6-(pyridin-3-yl)pyrimidin-4-yl)piperidin-4-yl)morpholine (<b>40</b>)</h3><div class="NLM_p last">To a stirred solution of 4-[1-[6-chloro-2-(2,6-dimethyl-4-pyridyl)pyrimidin-4-yl]-4-piperidyl]morpholine (0.042 g, 0.11 mmol) and 3-pyridylboronic acid (0.040 g, 0.32 mmol) in DMF (3 mL), a solution of potassium phosphate (0.069 g, 0.32 mmol) in water (1 mL) was added. The reaction mixture was degassed by bubbling argon through for 5 min, and then Pd(PPh<sub>3</sub>)<sub>4</sub> (0.006 g, 0.005 mmol) was added. The reaction was heated at 130 °C under microwave irradiation for 20 min. The reaction crude was partitioned between DCM (15 mL) and saturated aqueous solution of NaHCO<sub>3</sub> (5 mL). The organics phase was dried over MgSO<sub>4</sub> before concentration to dryness. The crude was then purified by preparative HLPC. The fractions containing product were pooled together and solvents were removed to obtain <b>40</b> as off-white solid (8 mg, 17% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.27–9.26 (m, 1H), 8.72 (dd, 1H, <i>J</i> = 1.6, 4.8 Hz), 8.45–8.42 (m, 1H), 8.03 (bs, 2H), 7.46 (ddd, 1H, <i>J</i> = 0.6, 4.8, 8.0 Hz), 6.93 (s, 1H), 4.69 (broad m, 2H), 3.78 (broad m, 4H), 3.12–3.06 (m, 2H), 2.67–2.61 (m, 11H), 2.09–2.07 (m, 2H), 1.67–1.57 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 431 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 4-(1-(2-(2-Methylpyridin-4-yl)-6-(pyridin-3-yl)pyrimidin-4-yl)piperidin-4-yl)morpholine (<b>41</b>)</h3><div class="NLM_p last"><b>41</b> was prepared in an analogous three-step procedure to that of compound <b>43</b>: In a sealed 5 mL microwave vial, a solution of 4-[1-[2-methylsulfanyl-6-(3-pyridyl)pyrimidin-4-yl]-4-piperidyl]morpholine (0.07 g, 0.20 mmol) in THF (4 mL) was degassed by bubbling argon through for 5 min. (2-Methyl-4-pyridyl)boronic acid (0.03 g, 0.20 mmol), thiophene-2-carbonyloxycopper (0.06 g, 0.30 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (0.02 g, 0.02 mmol) were added at room temperature. The reaction was heated in a sealed tube at 85 °C for 18 h. The reaction crude was filtered through Celite and partitioned between DCM (10 mL) and ammonium hydroxide (5 mL). The organic phase was dried over magnesium sulfate, and solvents were removed under reduced pressure. The product was purified by mass directed autopreparative HPLC under basic conditions (5–95 prep basic). The fractions containing product were pooled together and solvents were removed to obtain <b>41</b> as white solid (9 mg, 10% yield). Purity by LCMS (UV chromatogram, 190–450 nm) 97%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.26 (d, 1H, <i>J</i> = 2.0 Hz), 8.72–8.71 (m, 1H), 8.62 (d, 1H, <i>J</i> = 5.2 Hz), 8.45–8.42 (m, 1H), 8.19 (s, 1H), 8.13 (d, 1H, <i>J</i> = 5.1 Hz), 7.44 (dd, 1H, <i>J</i> = 4.8, 7.9 Hz), 6.92 (s, 1H), 4.67–4.66 (m, 2H), 3.75–3.73 (m, 4H), 3.10–3.04 (m, 2H), 2.67 (s, 3H), 2.61–2.54 (m, 5H), 2.05–2.00 (m, 2H), 1.63–1.55 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 417 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 4-(1-(6-(Pyridine-3-yl)-2-(2-(trifluoromethyl)pyridine-4-yl)pyrimidin-4-yl)piperidin-4-yl)morpholine (<b>42</b>)</h3><div class="NLM_p last"><b>42</b> was prepared in an analogous three-step procedure to that of compound <b>63</b>: To a solution of 4-[1-(6-chloro-2-iodo-pyrimidin-4-yl)-4-piperidyl]morpholine (0.15 g, 0.37 mmol) and (2-(trifluoromethyl)pyridine-4yl)boronic acid (0.07 mg, 0.37) in DME (3 mL) in a 5 mL sealed microwave tube, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (0.01 g, 0.02 mmol) and an aqueous 2 M Na<sub>2</sub>CO<sub>3</sub> solution (0.55 mL) were added. The reaction was heated at 120 °C for 20 min under microwave irradiation. The reaction mixture was diluted with methanol (10 mL) and applied to a SCX column (5 g), and the product was eluted with 2 M NH<sub>3</sub> in MeOH. Solvents were removed under reduced pressure and the product was further purified by column chromatography (12 g silica cartridge) using (A) DCM, (B) 10% MeOH in DCM as eluents and the following gradient: 1 min hold at 100% A, 18 min ramp to 50% B, and 3 min hold at 50% B. The fractions containing product were pooled together and solvents were removed to obtain 4-(1-(6-chloro-2-(2-(trifluoromethyl)pyridine-4-yl)pyrimidin-4-yl)piperidin-4-yl)morpholine as an off-white solid (100 mg, 64% yield, 77% purity by LCMS). The product was used for the next step without further purification. To a stirred solution of 4-(1-(6-chloro-2-(2-(trifluoromethyl)pyridine-4-yl)pyrimidin-4-yl)piperidin-4-yl)morpholine (0.10 g, 0.23 mmol) and 3-pyridylboronic acid (0.057 g, 0.46 mmol) in DME (3 mL), Pd(PPh<sub>3</sub>)<sub>4</sub> (0.015 g, 0.01 mmol) and an aqueous solution of potassium phosphate (2M, 0.5 mL) were added. The reaction was heated at 120 °C for 20 min under microwave irradiation. The reaction crude was diluted with methanol (5 mL) and applied to a SCX column (1 g), and the product was eluted with 2 M NH<sub>3</sub> in MeOH. The product was further purified by preparative HLPC under basic conditions. The fractions containing product were pooled together and solvents were removed to obtain <b>42</b> as off-white solid (69 mg, 63% yield). Purity by LCMS (UV chromatogram, 190–450 nm) 98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.27 (d, 1H, <i>J</i> = 1.5 Hz), 8.87–8.86 (m, 1H), 8.74 (dd, 1H, <i>J</i> = 1.2, 4.6 Hz), 8.74–8.71 (m, 1H), 8.55 (dd, 1H, <i>J</i> = 1.1, 5.0 Hz), 8.45–8.43 (m, 2H), 7.47 (dd, 1H, <i>J</i> = 5.1, 7.7 Hz), 6.97 (s, 1H), 4.69–4.61 (m, 2H), 3.75–3.73 (m, 4H), 3.15–3.10 (m, 2H), 2.61–2.55 (m, 5H), 2.07–2.04 (m, 2H), 1.64–1.56 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 471 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 4-(1-(2-(3-Methylpyridin-4-yl)-6-(pyridin-3-yl)pyrimidin-4-yl)piperidin-4-yl)morpholine (<b>43</b>)</h3><div class="NLM_p last">In a sealed 5 mL microwave vial, a solution of 4-[1-[2-methylsulfanyl-6-(3-pyridyl)pyrimidin-4-yl]-4-piperidyl]morpholine (0.10 g, 0.26 mmol) in 1,4-dioxane (4 mL) was degassed by bubbling argon through for 5 min. (3-Methyl-4-pyridyl)boronic acid (0.073 g, 0.54 mmol), thiophene-2-carbonyloxycopper (0.102 g, 0.54 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (0.031 g, 0.03 mmol) were added at room temperature. The reaction was heated under microwave irradiation at 130 °C for 1 h. The reaction crude was applied to a SCX column (2 g), and the product was eluted with 2 M NH<sub>3</sub> in MeOH. Solvents were removed, and the product was purified by mass directed autopreparative HPLC under basic conditions. The fractions containing product were pooled together and solvents were removed to obtain <b>43</b> as off-white solid (31 mg, 26% yield). Purity by LCMS (UV chromatogram, 190–450 nm) 95%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.26–9.21 (m, 1H), 8.72–8.71 (m, 1H), 8.69–8.52 (m, 2H), 8.39–8.37 (m, 1H), 7.87 (d, 1H, <i>J</i> = 4.5 Hz), 7.43 (dd, 1H, <i>J</i> = 4.8, 7.8 Hz), 6.91(s, 1H), 4.62–4.59 (m, 2H), 3.80–3.72 (m, 4H), 3.10–3.04 (m, 2H), 2.66 (s, 3H), 2.64–2.52 (m, 5H), 2.06–2.03 (m, 2H), 1.65–1.55 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 417 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 4-(1-(2-(3-Fluoropyridin-4-yl)-6-(pyridin-3-yl)pyrimidin-4-yl)piperidin-4-yl)morpholine (<b>44</b>)</h3><div class="NLM_p last"><b>44</b> was prepared in an analogous three-step procedure to that of compound <b>43</b>: In a sealed 5 mL microwave vial, a solution of 4-[1-[2-methylsulfanyl-6-(3-pyridyl)pyrimidin-4-yl]-4-piperidyl]morpholine (0.10 g, 0.26 mmol) in 1,4-dioxane (4 mL) was degassed by bubbling argon through for 5 min. (3-Fluoro-4-pyridyl)boronic acid (0.076 g, 0.54 mmol), thiophene-2-carbonyloxycopper (0.102 g, 0.54 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (0.031 g, 0.03 mmol) were added at room temperature. The reaction was heated under microwave irradiation at 130 °C for 1 h. The reaction crude was applied to a SCX column (2 g), and the product was eluted with 2 M NH<sub>3</sub> in MeOH. Solvents were removed and the product was purified by mass directed autopreparative HPLC under basic conditions. The fractions containing product were pooled together and solvents were removed to obtain <b>44</b> as off-white solid (10 mg, 9% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.32–9.31 (m, 1H), 8.58–8.51 (m, 1H), 8.96–8.52 (m, 2H), 8.55–8.54 (m, 1H), 8.49–8.47 (m, 1H), 8.10–8.08 (m, 1H), 7.51–7.47 (m, 1H), 7.00 (s, 1H), 4.88–4.84 (m, 2H), 3.41–3.38 (m, 2H), 4.03–3.99 (m, 2H), 3.42–3.36 (m, 3H), 3.08–2.95 (m, 4H), 2.47–2.45 (m, 2H), 2.00–1.91 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 421 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 4-(4-(4-Morpholinopiperidin-1-yl)-6-(pyridin-3-yl)pyrimidin-2-yl)pyridine-2-ol (<b>45</b>)</h3><div class="NLM_p last"><b>45</b> was prepared in an analogous three-step procedure to that of compound <b>43</b>: In a sealed vial, a solution of 4-[1-[2-methylsulfanyl-6-(3-pyridyl)pyrimidin-4-yl]-4-piperidyl]morpholine (0.15 g, 0.40 mmol) in THF (8 mL) was degassed by bubbling argon through for 5 min. 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-ol (0.09 g,0.40 mmol), thiophene-2-carbonyloxycopper (0.12 g, 0.61 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (0.05 g, 0.04 mmol) were added at room temperature. The reaction was heated in a sealed tube at 85 °C for 16 h. The reaction crude was applied to a SCX column (2 g), and the product was eluted with 2 M NH<sub>3</sub> in MeOH. Solvents were removed under reduced pressured, and the product was purified by mass directed autopreparative HPLC under basic conditions (5–95 prep basic). The fractions containing product were pooled together and solvents were removed to obtain the product as white solid (10 mg, 6% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >97%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.73 (bs, 1H), 9.43–9.42 (m, 1H), 8.70–8.69 (m, 1H), 8.61–8.60 (m, 1H), 7.56 (dd, 1H, <i>J</i> = 4.8, 8.0 Hz), 7.49 (s, 1H), 7.48 (d, 1H, <i>J</i> = 6.8 Hz), 7.32 (s, 1H), 7.13 (d, 1H, <i>J</i> = 6.9 Hz), 4.70–4.67 (m, 2H), 3.57–3.55 (m, 4H), 3.06–3.01 (m, 2H), 1.92–1.90 (m, 2H), 1.44–1.36 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 419 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 4-(1-(2-(1-Methyl-1<i>H</i>-pyrazol-4-yl)-6-(pyridin-3-yl)pyrimidin-4-yl)piperidin-4-yl)morpholine (<b>46</b>)</h3><div class="NLM_p last"><b>46</b> was prepared in an analogous three-step procedure to that of compound <b>40</b>: To a stirred solution of 4-[1-[6-chloro-2-(1-methylpyrazol-4-yl)pyrimidin-4-yl]-4-piperidyl]morpholine (0.070 g, 0.19 mmol) and 3-pyridylboronic acid (0.071 g, 0.58 mmol) in DMF (3 mL), a solution of potassium phosphate (0.122 g, 0.58 mmol) in water (1 mL) was added. The reaction mixture was degassed by bubbling argon through for 5 min, and then Pd(PPh<sub>3</sub>)<sub>4</sub> (0.011 g, 0.010 mmol) was added. The reaction was heated at 130 °C under microwave irradiation for 20 min. Reaction was filtered through Celite and partitioned between DCM (15 mL) and a saturated aqueous solution of NaHCO<sub>3</sub> (5 mL). The organics phase was dried over MgSO<sub>4</sub> before concentration to dryness. The crude was then purified by preparative HLPC. The fractions containing product were pooled together and solvents were removed to obtain <b>46</b> as off-white solid (27 mg, 35% yield). Purity by LCMS (UV chromatogram, 190–450 nm) 96%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.21 (m, 1H), 8.70–8.69 (m, 1H), 8.38–8.36 (m, 1H), 8.17 (s, 1H), 8.10 (s, 1H), 7.43–7.40 (m, 1H), 6.74 (s, 1H), 4.66–4.60 (m, 2H), 3.97 (m, 3H), 3.79–3.68 (m, 4H), 3.03–2.97 (m, 2H), 2.62–2.56 (m, 5H), 2.05–1.95 (m, 2H), 1.58–1.54 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 406 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 4-(1-(6-(Pyridin-3-yl)-[2,4′-bipyrimidin]-4-yl)piperidin-4-yl)morpholine (<b>47</b>)</h3><div class="NLM_p last"><b>47</b> was prepared in an analogous three-step procedure to that of compound <b>43</b>: In a sealed 5 mL microwave vial, a solution of 4-[1-[2-methylsulfanyl-6-(3-pyridyl)pyrimidin-4-yl]-4-piperidyl]morpholine (0.075 g, 0.20 mmol) in THF (4 mL) was degassed by bubbling argon through for 5 min. Pyrimidin-4-ylboronic acid (0.037 g, 0.30 mmol), thiophene-2-carbonyloxycopper (0.058 g, 0.30 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (0.023 g,0.02 mmol) were added at room temperature. The reaction was heated in the sealed tube at 85 °C for 18 h. Reaction was filtered through Celite and partitioned between DCM (10 mL) and NH<sub>3</sub> aq (5 mL). The organic phase was dried over magnesium sulfate, and solvents were removed under reduced pressure. The product was purified by the product was purified by mass directed autopreparative HPLC under basic conditions. The fractions containing product were pooled together and solvents were removed to obtain <b>47</b> as off-white solid (10 mg, 12% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.45 (d, 1H, <i>J</i> = 1.3 Hz), 9.23 (dd, 1H, <i>J</i> = 0.7, 2.3 Hz), 8.93 (d, 1H, <i>J</i> = 5.2 Hz), 8.72 (dd, 1H, <i>J</i> = 1.6, 4.8 Hz), 8.46–8.43 (m, 2H), 7.45 (ddd, 1H, <i>J</i> = 0.8, 4.8, 8.0 Hz), 7.00 (s, 1H), 4.77–4.75 (m, 2H), 3.82–3.70 (m, 4H), 3.14–3.09 (m, 2H), 3.67–2.55 (m, 5H), 2.11–2.01 (m, 2H), 1.62–1.61 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 404 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> (General Procedure for Intermediates). 4-(1-(6-Chloro-2-(2,6-dimethylpyridin-4-yl)pyrimidin-4-yl)piperidin-4-yl)morpholine (<b>54</b>)</h3><div class="NLM_p">To a solution of 2,4,6-trichloropyrimidine (<b>52</b>) (10 g, 54.52 mmol) in ethanol (125 mL) at −5 °C (salt–ice bath), a solution of 4-(4-piperidyl)morpholine (9.28 g, 54.52 mmol) in ethanol (100 mL) was added dropwise followed by <i>N</i>,<i>N</i>-diethylethanamine (8.27 g, 81.78 mmol). Reaction mixture was stirred at −5 °C for 4 h. A white precipitate was formed. Solvents were removed under vacuum, and the reaction crude was partitioned between DCM (300 mL) and a saturated aqueous solution of NaHCO<sub>3</sub> (2 × 200 mL). The organic phase was dried over MgSO<sub>4</sub>, filtered, and solvents were removed under reduced pressure. The product was purified by column chromatography (330 g silica cartridge) using (A) DCM and (B) 5% MeOH in DCM as eluents and the following gradient: 2 min hold to 100% A, 20 min ramp to 50% B, 3 min hold to 50% B. Fractions containing pure product were pooled together and solvents were removed to obtain intermediate 4-(1-(2,6-dichloropyrimidin-4-yl)piperidin-4-yl)morpholine as a white solid (5.6 g). Column fractions that contained a mixture of the desired product and a side product resulting from substitution at C-2 were pooled together and solvents removed under vacuum. The mixture was suspended in methanol, and DCM was added to obtain a clear solution that was left standing at −20 °C. The precipitate was filtered and dried to obtain 4-(1-(2,6-dichloropyrimidin-4-yl)piperidin-4-yl)morpholine as a white solid (1.7 g). Both product fractions were mixed together (7.3 g, 42% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 6.42 (s, 1H), 4.41 (broad peak, 2H), 3.72 (broad peak, 4H), 2.01–2.97 (m, 2H), 2.55–2.47 (m, 5H), 1.97–1.94 (m, 2H), 1.54–1.46 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 317 [M + H]<sup>+</sup>.</div><div class="NLM_p last">To a stirred solution of 4-[1-(2,6-dichloropyrimidin-4-yl)-4-piperidyl]morpholine (0.20 g, 0.63 mmol) and 2,6-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine (0.16 g,0.69 mmol) in 1,4-dioxane (6 mL), a solution sodium carbonate (0.20 g, 1.89 mmol) in water (2 mL) was added. The reaction mixture was degassed by bubbling argon through for 5 min, and then Pd(PPh<sub>3</sub>)<sub>4</sub> (0.036 g,0.03 mmol) was added. The reaction was heated at 120 °C under microwave irradiation for 1 h. The reaction crude filtered through Celite and partitioned between DCM (15 mL) and saturated aqueous solution of NaHCO<sub>3</sub> (5 mL). The organics phase was dried over MgSO<sub>4</sub> before concentration to dryness. The product was purified by column chromatography (4 g silica cartridge) using (A) DCM and (B) 10%MeOH in DCM as eluents and the following gradient: 1 min hold at 100% A, 18 min ramp to 40% B, 5 min hold at 40% B. The fractions containing product were pooled together and solvents were removed to obtain <b>54</b> as an off-white solid (42 mg, 15% yield). Purity by LCMS (UV chromatogram, 190–450 nm) 88%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.81 (s, 2H), 6.47 (s, 1H), 4.64 (broad peak, 2H), 3.71–3.69 (m, 4H), 3.02–2.97 (m, 2H), 2.58 (s, 6H), 2.56–2.43(m, 5H), 1.98–1.86 (m, 2H), 1.55–1.47 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 388 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a> (General Procedure for Intermediates). 4-(1-(2-(Methylthio)-6-(pyridin-3-yl)pyrimidin-4-yl)piperidin-4-yl)morpholine (<b>58</b>)</h3><div class="NLM_p">To a stirred solution of 4-(4-piperidyl)morpholine (4.36 g, 25.63 mmol) in ethanol (50 mL), a solution of 4,6-dichloro-2-methylsulfanylpyrimidine (<b>56</b>) (5.00 g, 25.63 mmol) in ethanol (50 mL) was added dropwise at room temperature. <i>N</i>,<i>N</i>-Diethylethanamine (3. 89 g, 38.45 mmol) was then added, and the reaction mixture was stirred at room temperature for 3 h. A white precipitate was formed. Solvents were removed under reduced pressured, and the reaction crude was purified by filtration through a silica plug. First, impurities were removed with a mixture 1/1 of petroleum ether and ethyl acetate, and then the product eluted with methanol. The fractions containing product were pooled together and methanol was removed to obtain 4-[1-(6-chloro-2-methylsulfanyl-pyrimidin-4-yl)-4-piperidyl]morpholine (<b>57</b>) as off-white solid (7.17 g, 84% yield). Purity by LCMS (UV chromatogram, 190–450 nm) >98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 6.19 (s, 1H), 4.37 (broad peak, 2H), 3.76 (broad peak, 4H), 2.95–2.90 (m, 2H), 2.69–2.53 (m, 5H), 2.47 (s, 3H), 1.98–1.96 (m, 2H), 1.54–1.48 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 329 [M + H]<sup>+</sup>.</div><div class="NLM_p last">A solution of <b>57</b> (4.00 g, 12.16 mmol) and 3-pyridylboronic acid (2.99 g, 24.3 mmol) in 1,4-dioxane (60 mL) was divided equally into four 20 mL microwave vials. A solution of K<sub>3</sub>PO<sub>4</sub> (5.16 g, 24.32 mmol) in water (20 mL) was prepared, and an amount of 5 mL was added to each reaction vial. The reaction mixtures were degassed by bubbling argon through for 5 min. Then, Pd(PPh<sub>3</sub>)<sub>4</sub> (0.70 mg, 0.61 mmol) was added and the reaction mixtures were heated under microwave irradiation at 130 °C for 30 min. The contents of the three vials were pooled together, and the reaction was filtered through Celite and partitioned between DCM (2 × 200 mL) and a saturated aqueous solution of NaHCO<sub>3</sub> (20 mL). The product was purified by column chromatography (120 g silica cartridge) using (A) DCM and (B) 10% MeOH in DCM as eluents and the following gradient: 1 min hold at 100% A, 20 min ramp to 50% B, 10 min hold at 50% B. The fractions containing product were pooled together and the solvents removed to obtain a dark color solid. The solid was dissolved in methanol (50 mL) and 3-mercaptopropyl ethyl sulfide silica (2 g, 60–200 μM, Phosphonics SPM-32) was added. The stirred suspension was heated at 50 °C overnight. The silica was filtered and washed with methanol (100 mL). Methanol was removed under reduced pressure to obtain the <b>58</b> as an off-white solid (2.24 g, 50% yield). Purity by LCMS (UV chromatogram, 190–450 nm) 98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.14 (dd, 1H, <i>J</i> = 0.6, 2.2 Hz), 8.66 (dd, 1H, <i>J</i> = 1.7, 4.8), 8.32–8.29 (m, 1H), 7.37 (ddd, 1H, <i>J</i> = 0.7, 4.8, 7.9 Hz), 6.61 (s, 1H), 4.49–4.51 (m, 2H), 3.73–3.71 (m, 4H), 3.00–2.94 (m, 2H), 2.58–2.56 (m, 7H), 2.53–2.46(m, 1H), 1.97–1.95 (m, 2H), 1.52 (ddd, 2H, <i>J</i> = 4.3, 12.3, 24.2 Hz); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 372 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a> (General Procedure for Intermediates). 4,6-Dichloro-2-iodopyrimidine (<b>60</b>)</h3><div class="NLM_p last">To a stirred solution 4,6-dichloropyrimidin-2-amine (4.23 g, 25.8 mmol) and diiodomethane (6.91 g, 25.8 mmol) in anhydrous acetonitrile (36 mL) was added <i>tert</i>-butyl nitrite (11.97 g, 116.1 mmol) at room temperature under nitrogen. The reaction mixture was heated at 80 °C for 3 h and 30 min. The reaction crude was concentrated under reduced pressure and purified by column chromatography (80 g silica cartridge) using (A) Hex, (B) ethyl acetate as eluents and the following gradient: 5 min hold at 100% A, 10 min ramp to 20% B, 1 min hold at 20% B. Fractions containing product were pooled together and solvents removed under reduced pressure to obtain <b>12</b> as an off-white solid (4.49 g, 63% yield). Purity by LCMS (UV chromatogram, 190–450 nm) 98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.42 (m, 1H).</div></div><div id="sec11_3_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 4-(1-(6-Chloro-2-iodopyrimidin-4-yl)piperidin-4-yl)morpholine (<b>61</b>)</h3><div class="NLM_p last">To a stirred solution of 4,6-dichloro-2-iodopyrimidine (<b>60</b>) (6.14 g, 22.33 mmol) in ethanol (120 mL), a solution of 4-(4-piperidyl)morpholine (3.80 g, 22.33 mmol) in 7 mL of ethanol was added in an ice bath. <i>N</i>,<i>N</i>-Diethylethanamine (6.78 g, 66.98 mmol) was then added, and the reaction was stirred for 3 h at 0 °C. Solvents were removed under reduced pressure, and the reaction was partitioned between a saturated aqueous solution of NaHCO<sub>3</sub> (50 mL) and DCM (150 mL). Solvents were removed under vacuum, and reaction crude was purified by column chromatography (80 g silica cartridge) using (A) Hex, (B) ethyl acetate as eluents and the following gradient: 1 min hold at 100% A, 25 min ramp to 100% B, 15 min hold at 100% B. Fractions containing product were pooled together and solvents removed under reduced pressure to obtain <b>61</b> as yellow solid (7 g, 77% yield). Purity by LCMS (UV chromatogram, 190–450 nm) 98%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 6.44 (s, 1H), 3.72–3.70 (m, 4H), 2.97–2.93 (m, 2H), 2.55–2.53 (m, 4H), 2.50–2.45 (m, 1H), 1.95–1.92 (m, 2H), 1.52–1.43 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 409 [M + H]<sup>+</sup>.</div></div><div id="sec11_3_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 4-Chloro-6-(4-morpholinopiperidin-1-yl)pyrimidine-2-carbonitrile (<b>62</b>)</h3><div class="NLM_p last">In a stirred sealed tube a solution of 4-[1-(6-chloro-2-iodo-pyrimidin-4-yl)-4-piperidyl]morpholine (<b>61</b>) (0.29 g, 0.72 mmol) and copper cyanide (0.077 g, 0.86 mmol) in NMP (3 mL) was heated at 120 °C for 5 h. Reaction crude was applied to a SCX cartridge (5 g), and the product was diluted with a solution of 2 N NH<sub>3</sub> in methanol. The product was further purified by column chromatography (12 g silica cartridge) using (A) DCM, (B) 10% MeOH in DCM as eluents and the following gradient: 1 min hold at 100% A, 10 min ramp to 50% B, and 3 min hold at 50% B. The fractions containing product were pooled together and solvents were removed to obtain 4-chloro-6-(4-morpholinopiperidin-1-yl)pyrimidine-2-carbonitrile (<b>62</b>) as an off-white solid (139 mg, 62% yield). Purity by LCMS (UV chromatogram, 190–450 nm) 90%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 6.44 (s, 1H), 3.73–3.71 (m, 4H), 3.06–3.01 (m, 2H), 2.56–2.48 (m, 5H), 1.99–1.96 (m, 2H), 1.55–1.47 (m, 2H); LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 308 [M + H]<sup>+</sup>.</div></div><div id="sec12" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Biology Materials and Methods</h3><div class="NLM_p last">This information is in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00028/suppl_file/jm6b00028_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="secz" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Ethical Statements</h3><div class="NLM_p">In vivo antimalarial efficacy studies in <i>P. berghei</i> carried out at the Swiss Tropical and Public Health Institute (Basel, Switzerland) adhere to local and national regulations of laboratory animal welfare in Switzerland (awarded permission no. 1731). Protocols are regularly reviewed and revised following approval by the local authority (Veterinäramt Basel Stadt).</div><div class="NLM_p">In vivo antimalarial efficacy studies using <i>P. falciparum</i> in SCID mice carried out at GSK were approved by the Diseases of the Developing World Ethical Committee on Animal Research and carried out in accordance with European Directive 2010/63/EU and the GSK Policy on the Care, Welfare and Treatment of Animals. The animal studies were performed at DDW Laboratory Animal Science facilities accredited by AAALAC. The human biological samples were sourced ethically, and their research use was in accord with the terms of the informed consents.</div><div class="NLM_p last">Mouse pharmacokinetics were carried out at the University of Dundee. All regulated procedures on living animals were carried out under the authority of a license issued by the Home Office under the Animals (Scientific Procedures) Act 1986, as amended in 2012 (and in compliance with EU Directive EU/2010/63). License applications will have been approved by the University’s Ethical Review Committee (ERC) before submission to the Home Office. The ERC has a general remit to develop and oversee policy on all aspects of the use of animals on University premises and is a subcommittee of the University Court, its highest governing body.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i78"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00028">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44517" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44517" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00028" class="ext-link">10.1021/acs.jmedchem.6b00028</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Synthetic details for all compounds, supplementary data tables, additional information on ADMET and pharmacology (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00028/suppl_file/jm6b00028_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00028/suppl_file/jm6b00028_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00028/suppl_file/jm6b00028_si_001.pdf">jm6b00028_si_001.pdf (2.01 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00028/suppl_file/jm6b00028_si_002.csv">jm6b00028_si_002.csv (0.78 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b00028" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08683" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08683" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin D. Read</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Division of Biological Chemistry and Drug Discovery,
School of Life Sciences, University of Dundee, Dundee, DD1 5EH, U.K.</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#bed590ccdbdfdafedacbd0dadbdb90dfdd90cbd5"><span class="__cf_email__" data-cfemail="b3d89dc1d6d2d7f3d7c6ddd7d6d69dd2d09dc6d8">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ian H. Gilbert</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Division of Biological Chemistry and Drug Discovery,
School of Life Sciences, University of Dundee, Dundee, DD1 5EH, U.K.</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#10793e783e77797c727562645074657e7475753e71733e657b"><span class="__cf_email__" data-cfemail="a1c88fc98fc6c8cdc3c4d3d5e1c5d4cfc5c4c48fc0c28fd4ca">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Neil R. Norcross</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Division of Biological Chemistry and Drug Discovery,
School of Life Sciences, University of Dundee, Dundee, DD1 5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Beatriz Baragaña</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Division of Biological Chemistry and Drug Discovery,
School of Life Sciences, University of Dundee, Dundee, DD1 5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Caroline Wilson</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Division of Biological Chemistry and Drug Discovery,
School of Life Sciences, University of Dundee, Dundee, DD1 5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Irene Hallyburton</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Division of Biological Chemistry and Drug Discovery,
School of Life Sciences, University of Dundee, Dundee, DD1 5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Osuna-Cabello</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Division of Biological Chemistry and Drug Discovery,
School of Life Sciences, University of Dundee, Dundee, DD1 5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Suzanne Norval</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Division of Biological Chemistry and Drug Discovery,
School of Life Sciences, University of Dundee, Dundee, DD1 5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer Riley</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Division of Biological Chemistry and Drug Discovery,
School of Life Sciences, University of Dundee, Dundee, DD1 5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laste Stojanovski</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Division of Biological Chemistry and Drug Discovery,
School of Life Sciences, University of Dundee, Dundee, DD1 5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frederick R. C. Simeons</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Division of Biological Chemistry and Drug Discovery,
School of Life Sciences, University of Dundee, Dundee, DD1 5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Achim Porzelle</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Division of Biological Chemistry and Drug Discovery,
School of Life Sciences, University of Dundee, Dundee, DD1 5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raffaella Grimaldi</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Division of Biological Chemistry and Drug Discovery,
School of Life Sciences, University of Dundee, Dundee, DD1 5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sergio Wittlin</span> - <span class="hlFld-Affiliation affiliation">Swiss
Tropical and Public Health Institute (Swiss TPH), Socinstrasse 57, 4051 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Basel, CH-4003 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandra Duffy</span> - <span class="hlFld-Affiliation affiliation">Discovery
Biology, Eskitis Institute for Drug Discovery, Griffith University, Nathan, Queensland 4111, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vicky M. Avery</span> - <span class="hlFld-Affiliation affiliation">Discovery
Biology, Eskitis Institute for Drug Discovery, Griffith University, Nathan, Queensland 4111, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephan Meister</span> - <span class="hlFld-Affiliation affiliation">Department
of Pediatrics, University of California,
San Diego School of Medicine, 9500 Gilman Drive, 0741, La Jolla, California 92093, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura Sanz</span> - <span class="hlFld-Affiliation affiliation">Diseases
of the Developing World-Tres Cantos Medicines Development Campus, GlaxoSmithKline, c/Severo Ochoa, 2, Tres Cantos, 28760, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Belén Jiménez-Díaz</span> - <span class="hlFld-Affiliation affiliation">Diseases
of the Developing World-Tres Cantos Medicines Development Campus, GlaxoSmithKline, c/Severo Ochoa, 2, Tres Cantos, 28760, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Iñigo Angulo-Barturen</span> - <span class="hlFld-Affiliation affiliation">Diseases
of the Developing World-Tres Cantos Medicines Development Campus, GlaxoSmithKline, c/Severo Ochoa, 2, Tres Cantos, 28760, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Santiago Ferrer</span> - <span class="hlFld-Affiliation affiliation">Diseases
of the Developing World-Tres Cantos Medicines Development Campus, GlaxoSmithKline, c/Severo Ochoa, 2, Tres Cantos, 28760, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">María Santos Martínez</span> - <span class="hlFld-Affiliation affiliation">Diseases
of the Developing World-Tres Cantos Medicines Development Campus, GlaxoSmithKline, c/Severo Ochoa, 2, Tres Cantos, 28760, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francisco Javier Gamo</span> - <span class="hlFld-Affiliation affiliation">Diseases
of the Developing World-Tres Cantos Medicines Development Campus, GlaxoSmithKline, c/Severo Ochoa, 2, Tres Cantos, 28760, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julie A. Frearson</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Division of Biological Chemistry and Drug Discovery,
School of Life Sciences, University of Dundee, Dundee, DD1 5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David W. Gray</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Division of Biological Chemistry and Drug Discovery,
School of Life Sciences, University of Dundee, Dundee, DD1 5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan H. Fairlamb</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Division of Biological Chemistry and Drug Discovery,
School of Life Sciences, University of Dundee, Dundee, DD1 5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elizabeth A. Winzeler</span> - <span class="hlFld-Affiliation affiliation">Department
of Pediatrics, University of California,
San Diego School of Medicine, 9500 Gilman Drive, 0741, La Jolla, California 92093, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Waterson</span> - <span class="hlFld-Affiliation affiliation">Medicines
for Malaria Venture, International Center Cointrin, Entrance G, 3rd Floor, Route de Pré-Bois
20, P.O. Box 1826, CH-1215, Geneva 15, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simon F. Campbell</span> - <span class="hlFld-Affiliation affiliation">Medicines
for Malaria Venture, International Center Cointrin, Entrance G, 3rd Floor, Route de Pré-Bois
20, P.O. Box 1826, CH-1215, Geneva 15, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Willis</span> - <span class="hlFld-Affiliation affiliation">Medicines
for Malaria Venture, International Center Cointrin, Entrance G, 3rd Floor, Route de Pré-Bois
20, P.O. Box 1826, CH-1215, Geneva 15, Switzerland</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d941e4501-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i79">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11875" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11875" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We acknowledge Medicines for Malaria for financial support. The University of Dundee also acknowledges support from the Wellcome Trust (Grant 100476 and a Principal Research Fellowship to A.H.F.). This work is partially funded by the MSD Scottish Life Sciences Fund. As part of an ongoing contribution to Scottish life sciences, Merck Sharp & Dohme (MSD) Ltd. (known as Merck & Co., Inc., Kenilworth, NJ, U.S., in the United States and Canada) has given substantial monetary funding to the Scottish Funding Council (SFC) for distribution via the Scottish Universities Life Sciences Alliance (SULSA) to develop and deliver a high quality drug discovery research and training program. All aspects of the program have been geared toward attaining the highest value in terms of scientific discovery, training, and impact. The opinions expressed in this research are those of the authors and do not necessarily represent those of MSD or its affiliates. We thank Jolanda Kamber for assistance in performing the in vivo (Pb) antimalarial assays. We thank L. D. Shultz and The Jackson Laboratory for providing access to nonobese diabetic scid IL2Rγc<sup>null</sup> mice through their collaboration with GSK Tres Cantos Medicines Development Campus.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i80" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i80"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i81" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i81"> Abbreviations Used</h2><tr><td class="NLM_term">ACT</td><td class="NLM_def"><p class="first last">artemisinin-based combination therapy</p></td></tr><tr><td class="NLM_term">MMV</td><td class="NLM_def"><p class="first last">Medicines for Malaria Venture</p></td></tr><tr><td class="NLM_term">PRR</td><td class="NLM_def"><p class="first last">parasite reduction ratio</p></td></tr><tr><td class="NLM_term">SCX</td><td class="NLM_def"><p class="first last">strong cation exchange</p></td></tr><tr><td class="NLM_term">SCID</td><td class="NLM_def"><p class="first last">nonobese diabetic scid IL2Rγc<sup>null</sup></p></td></tr><tr><td class="NLM_term">WHO</td><td class="NLM_def"><p class="first last">World Health Organization</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13135" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13135" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 22 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Flannery, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winzeler, E. A.</span><span> </span><span class="NLM_article-title">Antimalarial drug discovery - approaches and progress to new medicines</span> <span class="citation_source-journal">Nat. Rev. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">849</span><span class="NLM_x">–</span> <span class="NLM_lpage">862</span><span class="refDoi"> DOI: 10.1038/nrmicro3138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1038%2Fnrmicro3138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=24217412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCrtb3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=849-862&author=E.+L.+Flanneryauthor=A.+K.+Chatterjeeauthor=E.+A.+Winzeler&title=Antimalarial+drug+discovery+-+approaches+and+progress+to+new+medicines&doi=10.1038%2Fnrmicro3138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial drug discovery - approaches and progress towards new medicines</span></div><div class="casAuthors">Flannery, Erika L.; Chatterjee, Arnab K.; Winzeler, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">849-862</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Malaria elimination has recently been reinstated as a global health priority but current therapies seem to be insufficient for the task.  Elimination efforts require new drug classes that alleviate symptoms, prevent transmission and provide a radical cure.  To develop these next-generation medicines, public-private partnerships are funding innovative approaches to identify compds. that target multiple parasite species at multiple stages of the parasite life cycle.  In this Review, we discuss the cell-, chem.- and target-based approaches used to discover new drug candidates that are currently in clin. trials or undergoing preclin. testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZRHIU_Rei97Vg90H21EOLACvtfcHk0lgeqoAjwDUJZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCrtb3L&md5=0ebf2e2f81cce7ac4de3fe19524a6ed9</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro3138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro3138%26sid%3Dliteratum%253Aachs%26aulast%3DFlannery%26aufirst%3DE.%2BL.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DAntimalarial%2520drug%2520discovery%2520-%2520approaches%2520and%2520progress%2520to%2520new%2520medicines%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2013%26volume%3D11%26spage%3D849%26epage%3D862%26doi%3D10.1038%2Fnrmicro3138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">World Health Organization</span><span class="NLM_x">. </span><span> </span><span class="NLM_article-title">World Malaria Report 2014</span>. <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+Health+Organization.+World+Malaria+Report+2014.+World+Health+Organization%3A+Geneva%2C+Switzerland%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DWorld%2520Malaria%2520Report%25202014%26pub%3DWorld%2520Health%2520Organization%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Ariey, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amaratunga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beghain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langlois, A.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khim, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duru, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouchier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sreng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuor, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bout, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, W. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandeur, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miotto, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ringwald, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Bras, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barale, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairhurst, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benoit-Vical, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercereau-Puijalon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menard, D.</span><span> </span><span class="NLM_article-title">A molecular marker of artemisinin-resistant <i>Plasmodium falciparum</i> malaria</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">505</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span><span class="refDoi"> DOI: 10.1038/nature12876</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1038%2Fnature12876" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=24352242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A280%3ADC%252BC2c3ns1aqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=505&publication_year=2014&pages=50-55&author=F.+Arieyauthor=B.+Witkowskiauthor=C.+Amaratungaauthor=J.+Beghainauthor=A.-C.+Langloisauthor=N.+Khimauthor=S.+Kimauthor=V.+Duruauthor=C.+Bouchierauthor=L.+Maauthor=P.+Limauthor=R.+Leangauthor=S.+Duongauthor=S.+Srengauthor=S.+Suonauthor=C.+M.+Chuorauthor=D.+M.+Boutauthor=S.+Menardauthor=W.+O.+Rogersauthor=B.+Gentonauthor=T.+Fandeurauthor=O.+Miottoauthor=P.+Ringwaldauthor=J.+Le+Brasauthor=A.+Berryauthor=J.-C.+Baraleauthor=R.+M.+Fairhurstauthor=F.+Benoit-Vicalauthor=O.+Mercereau-Puijalonauthor=D.+Menard&title=A+molecular+marker+of+artemisinin-resistant+Plasmodium+falciparum+malaria&doi=10.1038%2Fnature12876"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A molecular marker of artemisinin-resistant Plasmodium falciparum malaria</span></div><div class="casAuthors">Ariey Frederic; Beghain Johann; Barale Jean-Christophe; Witkowski Benoit; Khim Nimol; Kim Saorin; Duru Valentine; Amaratunga Chanaki; Langlois Anne-Claire; Bouchier Christiane; Ma Laurence; Lim Pharath; Leang Rithea; Duong Socheat; Sreng Sokunthea; Suon Seila; Chuor Char Meng; Bout Denis Mey; Menard Sandie; Berry Antoine; Rogers William O; Genton Blaise; Fandeur Thierry; Miotto Olivo; Ringwald Pascal; Le Bras Jacques; Fairhurst Rick M; Benoit-Vical Francoise; Mercereau-Puijalon Odile; Menard Didier</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">505</span>
        (<span class="NLM_cas:issue">7481</span>),
    <span class="NLM_cas:pages">50-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Plasmodium falciparum resistance to artemisinin derivatives in southeast Asia threatens malaria control and elimination activities worldwide.  To monitor the spread of artemisinin resistance, a molecular marker is urgently needed.  Here, using whole-genome sequencing of an artemisinin-resistant parasite line from Africa and clinical parasite isolates from Cambodia, we associate mutations in the PF3D7_1343700 kelch propeller domain ('K13-propeller') with artemisinin resistance in vitro and in vivo.  Mutant K13-propeller alleles cluster in Cambodian provinces where resistance is prevalent, and the increasing frequency of a dominant mutant K13-propeller allele correlates with the recent spread of resistance in western Cambodia.  Strong correlations between the presence of a mutant allele, in vitro parasite survival rates and in vivo parasite clearance rates indicate that K13-propeller mutations are important determinants of artemisinin resistance.  K13-propeller polymorphism constitutes a useful molecular marker for large-scale surveillance efforts to contain artemisinin resistance in the Greater Mekong Subregion and prevent its global spread.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTg24yBOxa0oSjiVMCqkKxVfW6udTcc2eZ4WGPmFDobwLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3ns1aqtg%253D%253D&md5=e25f4dcc9ccc361de4c35e650391b7ca</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnature12876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12876%26sid%3Dliteratum%253Aachs%26aulast%3DAriey%26aufirst%3DF.%26aulast%3DWitkowski%26aufirst%3DB.%26aulast%3DAmaratunga%26aufirst%3DC.%26aulast%3DBeghain%26aufirst%3DJ.%26aulast%3DLanglois%26aufirst%3DA.-C.%26aulast%3DKhim%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DDuru%26aufirst%3DV.%26aulast%3DBouchier%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DLim%26aufirst%3DP.%26aulast%3DLeang%26aufirst%3DR.%26aulast%3DDuong%26aufirst%3DS.%26aulast%3DSreng%26aufirst%3DS.%26aulast%3DSuon%26aufirst%3DS.%26aulast%3DChuor%26aufirst%3DC.%2BM.%26aulast%3DBout%26aufirst%3DD.%2BM.%26aulast%3DMenard%26aufirst%3DS.%26aulast%3DRogers%26aufirst%3DW.%2BO.%26aulast%3DGenton%26aufirst%3DB.%26aulast%3DFandeur%26aufirst%3DT.%26aulast%3DMiotto%26aufirst%3DO.%26aulast%3DRingwald%26aufirst%3DP.%26aulast%3DLe%2BBras%26aufirst%3DJ.%26aulast%3DBerry%26aufirst%3DA.%26aulast%3DBarale%26aufirst%3DJ.-C.%26aulast%3DFairhurst%26aufirst%3DR.%2BM.%26aulast%3DBenoit-Vical%26aufirst%3DF.%26aulast%3DMercereau-Puijalon%26aufirst%3DO.%26aulast%3DMenard%26aufirst%3DD.%26atitle%3DA%2520molecular%2520marker%2520of%2520artemisinin-resistant%2520Plasmodium%2520falciparum%2520malaria%26jtitle%3DNature%26date%3D2014%26volume%3D505%26spage%3D50%26epage%3D55%26doi%3D10.1038%2Fnature12876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Baird, J. K.</span><span> </span><span class="NLM_article-title">Malaria caused by <i>Plasmodium vivax</i>: recurrent, difficult to treat, disabling, and threatening to life—averting the infectious bite preempts these hazards</span> <span class="citation_source-journal">Pathog. Global Health</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">479</span><span class="refDoi"> DOI: 10.1179/2047772413Z.000000000179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1179%2F2047772413Z.000000000179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=24428831" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2013&pages=475-479&author=J.+K.+Baird&title=Malaria+caused+by+Plasmodium+vivax%3A+recurrent%2C+difficult+to+treat%2C+disabling%2C+and+threatening+to+life%E2%80%94averting+the+infectious+bite+preempts+these+hazards&doi=10.1179%2F2047772413Z.000000000179"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1179%2F2047772413Z.000000000179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1179%252F2047772413Z.000000000179%26sid%3Dliteratum%253Aachs%26aulast%3DBaird%26aufirst%3DJ.%2BK.%26atitle%3DMalaria%2520caused%2520by%2520Plasmodium%2520vivax%253A%2520recurrent%252C%2520difficult%2520to%2520treat%252C%2520disabling%252C%2520and%2520threatening%2520to%2520life%25E2%2580%2594averting%2520the%2520infectious%2520bite%2520preempts%2520these%2520hazards%26jtitle%3DPathog.%2520Global%2520Health%26date%3D2013%26volume%3D107%26spage%3D475%26epage%3D479%26doi%3D10.1179%2F2047772413Z.000000000179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Paul, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mytelka, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunwiddie, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persinger, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munos, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindborg, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schacht, A. L.</span><span> </span><span class="NLM_article-title">How to improve R&D productivity: the pharmaceutical industry’s grand challenge</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span><span class="refDoi"> DOI: 10.1038/nrd3078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1038%2Fnrd3078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=20168317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFemsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=203-214&author=S.+M.+Paulauthor=D.+S.+Mytelkaauthor=C.+T.+Dunwiddieauthor=C.+C.+Persingerauthor=B.+H.+Munosauthor=S.+R.+Lindborgauthor=A.+L.+Schacht&title=How+to+improve+R%26D+productivity%3A+the+pharmaceutical+industry%E2%80%99s+grand+challenge&doi=10.1038%2Fnrd3078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">How to improve R&D productivity: the pharmaceutical industry's grand challenge</span></div><div class="casAuthors">Paul, Steven M.; Mytelka, Daniel S.; Dunwiddie, Christopher T.; Persinger, Charles C.; Munos, Bernard H.; Lindborg, Stacy R.; Schacht, Aaron L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">203-214</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The pharmaceutical industry is under growing pressure from a range of environmental issues, including major losses of revenue owing to patent expirations, increasingly cost-constrained healthcare systems and more demanding regulatory requirements.  In our view, the key to tackling the challenges such issues pose to both the future viability of the pharmaceutical industry and advances in healthcare is to substantially increase the no. and quality of innovative, cost-effective new medicines, without incurring unsustainable R&D costs.  However, it is widely acknowledged that trends in industry R&D productivity have been moving in the opposite direction for a no. of years.  Here, we present a detailed anal. based on comprehensive, recent, industry-wide data to identify the relative contributions of each of the steps in the drug discovery and development process to overall R&D productivity.  We then propose specific strategies that could have the most substantial impact in improving R&D productivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY67PCIhaBVLVg90H21EOLACvtfcHk0lgwpHenzdgTog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFemsbg%253D&md5=2f32bcc48c869290eef18ff9400afcc5</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd3078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3078%26sid%3Dliteratum%253Aachs%26aulast%3DPaul%26aufirst%3DS.%2BM.%26aulast%3DMytelka%26aufirst%3DD.%2BS.%26aulast%3DDunwiddie%26aufirst%3DC.%2BT.%26aulast%3DPersinger%26aufirst%3DC.%2BC.%26aulast%3DMunos%26aufirst%3DB.%2BH.%26aulast%3DLindborg%26aufirst%3DS.%2BR.%26aulast%3DSchacht%26aufirst%3DA.%2BL.%26atitle%3DHow%2520to%2520improve%2520R%2526D%2520productivity%253A%2520the%2520pharmaceutical%2520industry%25E2%2580%2599s%2520grand%2520challenge%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D203%26epage%3D214%26doi%3D10.1038%2Fnrd3078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Burrows, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Huijsduijnen, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohrle, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oeuvray, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, T. N.</span><span> </span><span class="NLM_article-title">Designing the next generation of medicines for malaria control and eradication</span> <span class="citation_source-journal">Malar. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="refDoi"> DOI: 10.1186/1475-2875-12-187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1186%2F1475-2875-12-187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=23742293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A280%3ADC%252BC3sjgsVSisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=187&author=J.+N.+Burrowsauthor=R.+H.+van+Huijsduijnenauthor=J.+J.+Mohrleauthor=C.+Oeuvrayauthor=T.+N.+Wells&title=Designing+the+next+generation+of+medicines+for+malaria+control+and+eradication&doi=10.1186%2F1475-2875-12-187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Designing the next generation of medicines for malaria control and eradication</span></div><div class="casAuthors">Burrows Jeremy N; van Huijsduijnen Rob Hooft; Mohrle Jorg J; Oeuvray Claude; Wells Timothy N C</div><div class="citationInfo"><span class="NLM_cas:title">Malaria journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">187</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In the fight against malaria new medicines are an essential weapon.  For the parts of the world where the current gold standard artemisinin combination therapies are active, significant improvements can still be made: for example combination medicines which allow for single dose regimens, cheaper, safer and more effective medicines, or improved stability under field conditions.  For those parts of the world where the existing combinations show less than optimal activity, the priority is to have activity against emerging resistant strains, and other criteria take a secondary role.  For new medicines to be optimal in malaria control they must also be able to reduce transmission and prevent relapse of dormant forms: additional constraints on a combination medicine.  In the absence of a highly effective vaccine, new medicines are also needed to protect patient populations.  In this paper, an outline definition of the ideal and minimally acceptable characteristics of the types of clinical candidate molecule which are needed (target candidate profiles) is suggested.  In addition, the optimal and minimally acceptable characteristics of combination medicines are outlined (target product profiles).  MMV presents now a suggested framework for combining the new candidates to produce the new medicines.  Sustained investment over the next decade in discovery and development of new molecules is essential to enable the long-term delivery of the medicines needed to combat malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSjy7sj0k3cHtFxYDaSSP8XfW6udTcc2ebJJQn6Qx0Qubntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjgsVSisA%253D%253D&md5=c4283af83b04bc217f40528dde196e23</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1186%2F1475-2875-12-187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1475-2875-12-187%26sid%3Dliteratum%253Aachs%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3Dvan%2BHuijsduijnen%26aufirst%3DR.%2BH.%26aulast%3DMohrle%26aufirst%3DJ.%2BJ.%26aulast%3DOeuvray%26aufirst%3DC.%26aulast%3DWells%26aufirst%3DT.%2BN.%26atitle%3DDesigning%2520the%2520next%2520generation%2520of%2520medicines%2520for%2520malaria%2520control%2520and%2520eradication%26jtitle%3DMalar.%2520J.%26date%3D2013%26volume%3D12%26spage%3D187%26doi%3D10.1186%2F1475-2875-12-187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Brenk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schipani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krasowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, I. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frearson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyatt, P. G.</span><span> </span><span class="NLM_article-title">Lessons learnt from assembling screening libraries for drug discovery for neglected diseases</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">444</span><span class="refDoi"> DOI: 10.1002/cmdc.200700139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1002%2Fcmdc.200700139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=18064617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlt1Krtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=435-444&author=R.+Brenkauthor=A.+Schipaniauthor=D.+Jamesauthor=A.+Krasowskiauthor=I.+H.+Gilbertauthor=J.+Frearsonauthor=P.+G.+Wyatt&title=Lessons+learnt+from+assembling+screening+libraries+for+drug+discovery+for+neglected+diseases&doi=10.1002%2Fcmdc.200700139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons learned from assembling screening libraries for drug discovery for neglected diseases</span></div><div class="casAuthors">Brenk, Ruth; Schipani, Alessandro; James, Daniel; Krasowski, Agata; Gilbert, Ian Hugh; Frearson, Julie; Wyatt, Paul Graham</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">435-444</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">To enable the establishment of a drug discovery operation for neglected diseases, out of 2.3 million com. available compds. 222 552 compds. were selected for an in silico library, 57 438 for a diverse general screening library, and 1 697 compds. for a focused kinase set.  Compiling these libraries required a robust strategy for compd. selection.  Rules for unwanted groups were defined and selection criteria to enrich for lead-like compds. which facilitate straightforward structure-activity relationship exploration were established.  Further, a literature and patent review was undertaken to ext. key recognition elements of kinase inhibitors ("core fragments") to assemble a focused library for hit discovery for kinases.  Computational and exptl. characterization of the general screening library revealed that the selected compds. (1) span a broad range of lead-like space, (2) show a high degree of structural integrity and purity, and (3) demonstrate appropriate soly. for the purposes of biochem. screening.  The implications of this study for compd. selection, esp. in an academic environment with limited resources, are considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy_Ybsdg8QS7Vg90H21EOLACvtfcHk0lgwpHenzdgTog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlt1Krtb4%253D&md5=b804d0ac8766e954391798e24aa7fbff</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200700139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200700139%26sid%3Dliteratum%253Aachs%26aulast%3DBrenk%26aufirst%3DR.%26aulast%3DSchipani%26aufirst%3DA.%26aulast%3DJames%26aufirst%3DD.%26aulast%3DKrasowski%26aufirst%3DA.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DFrearson%26aufirst%3DJ.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26atitle%3DLessons%2520learnt%2520from%2520assembling%2520screening%2520libraries%2520for%2520drug%2520discovery%2520for%2520neglected%2520diseases%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D435%26epage%3D444%26doi%3D10.1002%2Fcmdc.200700139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Bennett, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paguio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gligorijevic, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seudieu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosar, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roepe, P. D.</span><span> </span><span class="NLM_article-title">Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1807</span><span class="NLM_x">–</span> <span class="NLM_lpage">1810</span><span class="refDoi"> DOI: 10.1128/AAC.48.5.1807-1810.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1128%2FAAC.48.5.1807-1810.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=15105139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjslCks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=1807-1810&author=T.+N.+Bennettauthor=M.+Paguioauthor=B.+Gligorijevicauthor=C.+Seudieuauthor=A.+D.+Kosarauthor=E.+Davidsonauthor=P.+D.+Roepe&title=Novel%2C+rapid%2C+and+inexpensive+cell-based+quantification+of+antimalarial+drug+efficacy&doi=10.1128%2FAAC.48.5.1807-1810.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy</span></div><div class="casAuthors">Bennett, Tyler N.; Paguio, Michelle; Gligorijevic, Bojana; Seudieu, Clement; Kosar, Andrew D.; Davidson, Eugene; Roepe, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1807-1810</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We report on the development of a new SYBR Green I-based plate assay for analyzing the activities of antimalarial drugs against intraerythrocytic Plasmodium falciparum.  This assay is considerably faster, less labor-intensive, and less expensive than conventional radiotracer (e.g., [3H]hypoxanthine and [3H]ethanolamine)-based assays or P. falciparum lactate dehydrogenase activity-based assays.  The assay significantly improves the pace at which antimalarial drug discovery efforts may proceed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFhAlJNQSwX7Vg90H21EOLACvtfcHk0lhkTj-JU_fABA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjslCks7o%253D&md5=87ee6c113aefaf11160624c8fe8c8354</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1128%2FAAC.48.5.1807-1810.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.48.5.1807-1810.2004%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DT.%2BN.%26aulast%3DPaguio%26aufirst%3DM.%26aulast%3DGligorijevic%26aufirst%3DB.%26aulast%3DSeudieu%26aufirst%3DC.%26aulast%3DKosar%26aufirst%3DA.%2BD.%26aulast%3DDavidson%26aufirst%3DE.%26aulast%3DRoepe%26aufirst%3DP.%2BD.%26atitle%3DNovel%252C%2520rapid%252C%2520and%2520inexpensive%2520cell-based%2520quantification%2520of%2520antimalarial%2520drug%2520efficacy%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D1807%26epage%3D1810%26doi%3D10.1128%2FAAC.48.5.1807-1810.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Plouffe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adrian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matzen, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nam, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trager, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winzeler, E. A.</span><span> </span><span class="NLM_article-title">In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">9059</span><span class="NLM_x">–</span> <span class="NLM_lpage">9064</span><span class="refDoi"> DOI: 10.1073/pnas.0802982105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1073%2Fpnas.0802982105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=18579783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosVCiurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=9059-9064&author=D.+Plouffeauthor=A.+Brinkerauthor=C.+McNamaraauthor=K.+Hensonauthor=N.+Katoauthor=K.+Kuhenauthor=A.+Nagleauthor=F.+Adrianauthor=J.+T.+Matzenauthor=P.+Andersonauthor=T.+G.+Namauthor=N.+S.+Grayauthor=A.+Chatterjeeauthor=J.+Janesauthor=S.+F.+Yanauthor=R.+Tragerauthor=J.+S.+Caldwellauthor=P.+G.+Schultzauthor=Y.+Zhouauthor=E.+A.+Winzeler&title=In+silico+activity+profiling+reveals+the+mechanism+of+action+of+antimalarials+discovered+in+a+high-throughput+screen&doi=10.1073%2Fpnas.0802982105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen</span></div><div class="casAuthors">Plouffe, David; Brinker, Achim; McNamara, Case; Henson, Kerstin; Kato, Nobutaka; Kuhen, Kelli; Nagle, Advait; Adrian, Francisco; Matzen, Jason T.; Anderson, Paul; Nam, Tae-gyu; Gray, Nathanael S.; Chatterjee, Arnab; Janes, Jeff; Yan, S. Frank; Trager, Richard; Caldwell, Jeremy S.; Schultz, Peter G.; Zhou, Yingyao; Winzeler, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">9059-9064</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The growing resistance to current first-line antimalarial drugs represents a major health challenge.  To facilitate the discovery of new antimalarials, we have implemented an efficient and robust high-throughput cell-based screen (1,536-well format) based on proliferation of Plasmodium falciparum (Pf) in erythrocytes.  From a screen of ≈ 1.7 million compds., we identified a diverse collection of ≈ 6,000 small mols. comprised of > 530 distinct scaffolds, all of which show potent antimalarial activity (< 1.25 μM).  Most known antimalarials were identified in this screen, thus validating our approach.  In addn., we identified many novel chem. scaffolds, which likely act through both known and novel pathways.  We further show that in some cases the mechanism of action of these antimalarials can be detd. by in silico compd. activity profiling.  This method uses large datasets from unrelated cellular and biochem. screens and the guilt-by-assocn. principle to predict which cellular pathway and/or protein target is being inhibited by select compds.  In addn., the screening method has the potential to provide the malaria community with many new starting points for the development of biol. probes and drugs with novel antiparasitic activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL9PFy0SUhdbVg90H21EOLACvtfcHk0lhkTj-JU_fABA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosVCiurw%253D&md5=bf14f093078c982e3604089588827166</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0802982105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0802982105%26sid%3Dliteratum%253Aachs%26aulast%3DPlouffe%26aufirst%3DD.%26aulast%3DBrinker%26aufirst%3DA.%26aulast%3DMcNamara%26aufirst%3DC.%26aulast%3DHenson%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DN.%26aulast%3DKuhen%26aufirst%3DK.%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DAdrian%26aufirst%3DF.%26aulast%3DMatzen%26aufirst%3DJ.%2BT.%26aulast%3DAnderson%26aufirst%3DP.%26aulast%3DNam%26aufirst%3DT.%2BG.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DChatterjee%26aufirst%3DA.%26aulast%3DJanes%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DS.%2BF.%26aulast%3DTrager%26aufirst%3DR.%26aulast%3DCaldwell%26aufirst%3DJ.%2BS.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DIn%2520silico%2520activity%2520profiling%2520reveals%2520the%2520mechanism%2520of%2520action%2520of%2520antimalarials%2520discovered%2520in%2520a%2520high-throughput%2520screen%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D9059%26epage%3D9064%26doi%3D10.1073%2Fpnas.0802982105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Gamo, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Cozar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavandera, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderwall, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peishoff, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardon, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Bustos, J. F.</span><span> </span><span class="NLM_article-title">Thousands of chemical starting points for antimalarial lead identification</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">465</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">310</span><span class="refDoi"> DOI: 10.1038/nature09107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1038%2Fnature09107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=20485427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmt1Ois7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2010&pages=305-310&author=F.+J.+Gamoauthor=L.+M.+Sanzauthor=J.+Vidalauthor=C.+de+Cozarauthor=E.+Alvarezauthor=J.+L.+Lavanderaauthor=D.+E.+Vanderwallauthor=D.+V.+Greenauthor=V.+Kumarauthor=S.+Hasanauthor=J.+R.+Brownauthor=C.+E.+Peishoffauthor=L.+R.+Cardonauthor=J.+F.+Garcia-Bustos&title=Thousands+of+chemical+starting+points+for+antimalarial+lead+identification&doi=10.1038%2Fnature09107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Thousands of chemical starting points for antimalarial lead identification</span></div><div class="casAuthors">Gamo, Francisco-Javier; Sanz, Laura M.; Vidal, Jaume; de Cozar, Cristina; Alvarez, Emilio; Lavandera, Jose-Luis; Vanderwall, Dana E.; Green, Darren V. S.; Kumar, Vinod; Hasan, Samiul; Brown, James R.; Peishoff, Catherine E.; Cardon, Lon R.; Garcia-Bustos, Jose F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">465</span>
        (<span class="NLM_cas:issue">7296</span>),
    <span class="NLM_cas:pages">305-310</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Malaria is a devastating infection caused by protozoa of the genus Plasmodium.  Drug resistance is widespread, no new chem. class of antimalarials has been introduced into clin. practice since 1996 and there is a recent rise of parasite strains with reduced sensitivity to the newest drugs.  We screened nearly 2 million compds. in GlaxoSmithKline's chem. library for inhibitors of P. falciparum, of which 13,533 were confirmed to inhibit parasite growth by at least 80% at 2 μM concn.  More than 8,000 also showed potent activity against the multidrug resistant strain Dd2.  Most (82%) compds. originate from internal company projects and are new to the malaria community.  Analyses using historic assay data suggest several novel mechanisms of antimalarial action, such as inhibition of protein kinases and host-pathogen interaction related targets.  Chem. structures and assocd. data are hereby made public to encourage addnl. drug lead identification efforts and further research into this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHijpWK_kBF7Vg90H21EOLACvtfcHk0lhvvTiX-0-cTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmt1Ois7k%253D&md5=a1fd8c0b89a5650ecba31f5456928b42</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature09107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09107%26sid%3Dliteratum%253Aachs%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DVidal%26aufirst%3DJ.%26aulast%3Dde%2BCozar%26aufirst%3DC.%26aulast%3DAlvarez%26aufirst%3DE.%26aulast%3DLavandera%26aufirst%3DJ.%2BL.%26aulast%3DVanderwall%26aufirst%3DD.%2BE.%26aulast%3DGreen%26aufirst%3DD.%2BV.%26aulast%3DKumar%26aufirst%3DV.%26aulast%3DHasan%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DJ.%2BR.%26aulast%3DPeishoff%26aufirst%3DC.%2BE.%26aulast%3DCardon%26aufirst%3DL.%2BR.%26aulast%3DGarcia-Bustos%26aufirst%3DJ.%2BF.%26atitle%3DThousands%2520of%2520chemical%2520starting%2520points%2520for%2520antimalarial%2520lead%2520identification%26jtitle%3DNature%26date%3D2010%26volume%3D465%26spage%3D305%26epage%3D310%26doi%3D10.1038%2Fnature09107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Ritchie, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, S. J. F.</span><span> </span><span class="NLM_article-title">The impact of aromatic ring count on compound developability - are too many aromatic rings a liability in drug design?</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1011</span><span class="NLM_x">–</span> <span class="NLM_lpage">1020</span><span class="refDoi"> DOI: 10.1016/j.drudis.2009.07.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1016%2Fj.drudis.2009.07.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=19729075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCgt7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=1011-1020&author=T.+J.+Ritchieauthor=S.+J.+F.+MacDonald&title=The+impact+of+aromatic+ring+count+on+compound+developability+-+are+too+many+aromatic+rings+a+liability+in+drug+design%3F&doi=10.1016%2Fj.drudis.2009.07.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of aromatic ring count on compound developability: Are too many aromatic rings a liability in drug design?</span></div><div class="casAuthors">Ritchie, Timothy J.; MacDonald, Simon J. F.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">21/22</span>),
    <span class="NLM_cas:pages">1011-1020</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The impact of arom. ring count (the no. of arom. and heteroarom. rings) in mols. has been analyzed against various developability parameters, aq. soly., lipophilicity, serum albumin binding, CyP450 inhibition and hERG inhibition.  On the basis of this anal., it was concluded that the fewer arom. rings contained in an oral drug candidate, the more developable that candidate is probably to be; in addn., more than three arom. rings in a mol. correlates with poorer compd. developability and, thus, an increased risk of attrition in development.  Data are also presented that demonstrate that even within a defined lipophilicity range, increased arom. ring count leads to decreased aq. soly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2hOeD6TNGUbVg90H21EOLACvtfcHk0lhvvTiX-0-cTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCgt7nP&md5=48454c9809e8225b4336ea76aad3f3ba</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2009.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2009.07.014%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DMacDonald%26aufirst%3DS.%2BJ.%2BF.%26atitle%3DThe%2520impact%2520of%2520aromatic%2520ring%2520count%2520on%2520compound%2520developability%2520-%2520are%2520too%2520many%2520aromatic%2520rings%2520a%2520liability%2520in%2520drug%2520design%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26spage%3D1011%26epage%3D1020%26doi%3D10.1016%2Fj.drudis.2009.07.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Ritchie, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, S. J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickett, S. D.</span><span> </span><span class="NLM_article-title">The impact of aromatic ring count on compound developability: further insights by examiing carbo- and hetero-aromatic and -aliphatic ring types</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span><span class="refDoi"> DOI: 10.1016/j.drudis.2010.11.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1016%2Fj.drudis.2010.11.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=164-171&author=T.+J.+Ritchieauthor=S.+J.+F.+MacDonaldauthor=R.+J.+Youngauthor=S.+D.+Pickett&title=The+impact+of+aromatic+ring+count+on+compound+developability%3A+further+insights+by+examiing+carbo-+and+hetero-aromatic+and+-aliphatic+ring+types&doi=10.1016%2Fj.drudis.2010.11.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DMacDonald%26aufirst%3DS.%2BJ.%2BF.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DPickett%26aufirst%3DS.%2BD.%26atitle%3DThe%2520impact%2520of%2520aromatic%2520ring%2520count%2520on%2520compound%2520developability%253A%2520further%2520insights%2520by%2520examiing%2520carbo-%2520and%2520hetero-aromatic%2520and%2520-aliphatic%2520ring%2520types%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D164%26epage%3D171%26doi%3D10.1016%2Fj.drudis.2010.11.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Lovering, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bikker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span> </span><span class="NLM_article-title">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6752</span><span class="NLM_x">–</span> <span class="NLM_lpage">6756</span><span class="refDoi"> DOI: 10.1021/jm901241e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+Flatland%3A+Increasing+Saturation+as+an+Approach+to+Improving+Clinical+Success&doi=10.1021%2Fjm901241e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0lhmytaKtas1Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520Flatland%253A%2520Increasing%2520Saturation%2520as%2520an%2520Approach%2520to%2520Improving%2520Clinical%2520Success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756%26doi%3D10.1021%2Fjm901241e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Peters, W.</span> <span class="citation_source-book">Chemotherapy and Drug Resistance in Malaria</span>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">1987</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1987&author=W.+Peters&title=Chemotherapy+and+Drug+Resistance+in+Malaria"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DW.%26btitle%3DChemotherapy%2520and%2520Drug%2520Resistance%2520in%2520Malaria%26pub%3DAcademic%2520Press%26date%3D1987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Jimenez-Diaz, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulet, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viera, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garuti, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibanez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez-Doval, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shultz, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gargallo-Viola, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo-Barturen, I.</span><span> </span><span class="NLM_article-title">Improved murine model of malaria using <i>Plasmodium falciparum</i> competent strains and non-myelodepleted NOD-scid IL2Rgammanull mice engrafted with human erythrocytes</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4533</span><span class="NLM_x">–</span> <span class="NLM_lpage">4536</span><span class="refDoi"> DOI: 10.1128/AAC.00519-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1128%2FAAC.00519-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=19596869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KkurbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=4533-4536&author=M.+B.+Jimenez-Diazauthor=T.+Muletauthor=S.+Vieraauthor=V.+Gomezauthor=H.+Garutiauthor=J.+Ibanezauthor=A.+Alvarez-Dovalauthor=L.+D.+Shultzauthor=A.+Martinezauthor=D.+Gargallo-Violaauthor=I.+Angulo-Barturen&title=Improved+murine+model+of+malaria+using+Plasmodium+falciparum+competent+strains+and+non-myelodepleted+NOD-scid+IL2Rgammanull+mice+engrafted+with+human+erythrocytes&doi=10.1128%2FAAC.00519-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Improved murine model of malaria using Plasmodium falciparum competent strains and non-myelodepleted NOD-scid IL2Rγnull mice engrafted with human erythrocytes</span></div><div class="casAuthors">Jimenez-Diaz, Maria Belen; Mulet, Teresa; Viera, Sara; Gomez, Vanessa; Garuti, Helen; Ibanez, Javier; Alvarez-Doval, Angela; Shultz, Leonard D.; Martinez, Antonio; Gargallo-Viola, Domingo; Angulo-Barturen, Inigo</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4533-4536</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Murine models of Plasmodium falciparum malaria may become crucial tools in drug discovery.  Here we show that non-myelodepleted NOD-scid IL2Rγnull mice engrafted with human erythrocytes support an infectious burden up to tenfold higher than that supported by engrafted NOD-scid β2microglobulinnull mice.  The new model was validated for drug discovery and was used to assess the therapeutic efficacy of 4-pyridones, selective inhibitors of P. falciparum cytochrome bc1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoGw5NKfthdbVg90H21EOLACvtfcHk0lhmytaKtas1Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KkurbO&md5=df25f5f7382b0b422a9e9b2137a66093</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FAAC.00519-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00519-09%26sid%3Dliteratum%253Aachs%26aulast%3DJimenez-Diaz%26aufirst%3DM.%2BB.%26aulast%3DMulet%26aufirst%3DT.%26aulast%3DViera%26aufirst%3DS.%26aulast%3DGomez%26aufirst%3DV.%26aulast%3DGaruti%26aufirst%3DH.%26aulast%3DIbanez%26aufirst%3DJ.%26aulast%3DAlvarez-Doval%26aufirst%3DA.%26aulast%3DShultz%26aufirst%3DL.%2BD.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DGargallo-Viola%26aufirst%3DD.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26atitle%3DImproved%2520murine%2520model%2520of%2520malaria%2520using%2520Plasmodium%2520falciparum%2520competent%2520strains%2520and%2520non-myelodepleted%2520NOD-scid%2520IL2Rgammanull%2520mice%2520engrafted%2520with%2520human%2520erythrocytes%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D4533%26epage%3D4536%26doi%3D10.1128%2FAAC.00519-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Angulo-Barturen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez-Diaz, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulet, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rullas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herreros, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regadera, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bathurst, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompliano, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de las Heras, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gargallo-Viola, D.</span><span> </span><span class="NLM_article-title">A murine model of falciparum-malaria by <i>in vivo</i> selection of competent strains in non-myelodepleted mice engrafted with human erythrocytes</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e2252</span><span class="refDoi"> DOI: 10.1371/journal.pone.0002252</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1371%2Fjournal.pone.0002252" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=18493601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A280%3ADC%252BD1czjtVahsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=e2252&author=I.+Angulo-Barturenauthor=M.+B.+Jimenez-Diazauthor=T.+Muletauthor=J.+Rullasauthor=E.+Herrerosauthor=S.+Ferrerauthor=E.+Jimenezauthor=A.+Mendozaauthor=J.+Regaderaauthor=P.+J.+Rosenthalauthor=I.+Bathurstauthor=D.+L.+Pomplianoauthor=F.+G.+de+las+Herasauthor=D.+Gargallo-Viola&title=A+murine+model+of+falciparum-malaria+by+in+vivo+selection+of+competent+strains+in+non-myelodepleted+mice+engrafted+with+human+erythrocytes&doi=10.1371%2Fjournal.pone.0002252"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A murine model of falciparum-malaria by in vivo selection of competent strains in non-myelodepleted mice engrafted with human erythrocytes</span></div><div class="casAuthors">Angulo-Barturen Inigo; Jimenez-Diaz Maria Belen; Mulet Teresa; Rullas Joaquin; Herreros Esperanza; Ferrer Santiago; Jimenez Elena; Mendoza Alfonso; Regadera Javier; Rosenthal Philip J; Bathurst Ian; Pompliano David L; Gomez de las Heras Federico; Gargallo-Viola Domingo</div><div class="citationInfo"><span class="NLM_cas:title">PloS one</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e2252</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">To counter the global threat caused by Plasmodium falciparum malaria, new drugs and vaccines are urgently needed.  However, there are no practical animal models because P. falciparum infects human erythrocytes almost exclusively.  Here we describe a reliable falciparum murine model of malaria by generating strains of P. falciparum in vivo that can infect immunodeficient mice engrafted with human erythrocytes.  We infected NOD(scid/beta2m-/-) mice engrafted with human erythrocytes with P. falciparum obtained from in vitro cultures.  After apparent clearance, we obtained isolates of P. falciparum able to grow in peripheral blood of engrafted NOD(scid/beta2m-/-) mice.  Of the isolates obtained, we expanded in vivo and established the isolate Pf3D7(0087/N9) as a reference strain for model development.  Pf3D7(0087/N9) caused productive persistent infections in 100% of engrafted mice infected intravenously.  The infection caused a relative anemia due to selective elimination of human erythrocytes by a mechanism dependent on parasite density in peripheral blood.  Using this model, we implemented and validated a reproducible assay of antimalarial activity useful for drug discovery.  Thus, our results demonstrate that P. falciparum contains clones able to grow reproducibly in mice engrafted with human erythrocytes without the use of myeloablative methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSGBUV1EinlYVHFYivNCdPRfW6udTcc2eYVUTECxEC1irntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czjtVahsg%253D%253D&md5=02f4475ecc0524005f4538e98a0649d8</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0002252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0002252%26sid%3Dliteratum%253Aachs%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DJimenez-Diaz%26aufirst%3DM.%2BB.%26aulast%3DMulet%26aufirst%3DT.%26aulast%3DRullas%26aufirst%3DJ.%26aulast%3DHerreros%26aufirst%3DE.%26aulast%3DFerrer%26aufirst%3DS.%26aulast%3DJimenez%26aufirst%3DE.%26aulast%3DMendoza%26aufirst%3DA.%26aulast%3DRegadera%26aufirst%3DJ.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DBathurst%26aufirst%3DI.%26aulast%3DPompliano%26aufirst%3DD.%2BL.%26aulast%3Dde%2Blas%2BHeras%26aufirst%3DF.%2BG.%26aulast%3DGargallo-Viola%26aufirst%3DD.%26atitle%3DA%2520murine%2520model%2520of%2520falciparum-malaria%2520by%2520in%2520vivo%2520selection%2520of%2520competent%2520strains%2520in%2520non-myelodepleted%2520mice%2520engrafted%2520with%2520human%2520erythrocytes%26jtitle%3DPLoS%2520One%26date%3D2008%26volume%3D3%26spage%3De2252%26doi%3D10.1371%2Fjournal.pone.0002252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Sanz, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De-Cozar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, X. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llergo, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Bustos, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, F. J.</span><span> </span><span class="NLM_article-title"><i>P. falciparum</i> in vitro killing rates allow to discriminate between different antimalarial mode-of-action</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e30949</span><span class="refDoi"> DOI: 10.1371/journal.pone.0030949</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1371%2Fjournal.pone.0030949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=22383983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsFynsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e30949&author=L.+M.+Sanzauthor=B.+Crespoauthor=C.+De-Cozarauthor=X.+C.+Dingauthor=J.+L.+Llergoauthor=J.+N.+Burrowsauthor=J.+F.+Garcia-Bustosauthor=F.+J.+Gamo&title=P.+falciparum+in+vitro+killing+rates+allow+to+discriminate+between+different+antimalarial+mode-of-action&doi=10.1371%2Fjournal.pone.0030949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">P. falciparum in vitro killing rates allow to discriminate between different antimalarial mode-of-action</span></div><div class="casAuthors">Sanz, Laura M.; Crespo, Benigno; De-Cozar, Cristina; Ding, Xavier C.; Llergo, Jose L.; Burrows, Jeremy N.; Garcia-Bustos, Jose F.; Gamo, Francisco-Javier</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e30949</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Chemotherapy is still the cornerstone for malaria control.  Developing drugs against Plasmodium parasites and monitoring their efficacy requires methods to accurately det. the parasite killing rate in response to treatment.  Commonly used techniques essentially measure metabolic activity as a proxy for parasite viability.  However, these approaches are susceptible to artifacts, as viability and metab. are two parameters that are coupled during the parasite life cycle but can be differentially affected in response to drug actions.  Moreover, traditional techniques do not allow to measure the speed-of-action of compds. on parasite viability, which is an essential efficacy determinant.  We present here a comprehensive methodol. to measure in vitro the direct effect of antimalarial compds. over the parasite viability, which is based on limiting serial diln. of treated parasites and re-growth monitoring.  This methodol. allows to precisely det. the killing rate of antimalarial compds., which can be quantified by the parasite redn. ratio and parasite clearance time, which are key mode-of-action parameters.  Importantly, we demonstrate that this technique readily permits to det. compd. killing activities that might be otherwise missed by traditional, metab.-based techniques.  The anal. of a large set of antimalarial drugs reveals that this viability-based assay allows to discriminate compds. based on their antimalarial mode-of-action.  This approach has been adapted to perform medium throughput screening, facilitating the identification of fast-acting antimalarial compds., which are crucially needed for the control and possibly the eradication of malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlaUZufRfYxbVg90H21EOLACvtfcHk0lg4cb0BJf1ggQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsFynsLY%253D&md5=65d5d1a24dbe1811301ac5e684c886c5</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0030949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0030949%26sid%3Dliteratum%253Aachs%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DCrespo%26aufirst%3DB.%26aulast%3DDe-Cozar%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DX.%2BC.%26aulast%3DLlergo%26aufirst%3DJ.%2BL.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DGarcia-Bustos%26aufirst%3DJ.%2BF.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26atitle%3DP.%2520falciparum%2520in%2520vitro%2520killing%2520rates%2520allow%2520to%2520discriminate%2520between%2520different%2520antimalarial%2520mode-of-action%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De30949%26doi%3D10.1371%2Fjournal.pone.0030949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Meister, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plouffe, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhen, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonamy, G. M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bopp, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borboa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bright, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dharia, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gagaring, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gettayacamin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groessl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidock, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nam, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richmond, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rottmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Froissard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glynne, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sattabongkot, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuntland, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diagana, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winzeler, E. A.</span><span> </span><span class="NLM_article-title">Imaging of <i>Plasmodium</i> liver stages to drive next-generation antimalarial drug discovery</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">334</span><span class="NLM_x">, </span> <span class="NLM_fpage">1372</span><span class="NLM_x">–</span> <span class="NLM_lpage">1377</span><span class="refDoi"> DOI: 10.1126/science.1211936</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1126%2Fscience.1211936" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=22096101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFOjt7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2011&pages=1372-1377&author=S.+Meisterauthor=D.+M.+Plouffeauthor=K.+L.+Kuhenauthor=G.+M.+C.+Bonamyauthor=T.+Wuauthor=S.+W.+Barnesauthor=S.+E.+Boppauthor=R.+Borboaauthor=A.+T.+Brightauthor=J.+W.+Cheauthor=S.+Cohenauthor=N.+V.+Dhariaauthor=K.+Gagaringauthor=M.+Gettayacaminauthor=P.+Gordonauthor=T.+Groesslauthor=N.+Katoauthor=M.+C.+S.+Leeauthor=C.+W.+McNamaraauthor=D.+A.+Fidockauthor=A.+Nagleauthor=T.+G.+Namauthor=W.+Richmondauthor=J.+Rolandauthor=M.+Rottmannauthor=B.+Zhouauthor=P.+Froissardauthor=R.+J.+Glynneauthor=D.+Mazierauthor=J.+Sattabongkotauthor=P.+G.+Schultzauthor=T.+Tuntlandauthor=J.+R.+Walkerauthor=Y.+Y.+Zhouauthor=A.+Chatterjeeauthor=T.+T.+Diaganaauthor=E.+A.+Winzeler&title=Imaging+of+Plasmodium+liver+stages+to+drive+next-generation+antimalarial+drug+discovery&doi=10.1126%2Fscience.1211936"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery</span></div><div class="casAuthors">Meister, Stephan; Plouffe, David M.; Kuhen, Kelli L.; Bonamy, Ghislain M. C.; Wu, Tao; Barnes, S. Whitney; Bopp, Selina E.; Borboa, Rachel; Bright, A. Taylor; Che, Jianwei; Cohen, Steve; Dharia, Neekesh V.; Gagaring, Kerstin; Gettayacamin, Montip; Gordon, Perry; Groessl, Todd; Kato, Nobutaka; Lee, Marcus C. S.; McNamara, Case W.; Fidock, David A.; Nagle, Advait; Nam, Tae-gyu; Richmond, Wendy; Roland, Jason; Rottmann, Matthias; Zhou, Bin; Froissard, Patrick; Glynne, Richard J.; Mazier, Dominique; Sattabongkot, Jetsumon; Schultz, Peter G.; Tuntland, Tove; Walker, John R.; Zhou, Yingyao; Chatterjee, Arnab; Diagana, Thierry T.; Winzeler, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">6061</span>),
    <span class="NLM_cas:pages">1372-1377</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Most malaria drug development focuses on parasite stages detected in red blood cells, even though, to achieve eradication, next-generation drugs active against both erythrocytic and exo-erythrocytic forms would be preferable.  We applied a multifactorial approach to a set of >4000 com. available compds. with previously demonstrated blood-stage activity (median inhibitory concn. < 1 micromolar) and identified chem. scaffolds with potent activity against both forms.  From this screen, we identified an imidazolopiperazine scaffold series that was highly enriched among compds. active against Plasmodium liver stages.  The orally bioavailable lead imidazolopiperazine confers complete causal prophylactic protection (15 mg/kg) in rodent models of malaria and shows potent in vivo blood-stage therapeutic activity.  The open-source chem. tools resulting from our effort provide starting points for future drug discovery programs, as well as opportunities for researchers to investigate the biol. of exo-erythrocytic forms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyO41naZtcdrVg90H21EOLACvtfcHk0liJL5kAfxEBfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFOjt7vN&md5=45b2993be36e36eabe1d9280c86c3db2</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1126%2Fscience.1211936&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1211936%26sid%3Dliteratum%253Aachs%26aulast%3DMeister%26aufirst%3DS.%26aulast%3DPlouffe%26aufirst%3DD.%2BM.%26aulast%3DKuhen%26aufirst%3DK.%2BL.%26aulast%3DBonamy%26aufirst%3DG.%2BM.%2BC.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DBarnes%26aufirst%3DS.%2BW.%26aulast%3DBopp%26aufirst%3DS.%2BE.%26aulast%3DBorboa%26aufirst%3DR.%26aulast%3DBright%26aufirst%3DA.%2BT.%26aulast%3DChe%26aufirst%3DJ.%2BW.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DDharia%26aufirst%3DN.%2BV.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DGettayacamin%26aufirst%3DM.%26aulast%3DGordon%26aufirst%3DP.%26aulast%3DGroessl%26aufirst%3DT.%26aulast%3DKato%26aufirst%3DN.%26aulast%3DLee%26aufirst%3DM.%2BC.%2BS.%26aulast%3DMcNamara%26aufirst%3DC.%2BW.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DNam%26aufirst%3DT.%2BG.%26aulast%3DRichmond%26aufirst%3DW.%26aulast%3DRoland%26aufirst%3DJ.%26aulast%3DRottmann%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DB.%26aulast%3DFroissard%26aufirst%3DP.%26aulast%3DGlynne%26aufirst%3DR.%2BJ.%26aulast%3DMazier%26aufirst%3DD.%26aulast%3DSattabongkot%26aufirst%3DJ.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DZhou%26aufirst%3DY.%2BY.%26aulast%3DChatterjee%26aufirst%3DA.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DImaging%2520of%2520Plasmodium%2520liver%2520stages%2520to%2520drive%2520next-generation%2520antimalarial%2520drug%2520discovery%26jtitle%3DScience%26date%3D2011%26volume%3D334%26spage%3D1372%26epage%3D1377%26doi%3D10.1126%2Fscience.1211936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Duffy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, V. M.</span><span> </span><span class="NLM_article-title">Identification of inhibitors of <i>Plasmodium falciparum</i> gametocyte development</span> <span class="citation_source-journal">Malar. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">408</span><span class="refDoi"> DOI: 10.1186/1475-2875-12-408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1186%2F1475-2875-12-408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=24206914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvFehs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=408&author=S.+Duffyauthor=V.+M.+Avery&title=Identification+of+inhibitors+of+Plasmodium+falciparum+gametocyte+development&doi=10.1186%2F1475-2875-12-408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of inhibitors of Plasmodium falciparum gametocyte development</span></div><div class="casAuthors">Duffy, Sandra; Avery, Vicky M.</div><div class="citationInfo"><span class="NLM_cas:title">Malaria Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">408/1-408/15, 15 pp.</span>CODEN:
                <span class="NLM_cas:coden">MJAOAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-2875</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Plasmodium falciparum gametocytes, specifically mature stages, are the only stage in man transmissible to the mosquito vector responsible for malaria transmission.  Anti-malarial drugs capable of killing these forms are considered essential for the eradication of malaria.  The comprehensive profiling of in vitro activity of anti-malarial compds. against both early (I-III) and late (IV-V) stage P. falciparum gametocytes, along with the high throughput screening (HTS) outcomes from the MMV malaria box are described.  Method: Two anti-gametocyte HTS assays based on confocal fluorescence microscopy, utilizing both a gametocyte specific protein (pfs16-Luc-GFP) and a viability marker (MitoTracker Red CM-H2XRos) (MTR), were used for the measurement of anti-gametocytocidal activity.  This combination provided a direct observation of gametocyte no. per assay well, while defining the viability of each gametocyte imaged.  Results: IC50 values were obtained for 36 current anti-malarial compds. for activities against asexual, early and late stage gametocytes.  The MMV malaria box was screened and actives progressed for IC50 evaluation.  Seven % of the "drug-like" and 21% of the "probe-like" compds. from the MMV malaria box demonstrated equiv. activity against both asexual and late stage gametocytes.  Conclusions: The assays described were shown to selectively identify compds. with gametocytocidal activity and have been demonstrated suitable for HTS with the capability of screening in the order of 20,000 compds. per screening campaign, two to three times per seven-day week.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKk3vbc59HXrVg90H21EOLACvtfcHk0liJL5kAfxEBfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvFehs7k%253D&md5=5b38ae9bee99e2566f7765099ca7801c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1186%2F1475-2875-12-408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1475-2875-12-408%26sid%3Dliteratum%253Aachs%26aulast%3DDuffy%26aufirst%3DS.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26atitle%3DIdentification%2520of%2520inhibitors%2520of%2520Plasmodium%2520falciparum%2520gametocyte%2520development%26jtitle%3DMalar.%2520J.%26date%3D2013%26volume%3D12%26spage%3D408%26doi%3D10.1186%2F1475-2875-12-408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Slee, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorjani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanier, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueter, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro-Palomino, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gual, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span> </span><span class="NLM_article-title">2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 1. Structure-activity relationships and optimization of heterocyclic substituents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1719</span><span class="NLM_x">–</span> <span class="NLM_lpage">1729</span><span class="refDoi"> DOI: 10.1021/jm701185v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701185v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1719-1729&author=D.+H.+Sleeauthor=Y.+Chenauthor=X.+Zhangauthor=M.+Moorjaniauthor=M.+C.+Lanierauthor=E.+Linauthor=J.+K.+Rueterauthor=J.+P.+Williamsauthor=S.+M.+Lechnerauthor=S.+Markisonauthor=S.+Malanyauthor=M.+Santosauthor=R.+S.+Grossauthor=K.+Jalaliauthor=Y.+Saiauthor=Z.+Zuoauthor=C.+Yangauthor=J.+C.+Castro-Palominoauthor=M.+I.+Crespoauthor=M.+Pratauthor=S.+Gualauthor=J.+L.+Diazauthor=J.+Saunders&title=2-Amino-N-pyrimidin-4-ylacetamides+as+A2A+receptor+antagonists%3A+1.+Structure-activity+relationships+and+optimization+of+heterocyclic+substituents&doi=10.1021%2Fjm701185v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm701185v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701185v%26sid%3Dliteratum%253Aachs%26aulast%3DSlee%26aufirst%3DD.%2BH.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMoorjani%26aufirst%3DM.%26aulast%3DLanier%26aufirst%3DM.%2BC.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DRueter%26aufirst%3DJ.%2BK.%26aulast%3DWilliams%26aufirst%3DJ.%2BP.%26aulast%3DLechner%26aufirst%3DS.%2BM.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DMalany%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DM.%26aulast%3DGross%26aufirst%3DR.%2BS.%26aulast%3DJalali%26aufirst%3DK.%26aulast%3DSai%26aufirst%3DY.%26aulast%3DZuo%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DCastro-Palomino%26aufirst%3DJ.%2BC.%26aulast%3DCrespo%26aufirst%3DM.%2BI.%26aulast%3DPrat%26aufirst%3DM.%26aulast%3DGual%26aufirst%3DS.%26aulast%3DDiaz%26aufirst%3DJ.%2BL.%26aulast%3DSaunders%26aufirst%3DJ.%26atitle%3D2-Amino-N-pyrimidin-4-ylacetamides%2520as%2520A2A%2520receptor%2520antagonists%253A%25201.%2520Structure-activity%2520relationships%2520and%2520optimization%2520of%2520heterocyclic%2520substituents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1719%26epage%3D1729%26doi%3D10.1021%2Fjm701185v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Liebeskind, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srogl, J.</span><span> </span><span class="NLM_article-title">Heteroaromatic thioether-boronic acid cross-coupling under neutral reaction conditions</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">979</span><span class="NLM_x">–</span> <span class="NLM_lpage">981</span><span class="refDoi"> DOI: 10.1021/ol0200091</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol0200091" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A528%3ADC%252BD38Xht1Gktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=979-981&author=L.+S.+Liebeskindauthor=J.+Srogl&title=Heteroaromatic+thioether-boronic+acid+cross-coupling+under+neutral+reaction+conditions&doi=10.1021%2Fol0200091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Heteroaromatic Thioether-Boronic Acid Cross-Coupling under Neutral Reaction Conditions</span></div><div class="casAuthors">Liebeskind, Lanny S.; Srogl, Jiri</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">979-981</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">π-Deficient heteroarom. thioethers undergo efficient palladium-catalyzed cross-coupling with boronic acids, mediated by copper(I) thiophene-2-carboxylate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowmqoxHMYfLbVg90H21EOLACvtfcHk0liJL5kAfxEBfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xht1Gktb0%253D&md5=ce42d2952572e0b36f0f60e6037a18f6</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fol0200091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0200091%26sid%3Dliteratum%253Aachs%26aulast%3DLiebeskind%26aufirst%3DL.%2BS.%26aulast%3DSrogl%26aufirst%3DJ.%26atitle%3DHeteroaromatic%2520thioether-boronic%2520acid%2520cross-coupling%2520under%2520neutral%2520reaction%2520conditions%26jtitle%3DOrg.%2520Lett.%26date%3D2002%26volume%3D4%26spage%3D979%26epage%3D981%26doi%3D10.1021%2Fol0200091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Parra, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercader, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agullo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abad-Somovilla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abad-Fuentes, A.</span><span> </span><span class="NLM_article-title">Generation of anti-azoxystrobin monoclonal antibodies from regioisomeric haptens functionalized at selected sites and development of indirect competitive immunoassays</span> <span class="citation_source-journal">Anal. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">715</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span><span class="refDoi"> DOI: 10.1016/j.aca.2011.12.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1016%2Fj.aca.2011.12.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=22244174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsFWhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=715&publication_year=2012&pages=105-112&author=J.+Parraauthor=J.+V.+Mercaderauthor=C.+Agulloauthor=A.+Abad-Somovillaauthor=A.+Abad-Fuentes&title=Generation+of+anti-azoxystrobin+monoclonal+antibodies+from+regioisomeric+haptens+functionalized+at+selected+sites+and+development+of+indirect+competitive+immunoassays&doi=10.1016%2Fj.aca.2011.12.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of anti-azoxystrobin monoclonal antibodies from regioisomeric haptens functionalized at selected sites and development of indirect competitive immunoassays</span></div><div class="casAuthors">Parra, Javier; Mercader, Josep V.; Agullo, Consuelo; Abad-Somovilla, Antonio; Abad-Fuentes, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Analytica Chimica Acta</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">715</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105-112</span>CODEN:
                <span class="NLM_cas:coden">ACACAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2670</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Azoxystrobin is a modern strobilurin fungicide used around the world to combat prime diseases affecting highly valuable crops.  Accordingly, residues of this chem. are frequently found in food, even though mostly under max. tolerated levels.  We herein describe the development of an indirect competitive immunoassay for the detn. of azoxystrobin residues.  A panel of monoclonal antibodies displaying subnanomolar affinity to azoxystrobin was generated using, as immunizing haptens in mice, four functionalized derivs. carrying the same spacer arm located at different rationally chosen positions.  This collection of antibodies was thoroughly characterized with homologous and heterologous antigens, and the immunoassay consisting of monoclonal antibody AZo6#49 and the coating conjugate OVA-AZb6, which displayed an IC50 value of 0.102 μg L-1 and a LOD of 0.017 μg L-1, was eventually optimized.  The response to different pH and ionic strength conditions of the specific assay was studied using a biparametric approach.  In addn., the influence of Tween 20 and org. solvents over the assay parameters was also evaluated.  After optimization, the developed immunochem. assay was applied to the anal. of azoxystrobin in spiked juices of relevant fruits and vegetables, showing excellent recoveries between 2 and 500 μg L-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo75sHlEBpEr7Vg90H21EOLACvtfcHk0lgm9H2Wf-K_6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsFWhsw%253D%253D&md5=b587cd8acf13f95f6f94ecf0eed6a95c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.aca.2011.12.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.aca.2011.12.014%26sid%3Dliteratum%253Aachs%26aulast%3DParra%26aufirst%3DJ.%26aulast%3DMercader%26aufirst%3DJ.%2BV.%26aulast%3DAgullo%26aufirst%3DC.%26aulast%3DAbad-Somovilla%26aufirst%3DA.%26aulast%3DAbad-Fuentes%26aufirst%3DA.%26atitle%3DGeneration%2520of%2520anti-azoxystrobin%2520monoclonal%2520antibodies%2520from%2520regioisomeric%2520haptens%2520functionalized%2520at%2520selected%2520sites%2520and%2520development%2520of%2520indirect%2520competitive%2520immunoassays%26jtitle%3DAnal.%2520Chim.%2520Acta%26date%3D2012%26volume%3D715%26spage%3D105%26epage%3D112%26doi%3D10.1016%2Fj.aca.2011.12.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 6 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tanjore S.  Balganesh</span>, <span class="hlFld-ContribAuthor ">Jagadeesh J.  Bhat</span>, <span class="hlFld-ContribAuthor ">Bheemarao  Ugarkar</span>. </span><span class="cited-content_cbyCitation_article-title">Modern Drug Discovery and Development for TB: The India Narrative. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 37-61. <a href="https://doi.org/10.1007/978-981-15-8002-4_2" title="DOI URL">https://doi.org/10.1007/978-981-15-8002-4_2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-15-8002-4_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-15-8002-4_2%26sid%3Dliteratum%253Aachs%26atitle%3DModern%252BDrug%252BDiscovery%252Band%252BDevelopment%252Bfor%252BTB%25253A%252BThe%252BIndia%252BNarrative%26aulast%3DBalganesh%26aufirst%3DTanjore%2BS.%26date%3D2021%26date%3D2021%26spage%3D37%26epage%3D61%26pub%3DSpringer%2520Singapore%26atitle%3DDrug%252BDiscovery%252Band%252BDrug%252BDevelopment%26aulast%3DDikshit%26aufirst%3DMadhu%26date%3D2021%26volume%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mariana L.  Garcia</span>, <span class="hlFld-ContribAuthor ">Andrew A.  Oliveira</span>, <span class="hlFld-ContribAuthor ">Renata V.  Bueno</span>, <span class="hlFld-ContribAuthor ">Victor H. R.  Nogueira</span>, <span class="hlFld-ContribAuthor ">Guilherme E.  Souza</span>, <span class="hlFld-ContribAuthor ">Rafael V. C.  Guido</span>. </span><span class="cited-content_cbyCitation_article-title">QSAR studies on benzothiophene derivatives as
              
                Plasmodium falciparum
              
              N‐myristoyltransferase inhibitors: Molecular insights into affinity and selectivity. </span><span class="cited-content_cbyCitation_journal-name">Drug Development Research</span><span> <strong>2020,</strong> <em>61 </em><a href="https://doi.org/10.1002/ddr.21646" title="DOI URL">https://doi.org/10.1002/ddr.21646</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ddr.21646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fddr.21646%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Development%2520Research%26atitle%3DQSAR%252Bstudies%252Bon%252Bbenzothiophene%252Bderivatives%252Bas%252BPlasmodium%252Bfalciparum%252BN%2525E2%252580%252590myristoyltransferase%252Binhibitors%25253A%252BMolecular%252Binsights%252Binto%252Baffinity%252Band%252Bselectivity%26aulast%3DGarcia%26aufirst%3DMariana%2BL.%26date%3D2020%26date%3D2020%26volume%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alicia  Moreno-Sabater</span>, <span class="hlFld-ContribAuthor ">Jean Louis  Pérignon</span>, <span class="hlFld-ContribAuthor ">Dominique  Mazier</span>, <span class="hlFld-ContribAuthor ">Catherine  Lavazec</span>, <span class="hlFld-ContribAuthor ">Valerie  Soulard</span>. </span><span class="cited-content_cbyCitation_article-title">Humanized mouse models infected with human
              Plasmodium
              species for antimalarial drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2018,</strong> <em>13 </em>
                                    (2)
                                     , 131-140. <a href="https://doi.org/10.1080/17460441.2018.1410136" title="DOI URL">https://doi.org/10.1080/17460441.2018.1410136</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2018.1410136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2018.1410136%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DHumanized%252Bmouse%252Bmodels%252Binfected%252Bwith%252Bhuman%252BPlasmodium%252Bspecies%252Bfor%252Bantimalarial%252Bdrug%252Bdiscovery%26aulast%3DMoreno-Sabater%26aufirst%3DAlicia%26date%3D2018%26date%3D2017%26volume%3D13%26issue%3D2%26spage%3D131%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irene  Hallyburton</span>, <span class="hlFld-ContribAuthor ">Raffaella  Grimaldi</span>, <span class="hlFld-ContribAuthor ">Andrew  Woodland</span>, <span class="hlFld-ContribAuthor ">Beatriz  Baragaña</span>, <span class="hlFld-ContribAuthor ">Torsten  Luksch</span>, <span class="hlFld-ContribAuthor ">Daniel  Spinks</span>, <span class="hlFld-ContribAuthor ">Daniel  James</span>, <span class="hlFld-ContribAuthor ">Didier  Leroy</span>, <span class="hlFld-ContribAuthor ">David  Waterson</span>, <span class="hlFld-ContribAuthor ">Alan H.  Fairlamb</span>, <span class="hlFld-ContribAuthor ">Paul G.  Wyatt</span>, <span class="hlFld-ContribAuthor ">Ian H.  Gilbert</span>, <span class="hlFld-ContribAuthor ">Julie A.  Frearson</span>. </span><span class="cited-content_cbyCitation_article-title">Screening a protein kinase inhibitor library against Plasmodium falciparum. </span><span class="cited-content_cbyCitation_journal-name">Malaria Journal</span><span> <strong>2017,</strong> <em>16 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12936-017-2085-4" title="DOI URL">https://doi.org/10.1186/s12936-017-2085-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12936-017-2085-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12936-017-2085-4%26sid%3Dliteratum%253Aachs%26jtitle%3DMalaria%2520Journal%26atitle%3DScreening%252Ba%252Bprotein%252Bkinase%252Binhibitor%252Blibrary%252Bagainst%252BPlasmodium%252Bfalciparum%26aulast%3DHallyburton%26aufirst%3DIrene%26date%3D2017%26date%3D2017%26volume%3D16%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Balaraman  Selvakumar</span>, <span class="hlFld-ContribAuthor ">Kuppanagounder P.  Elango</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, characterization and in vitro antibacterial evaluation of 1-(7,7-dimethyl-2-morpholino-5,6,7,8-tetrahydroquinazolin-4-yl)piperidine-4-carboxamide derivatives. </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2017,</strong> <em>43 </em>
                                    (10)
                                     , 5535-5546. <a href="https://doi.org/10.1007/s11164-017-2945-0" title="DOI URL">https://doi.org/10.1007/s11164-017-2945-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-017-2945-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-017-2945-0%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DSynthesis%25252C%252Bcharacterization%252Band%252Bin%252Bvitro%252Bantibacterial%252Bevaluation%252Bof%252B1-%2525287%25252C7-dimethyl-2-morpholino-5%25252C6%25252C7%25252C8-tetrahydroquinazolin-4-yl%252529piperidine-4-carboxamide%252Bderivatives%26aulast%3DSelvakumar%26aufirst%3DBalaraman%26date%3D2017%26date%3D2017%26volume%3D43%26issue%3D10%26spage%3D5535%26epage%3D5546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandra  Duffy</span>, <span class="hlFld-ContribAuthor ">Melissa L.  Sykes</span>, <span class="hlFld-ContribAuthor ">Amy J.  Jones</span>, <span class="hlFld-ContribAuthor ">Todd B.  Shelper</span>, <span class="hlFld-ContribAuthor ">Moana  Simpson</span>, <span class="hlFld-ContribAuthor ">Rebecca  Lang</span>, <span class="hlFld-ContribAuthor ">Sally-Ann  Poulsen</span>, <span class="hlFld-ContribAuthor ">Brad E.  Sleebs</span>, <span class="hlFld-ContribAuthor ">Vicky M.  Avery</span>. </span><span class="cited-content_cbyCitation_article-title">Screening the Medicines for Malaria Venture Pathogen Box across Multiple Pathogens Reclassifies Starting Points for Open-Source Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2017,</strong> <em>61 </em>
                                    (9)
                                     <a href="https://doi.org/10.1128/AAC.00379-17" title="DOI URL">https://doi.org/10.1128/AAC.00379-17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.00379-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.00379-17%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DScreening%252Bthe%252BMedicines%252Bfor%252BMalaria%252BVenture%252BPathogen%252BBox%252Bacross%252BMultiple%252BPathogens%252BReclassifies%252BStarting%252BPoints%252Bfor%252BOpen-Source%252BDrug%252BDiscovery%26aulast%3DDuffy%26aufirst%3DSandra%26date%3D2017%26volume%3D61%26issue%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/medium/jm-2016-00028z_0020.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/large/jm-2016-00028z_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00028&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/medium/jm-2016-00028z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/large/jm-2016-00028z_0002.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Published analogue compound <b>2</b>, codes TCMDC-125419 (GSK) and GNF-Pf-1034/GNF-Pf-1447 (Novartis).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/large/jm-2016-00028z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00028&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/medium/jm-2016-00028z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/large/jm-2016-00028z_0003.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) In vivo efficacy data for compound <b>13</b> in <i>P. falciparum</i> infected SCID mice. (b) Levels of compound <b>13</b> in blood of the mice of the efficacy experiment during 23 h after the first oral dose. The symbols represent the same individuals depicted in plot a. (c) In vitro PRR data for compound <b>13</b> when parasites were treated at 10 × EC<sub>50</sub>. Comparator data for other standard drugs are included for reference (data previously reported<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a>). Compound <b>13</b> showed a similar rate of kill to pyrimethamine. (d) Comparison of morphology of parasitized human RBC in vehicle and compound <b>13</b> treated mice. Erythrocytes with only remnants of parasites showing nuclear condensation were seen following 2-day treatment with compound <b>13</b>. Compound dosed as the fumarate salt.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/large/jm-2016-00028z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00028&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/medium/jm-2016-00028z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/large/jm-2016-00028z_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/large/jm-2016-00028z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00028&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) Dimethyl malonate (DMM), NaOMe, MeOH, reflux, 3 days, 55%; or DMM, NaOMe, <i>N</i>-methylpyrrolidinone, microwave, 1 h, 150 °C, 70%; (ii) POCl<sub>3</sub>, 90°C, 58%; (iii) amine, DIPEA, THF, rt ; (iv) boronic ester/acid, K<sub>3</sub>PO<sub>4</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DMF/water, microwave, 120 °C, 20 min.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/medium/jm-2016-00028z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/large/jm-2016-00028z_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/large/jm-2016-00028z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00028&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) Amine, Et<sub>3</sub>N, ethanol, −5 °C, 4 h; (ii) boronic acid/ester, 2 M aq Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane/water, microwave at 120 °C, 20 min; (iii) amine, Et<sub>3</sub>N, acetonitrile, 40–70°C; (iv) 3-pyridyl boronic acid, K<sub>3</sub>PO<sub>4</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>,DMF/water 3/1, microwave at 120 °C, 20 min.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/medium/jm-2016-00028z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/large/jm-2016-00028z_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/large/jm-2016-00028z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00028&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) Amine, Et<sub>3</sub>N, ethanol, rt, 16 h, 56%; (ii) 3-pyridylboronic acid, K<sub>3</sub>PO<sub>4</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane/water 3/1, microwave at 130 °C, 20 min, 96%; (iii) boronic acid, thiophene-2-carbonyloxycopper, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane or THF, microwave at 130 °C, 1 h or 85 °C, 18 h.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/medium/jm-2016-00028z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/large/jm-2016-00028z_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00028/20160708/images/large/jm-2016-00028z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00028&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) CH<sub>2</sub>I<sub>2</sub>, <i>t</i>-BuONO, acetonitrile, 80 °C, 3 h 30 min, 64%; (ii) amine, Et<sub>3</sub>N, ethanol, 0 °C, 3 h; (iii) acetylene, CuI, Et<sub>3</sub>N, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, acetonitrile, rt, 18 h; (iv) amine, DIPEA, NMP, microwave at 200 °C, 15 min; (v) boronic acid/ester, 2 M aq Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, DME, microwave at 200 °C, 20 min; (vi) 3-pyridylboronic acid, K<sub>3</sub>PO<sub>4</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DMF, microwave at 120 °C, 20 min.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i82">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33014" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33014" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 22 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Flannery, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winzeler, E. A.</span><span> </span><span class="NLM_article-title">Antimalarial drug discovery - approaches and progress to new medicines</span> <span class="citation_source-journal">Nat. Rev. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">849</span><span class="NLM_x">–</span> <span class="NLM_lpage">862</span><span class="refDoi"> DOI: 10.1038/nrmicro3138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1038%2Fnrmicro3138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=24217412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCrtb3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=849-862&author=E.+L.+Flanneryauthor=A.+K.+Chatterjeeauthor=E.+A.+Winzeler&title=Antimalarial+drug+discovery+-+approaches+and+progress+to+new+medicines&doi=10.1038%2Fnrmicro3138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial drug discovery - approaches and progress towards new medicines</span></div><div class="casAuthors">Flannery, Erika L.; Chatterjee, Arnab K.; Winzeler, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">849-862</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Malaria elimination has recently been reinstated as a global health priority but current therapies seem to be insufficient for the task.  Elimination efforts require new drug classes that alleviate symptoms, prevent transmission and provide a radical cure.  To develop these next-generation medicines, public-private partnerships are funding innovative approaches to identify compds. that target multiple parasite species at multiple stages of the parasite life cycle.  In this Review, we discuss the cell-, chem.- and target-based approaches used to discover new drug candidates that are currently in clin. trials or undergoing preclin. testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZRHIU_Rei97Vg90H21EOLACvtfcHk0lgCfN6FUehC9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCrtb3L&md5=0ebf2e2f81cce7ac4de3fe19524a6ed9</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro3138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro3138%26sid%3Dliteratum%253Aachs%26aulast%3DFlannery%26aufirst%3DE.%2BL.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DAntimalarial%2520drug%2520discovery%2520-%2520approaches%2520and%2520progress%2520to%2520new%2520medicines%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2013%26volume%3D11%26spage%3D849%26epage%3D862%26doi%3D10.1038%2Fnrmicro3138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">World Health Organization</span><span class="NLM_x">. </span><span> </span><span class="NLM_article-title">World Malaria Report 2014</span>. <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+Health+Organization.+World+Malaria+Report+2014.+World+Health+Organization%3A+Geneva%2C+Switzerland%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DWorld%2520Malaria%2520Report%25202014%26pub%3DWorld%2520Health%2520Organization%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Ariey, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amaratunga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beghain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langlois, A.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khim, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duru, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouchier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sreng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuor, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bout, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, W. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandeur, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miotto, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ringwald, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Bras, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barale, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairhurst, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benoit-Vical, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercereau-Puijalon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menard, D.</span><span> </span><span class="NLM_article-title">A molecular marker of artemisinin-resistant <i>Plasmodium falciparum</i> malaria</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">505</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span><span class="refDoi"> DOI: 10.1038/nature12876</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1038%2Fnature12876" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=24352242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A280%3ADC%252BC2c3ns1aqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=505&publication_year=2014&pages=50-55&author=F.+Arieyauthor=B.+Witkowskiauthor=C.+Amaratungaauthor=J.+Beghainauthor=A.-C.+Langloisauthor=N.+Khimauthor=S.+Kimauthor=V.+Duruauthor=C.+Bouchierauthor=L.+Maauthor=P.+Limauthor=R.+Leangauthor=S.+Duongauthor=S.+Srengauthor=S.+Suonauthor=C.+M.+Chuorauthor=D.+M.+Boutauthor=S.+Menardauthor=W.+O.+Rogersauthor=B.+Gentonauthor=T.+Fandeurauthor=O.+Miottoauthor=P.+Ringwaldauthor=J.+Le+Brasauthor=A.+Berryauthor=J.-C.+Baraleauthor=R.+M.+Fairhurstauthor=F.+Benoit-Vicalauthor=O.+Mercereau-Puijalonauthor=D.+Menard&title=A+molecular+marker+of+artemisinin-resistant+Plasmodium+falciparum+malaria&doi=10.1038%2Fnature12876"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A molecular marker of artemisinin-resistant Plasmodium falciparum malaria</span></div><div class="casAuthors">Ariey Frederic; Beghain Johann; Barale Jean-Christophe; Witkowski Benoit; Khim Nimol; Kim Saorin; Duru Valentine; Amaratunga Chanaki; Langlois Anne-Claire; Bouchier Christiane; Ma Laurence; Lim Pharath; Leang Rithea; Duong Socheat; Sreng Sokunthea; Suon Seila; Chuor Char Meng; Bout Denis Mey; Menard Sandie; Berry Antoine; Rogers William O; Genton Blaise; Fandeur Thierry; Miotto Olivo; Ringwald Pascal; Le Bras Jacques; Fairhurst Rick M; Benoit-Vical Francoise; Mercereau-Puijalon Odile; Menard Didier</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">505</span>
        (<span class="NLM_cas:issue">7481</span>),
    <span class="NLM_cas:pages">50-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Plasmodium falciparum resistance to artemisinin derivatives in southeast Asia threatens malaria control and elimination activities worldwide.  To monitor the spread of artemisinin resistance, a molecular marker is urgently needed.  Here, using whole-genome sequencing of an artemisinin-resistant parasite line from Africa and clinical parasite isolates from Cambodia, we associate mutations in the PF3D7_1343700 kelch propeller domain ('K13-propeller') with artemisinin resistance in vitro and in vivo.  Mutant K13-propeller alleles cluster in Cambodian provinces where resistance is prevalent, and the increasing frequency of a dominant mutant K13-propeller allele correlates with the recent spread of resistance in western Cambodia.  Strong correlations between the presence of a mutant allele, in vitro parasite survival rates and in vivo parasite clearance rates indicate that K13-propeller mutations are important determinants of artemisinin resistance.  K13-propeller polymorphism constitutes a useful molecular marker for large-scale surveillance efforts to contain artemisinin resistance in the Greater Mekong Subregion and prevent its global spread.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTg24yBOxa0oSjiVMCqkKxVfW6udTcc2eZ2AKtrdBLI8rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3ns1aqtg%253D%253D&md5=e25f4dcc9ccc361de4c35e650391b7ca</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnature12876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12876%26sid%3Dliteratum%253Aachs%26aulast%3DAriey%26aufirst%3DF.%26aulast%3DWitkowski%26aufirst%3DB.%26aulast%3DAmaratunga%26aufirst%3DC.%26aulast%3DBeghain%26aufirst%3DJ.%26aulast%3DLanglois%26aufirst%3DA.-C.%26aulast%3DKhim%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DDuru%26aufirst%3DV.%26aulast%3DBouchier%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DLim%26aufirst%3DP.%26aulast%3DLeang%26aufirst%3DR.%26aulast%3DDuong%26aufirst%3DS.%26aulast%3DSreng%26aufirst%3DS.%26aulast%3DSuon%26aufirst%3DS.%26aulast%3DChuor%26aufirst%3DC.%2BM.%26aulast%3DBout%26aufirst%3DD.%2BM.%26aulast%3DMenard%26aufirst%3DS.%26aulast%3DRogers%26aufirst%3DW.%2BO.%26aulast%3DGenton%26aufirst%3DB.%26aulast%3DFandeur%26aufirst%3DT.%26aulast%3DMiotto%26aufirst%3DO.%26aulast%3DRingwald%26aufirst%3DP.%26aulast%3DLe%2BBras%26aufirst%3DJ.%26aulast%3DBerry%26aufirst%3DA.%26aulast%3DBarale%26aufirst%3DJ.-C.%26aulast%3DFairhurst%26aufirst%3DR.%2BM.%26aulast%3DBenoit-Vical%26aufirst%3DF.%26aulast%3DMercereau-Puijalon%26aufirst%3DO.%26aulast%3DMenard%26aufirst%3DD.%26atitle%3DA%2520molecular%2520marker%2520of%2520artemisinin-resistant%2520Plasmodium%2520falciparum%2520malaria%26jtitle%3DNature%26date%3D2014%26volume%3D505%26spage%3D50%26epage%3D55%26doi%3D10.1038%2Fnature12876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Baird, J. K.</span><span> </span><span class="NLM_article-title">Malaria caused by <i>Plasmodium vivax</i>: recurrent, difficult to treat, disabling, and threatening to life—averting the infectious bite preempts these hazards</span> <span class="citation_source-journal">Pathog. Global Health</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">479</span><span class="refDoi"> DOI: 10.1179/2047772413Z.000000000179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1179%2F2047772413Z.000000000179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=24428831" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2013&pages=475-479&author=J.+K.+Baird&title=Malaria+caused+by+Plasmodium+vivax%3A+recurrent%2C+difficult+to+treat%2C+disabling%2C+and+threatening+to+life%E2%80%94averting+the+infectious+bite+preempts+these+hazards&doi=10.1179%2F2047772413Z.000000000179"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1179%2F2047772413Z.000000000179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1179%252F2047772413Z.000000000179%26sid%3Dliteratum%253Aachs%26aulast%3DBaird%26aufirst%3DJ.%2BK.%26atitle%3DMalaria%2520caused%2520by%2520Plasmodium%2520vivax%253A%2520recurrent%252C%2520difficult%2520to%2520treat%252C%2520disabling%252C%2520and%2520threatening%2520to%2520life%25E2%2580%2594averting%2520the%2520infectious%2520bite%2520preempts%2520these%2520hazards%26jtitle%3DPathog.%2520Global%2520Health%26date%3D2013%26volume%3D107%26spage%3D475%26epage%3D479%26doi%3D10.1179%2F2047772413Z.000000000179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Paul, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mytelka, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunwiddie, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persinger, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munos, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindborg, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schacht, A. L.</span><span> </span><span class="NLM_article-title">How to improve R&D productivity: the pharmaceutical industry’s grand challenge</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span><span class="refDoi"> DOI: 10.1038/nrd3078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1038%2Fnrd3078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=20168317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFemsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=203-214&author=S.+M.+Paulauthor=D.+S.+Mytelkaauthor=C.+T.+Dunwiddieauthor=C.+C.+Persingerauthor=B.+H.+Munosauthor=S.+R.+Lindborgauthor=A.+L.+Schacht&title=How+to+improve+R%26D+productivity%3A+the+pharmaceutical+industry%E2%80%99s+grand+challenge&doi=10.1038%2Fnrd3078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">How to improve R&D productivity: the pharmaceutical industry's grand challenge</span></div><div class="casAuthors">Paul, Steven M.; Mytelka, Daniel S.; Dunwiddie, Christopher T.; Persinger, Charles C.; Munos, Bernard H.; Lindborg, Stacy R.; Schacht, Aaron L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">203-214</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The pharmaceutical industry is under growing pressure from a range of environmental issues, including major losses of revenue owing to patent expirations, increasingly cost-constrained healthcare systems and more demanding regulatory requirements.  In our view, the key to tackling the challenges such issues pose to both the future viability of the pharmaceutical industry and advances in healthcare is to substantially increase the no. and quality of innovative, cost-effective new medicines, without incurring unsustainable R&D costs.  However, it is widely acknowledged that trends in industry R&D productivity have been moving in the opposite direction for a no. of years.  Here, we present a detailed anal. based on comprehensive, recent, industry-wide data to identify the relative contributions of each of the steps in the drug discovery and development process to overall R&D productivity.  We then propose specific strategies that could have the most substantial impact in improving R&D productivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY67PCIhaBVLVg90H21EOLACvtfcHk0lglyaBb6IgJBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFemsbg%253D&md5=2f32bcc48c869290eef18ff9400afcc5</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd3078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3078%26sid%3Dliteratum%253Aachs%26aulast%3DPaul%26aufirst%3DS.%2BM.%26aulast%3DMytelka%26aufirst%3DD.%2BS.%26aulast%3DDunwiddie%26aufirst%3DC.%2BT.%26aulast%3DPersinger%26aufirst%3DC.%2BC.%26aulast%3DMunos%26aufirst%3DB.%2BH.%26aulast%3DLindborg%26aufirst%3DS.%2BR.%26aulast%3DSchacht%26aufirst%3DA.%2BL.%26atitle%3DHow%2520to%2520improve%2520R%2526D%2520productivity%253A%2520the%2520pharmaceutical%2520industry%25E2%2580%2599s%2520grand%2520challenge%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D203%26epage%3D214%26doi%3D10.1038%2Fnrd3078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Burrows, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Huijsduijnen, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohrle, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oeuvray, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, T. N.</span><span> </span><span class="NLM_article-title">Designing the next generation of medicines for malaria control and eradication</span> <span class="citation_source-journal">Malar. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="refDoi"> DOI: 10.1186/1475-2875-12-187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1186%2F1475-2875-12-187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=23742293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A280%3ADC%252BC3sjgsVSisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=187&author=J.+N.+Burrowsauthor=R.+H.+van+Huijsduijnenauthor=J.+J.+Mohrleauthor=C.+Oeuvrayauthor=T.+N.+Wells&title=Designing+the+next+generation+of+medicines+for+malaria+control+and+eradication&doi=10.1186%2F1475-2875-12-187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Designing the next generation of medicines for malaria control and eradication</span></div><div class="casAuthors">Burrows Jeremy N; van Huijsduijnen Rob Hooft; Mohrle Jorg J; Oeuvray Claude; Wells Timothy N C</div><div class="citationInfo"><span class="NLM_cas:title">Malaria journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">187</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In the fight against malaria new medicines are an essential weapon.  For the parts of the world where the current gold standard artemisinin combination therapies are active, significant improvements can still be made: for example combination medicines which allow for single dose regimens, cheaper, safer and more effective medicines, or improved stability under field conditions.  For those parts of the world where the existing combinations show less than optimal activity, the priority is to have activity against emerging resistant strains, and other criteria take a secondary role.  For new medicines to be optimal in malaria control they must also be able to reduce transmission and prevent relapse of dormant forms: additional constraints on a combination medicine.  In the absence of a highly effective vaccine, new medicines are also needed to protect patient populations.  In this paper, an outline definition of the ideal and minimally acceptable characteristics of the types of clinical candidate molecule which are needed (target candidate profiles) is suggested.  In addition, the optimal and minimally acceptable characteristics of combination medicines are outlined (target product profiles).  MMV presents now a suggested framework for combining the new candidates to produce the new medicines.  Sustained investment over the next decade in discovery and development of new molecules is essential to enable the long-term delivery of the medicines needed to combat malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSjy7sj0k3cHtFxYDaSSP8XfW6udTcc2ebENToI6_Daxbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjgsVSisA%253D%253D&md5=c4283af83b04bc217f40528dde196e23</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1186%2F1475-2875-12-187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1475-2875-12-187%26sid%3Dliteratum%253Aachs%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3Dvan%2BHuijsduijnen%26aufirst%3DR.%2BH.%26aulast%3DMohrle%26aufirst%3DJ.%2BJ.%26aulast%3DOeuvray%26aufirst%3DC.%26aulast%3DWells%26aufirst%3DT.%2BN.%26atitle%3DDesigning%2520the%2520next%2520generation%2520of%2520medicines%2520for%2520malaria%2520control%2520and%2520eradication%26jtitle%3DMalar.%2520J.%26date%3D2013%26volume%3D12%26spage%3D187%26doi%3D10.1186%2F1475-2875-12-187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Brenk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schipani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krasowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, I. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frearson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyatt, P. G.</span><span> </span><span class="NLM_article-title">Lessons learnt from assembling screening libraries for drug discovery for neglected diseases</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">444</span><span class="refDoi"> DOI: 10.1002/cmdc.200700139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1002%2Fcmdc.200700139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=18064617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlt1Krtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=435-444&author=R.+Brenkauthor=A.+Schipaniauthor=D.+Jamesauthor=A.+Krasowskiauthor=I.+H.+Gilbertauthor=J.+Frearsonauthor=P.+G.+Wyatt&title=Lessons+learnt+from+assembling+screening+libraries+for+drug+discovery+for+neglected+diseases&doi=10.1002%2Fcmdc.200700139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons learned from assembling screening libraries for drug discovery for neglected diseases</span></div><div class="casAuthors">Brenk, Ruth; Schipani, Alessandro; James, Daniel; Krasowski, Agata; Gilbert, Ian Hugh; Frearson, Julie; Wyatt, Paul Graham</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">435-444</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">To enable the establishment of a drug discovery operation for neglected diseases, out of 2.3 million com. available compds. 222 552 compds. were selected for an in silico library, 57 438 for a diverse general screening library, and 1 697 compds. for a focused kinase set.  Compiling these libraries required a robust strategy for compd. selection.  Rules for unwanted groups were defined and selection criteria to enrich for lead-like compds. which facilitate straightforward structure-activity relationship exploration were established.  Further, a literature and patent review was undertaken to ext. key recognition elements of kinase inhibitors ("core fragments") to assemble a focused library for hit discovery for kinases.  Computational and exptl. characterization of the general screening library revealed that the selected compds. (1) span a broad range of lead-like space, (2) show a high degree of structural integrity and purity, and (3) demonstrate appropriate soly. for the purposes of biochem. screening.  The implications of this study for compd. selection, esp. in an academic environment with limited resources, are considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy_Ybsdg8QS7Vg90H21EOLACvtfcHk0li_KM4n7EhvMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlt1Krtb4%253D&md5=b804d0ac8766e954391798e24aa7fbff</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200700139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200700139%26sid%3Dliteratum%253Aachs%26aulast%3DBrenk%26aufirst%3DR.%26aulast%3DSchipani%26aufirst%3DA.%26aulast%3DJames%26aufirst%3DD.%26aulast%3DKrasowski%26aufirst%3DA.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DFrearson%26aufirst%3DJ.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26atitle%3DLessons%2520learnt%2520from%2520assembling%2520screening%2520libraries%2520for%2520drug%2520discovery%2520for%2520neglected%2520diseases%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D435%26epage%3D444%26doi%3D10.1002%2Fcmdc.200700139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Bennett, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paguio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gligorijevic, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seudieu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosar, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roepe, P. D.</span><span> </span><span class="NLM_article-title">Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1807</span><span class="NLM_x">–</span> <span class="NLM_lpage">1810</span><span class="refDoi"> DOI: 10.1128/AAC.48.5.1807-1810.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1128%2FAAC.48.5.1807-1810.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=15105139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjslCks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=1807-1810&author=T.+N.+Bennettauthor=M.+Paguioauthor=B.+Gligorijevicauthor=C.+Seudieuauthor=A.+D.+Kosarauthor=E.+Davidsonauthor=P.+D.+Roepe&title=Novel%2C+rapid%2C+and+inexpensive+cell-based+quantification+of+antimalarial+drug+efficacy&doi=10.1128%2FAAC.48.5.1807-1810.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy</span></div><div class="casAuthors">Bennett, Tyler N.; Paguio, Michelle; Gligorijevic, Bojana; Seudieu, Clement; Kosar, Andrew D.; Davidson, Eugene; Roepe, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1807-1810</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We report on the development of a new SYBR Green I-based plate assay for analyzing the activities of antimalarial drugs against intraerythrocytic Plasmodium falciparum.  This assay is considerably faster, less labor-intensive, and less expensive than conventional radiotracer (e.g., [3H]hypoxanthine and [3H]ethanolamine)-based assays or P. falciparum lactate dehydrogenase activity-based assays.  The assay significantly improves the pace at which antimalarial drug discovery efforts may proceed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFhAlJNQSwX7Vg90H21EOLACvtfcHk0li_KM4n7EhvMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjslCks7o%253D&md5=87ee6c113aefaf11160624c8fe8c8354</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1128%2FAAC.48.5.1807-1810.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.48.5.1807-1810.2004%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DT.%2BN.%26aulast%3DPaguio%26aufirst%3DM.%26aulast%3DGligorijevic%26aufirst%3DB.%26aulast%3DSeudieu%26aufirst%3DC.%26aulast%3DKosar%26aufirst%3DA.%2BD.%26aulast%3DDavidson%26aufirst%3DE.%26aulast%3DRoepe%26aufirst%3DP.%2BD.%26atitle%3DNovel%252C%2520rapid%252C%2520and%2520inexpensive%2520cell-based%2520quantification%2520of%2520antimalarial%2520drug%2520efficacy%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D1807%26epage%3D1810%26doi%3D10.1128%2FAAC.48.5.1807-1810.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Plouffe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adrian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matzen, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nam, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trager, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winzeler, E. A.</span><span> </span><span class="NLM_article-title">In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">9059</span><span class="NLM_x">–</span> <span class="NLM_lpage">9064</span><span class="refDoi"> DOI: 10.1073/pnas.0802982105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1073%2Fpnas.0802982105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=18579783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosVCiurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=9059-9064&author=D.+Plouffeauthor=A.+Brinkerauthor=C.+McNamaraauthor=K.+Hensonauthor=N.+Katoauthor=K.+Kuhenauthor=A.+Nagleauthor=F.+Adrianauthor=J.+T.+Matzenauthor=P.+Andersonauthor=T.+G.+Namauthor=N.+S.+Grayauthor=A.+Chatterjeeauthor=J.+Janesauthor=S.+F.+Yanauthor=R.+Tragerauthor=J.+S.+Caldwellauthor=P.+G.+Schultzauthor=Y.+Zhouauthor=E.+A.+Winzeler&title=In+silico+activity+profiling+reveals+the+mechanism+of+action+of+antimalarials+discovered+in+a+high-throughput+screen&doi=10.1073%2Fpnas.0802982105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen</span></div><div class="casAuthors">Plouffe, David; Brinker, Achim; McNamara, Case; Henson, Kerstin; Kato, Nobutaka; Kuhen, Kelli; Nagle, Advait; Adrian, Francisco; Matzen, Jason T.; Anderson, Paul; Nam, Tae-gyu; Gray, Nathanael S.; Chatterjee, Arnab; Janes, Jeff; Yan, S. Frank; Trager, Richard; Caldwell, Jeremy S.; Schultz, Peter G.; Zhou, Yingyao; Winzeler, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">9059-9064</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The growing resistance to current first-line antimalarial drugs represents a major health challenge.  To facilitate the discovery of new antimalarials, we have implemented an efficient and robust high-throughput cell-based screen (1,536-well format) based on proliferation of Plasmodium falciparum (Pf) in erythrocytes.  From a screen of ≈ 1.7 million compds., we identified a diverse collection of ≈ 6,000 small mols. comprised of > 530 distinct scaffolds, all of which show potent antimalarial activity (< 1.25 μM).  Most known antimalarials were identified in this screen, thus validating our approach.  In addn., we identified many novel chem. scaffolds, which likely act through both known and novel pathways.  We further show that in some cases the mechanism of action of these antimalarials can be detd. by in silico compd. activity profiling.  This method uses large datasets from unrelated cellular and biochem. screens and the guilt-by-assocn. principle to predict which cellular pathway and/or protein target is being inhibited by select compds.  In addn., the screening method has the potential to provide the malaria community with many new starting points for the development of biol. probes and drugs with novel antiparasitic activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL9PFy0SUhdbVg90H21EOLACvtfcHk0lhpaAFeG1T5YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosVCiurw%253D&md5=bf14f093078c982e3604089588827166</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0802982105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0802982105%26sid%3Dliteratum%253Aachs%26aulast%3DPlouffe%26aufirst%3DD.%26aulast%3DBrinker%26aufirst%3DA.%26aulast%3DMcNamara%26aufirst%3DC.%26aulast%3DHenson%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DN.%26aulast%3DKuhen%26aufirst%3DK.%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DAdrian%26aufirst%3DF.%26aulast%3DMatzen%26aufirst%3DJ.%2BT.%26aulast%3DAnderson%26aufirst%3DP.%26aulast%3DNam%26aufirst%3DT.%2BG.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DChatterjee%26aufirst%3DA.%26aulast%3DJanes%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DS.%2BF.%26aulast%3DTrager%26aufirst%3DR.%26aulast%3DCaldwell%26aufirst%3DJ.%2BS.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DIn%2520silico%2520activity%2520profiling%2520reveals%2520the%2520mechanism%2520of%2520action%2520of%2520antimalarials%2520discovered%2520in%2520a%2520high-throughput%2520screen%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D9059%26epage%3D9064%26doi%3D10.1073%2Fpnas.0802982105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Gamo, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Cozar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavandera, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderwall, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peishoff, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardon, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Bustos, J. F.</span><span> </span><span class="NLM_article-title">Thousands of chemical starting points for antimalarial lead identification</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">465</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">310</span><span class="refDoi"> DOI: 10.1038/nature09107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1038%2Fnature09107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=20485427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmt1Ois7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2010&pages=305-310&author=F.+J.+Gamoauthor=L.+M.+Sanzauthor=J.+Vidalauthor=C.+de+Cozarauthor=E.+Alvarezauthor=J.+L.+Lavanderaauthor=D.+E.+Vanderwallauthor=D.+V.+Greenauthor=V.+Kumarauthor=S.+Hasanauthor=J.+R.+Brownauthor=C.+E.+Peishoffauthor=L.+R.+Cardonauthor=J.+F.+Garcia-Bustos&title=Thousands+of+chemical+starting+points+for+antimalarial+lead+identification&doi=10.1038%2Fnature09107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Thousands of chemical starting points for antimalarial lead identification</span></div><div class="casAuthors">Gamo, Francisco-Javier; Sanz, Laura M.; Vidal, Jaume; de Cozar, Cristina; Alvarez, Emilio; Lavandera, Jose-Luis; Vanderwall, Dana E.; Green, Darren V. S.; Kumar, Vinod; Hasan, Samiul; Brown, James R.; Peishoff, Catherine E.; Cardon, Lon R.; Garcia-Bustos, Jose F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">465</span>
        (<span class="NLM_cas:issue">7296</span>),
    <span class="NLM_cas:pages">305-310</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Malaria is a devastating infection caused by protozoa of the genus Plasmodium.  Drug resistance is widespread, no new chem. class of antimalarials has been introduced into clin. practice since 1996 and there is a recent rise of parasite strains with reduced sensitivity to the newest drugs.  We screened nearly 2 million compds. in GlaxoSmithKline's chem. library for inhibitors of P. falciparum, of which 13,533 were confirmed to inhibit parasite growth by at least 80% at 2 μM concn.  More than 8,000 also showed potent activity against the multidrug resistant strain Dd2.  Most (82%) compds. originate from internal company projects and are new to the malaria community.  Analyses using historic assay data suggest several novel mechanisms of antimalarial action, such as inhibition of protein kinases and host-pathogen interaction related targets.  Chem. structures and assocd. data are hereby made public to encourage addnl. drug lead identification efforts and further research into this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHijpWK_kBF7Vg90H21EOLACvtfcHk0lhpaAFeG1T5YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmt1Ois7k%253D&md5=a1fd8c0b89a5650ecba31f5456928b42</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature09107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09107%26sid%3Dliteratum%253Aachs%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DVidal%26aufirst%3DJ.%26aulast%3Dde%2BCozar%26aufirst%3DC.%26aulast%3DAlvarez%26aufirst%3DE.%26aulast%3DLavandera%26aufirst%3DJ.%2BL.%26aulast%3DVanderwall%26aufirst%3DD.%2BE.%26aulast%3DGreen%26aufirst%3DD.%2BV.%26aulast%3DKumar%26aufirst%3DV.%26aulast%3DHasan%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DJ.%2BR.%26aulast%3DPeishoff%26aufirst%3DC.%2BE.%26aulast%3DCardon%26aufirst%3DL.%2BR.%26aulast%3DGarcia-Bustos%26aufirst%3DJ.%2BF.%26atitle%3DThousands%2520of%2520chemical%2520starting%2520points%2520for%2520antimalarial%2520lead%2520identification%26jtitle%3DNature%26date%3D2010%26volume%3D465%26spage%3D305%26epage%3D310%26doi%3D10.1038%2Fnature09107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Ritchie, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, S. J. F.</span><span> </span><span class="NLM_article-title">The impact of aromatic ring count on compound developability - are too many aromatic rings a liability in drug design?</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1011</span><span class="NLM_x">–</span> <span class="NLM_lpage">1020</span><span class="refDoi"> DOI: 10.1016/j.drudis.2009.07.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1016%2Fj.drudis.2009.07.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=19729075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCgt7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=1011-1020&author=T.+J.+Ritchieauthor=S.+J.+F.+MacDonald&title=The+impact+of+aromatic+ring+count+on+compound+developability+-+are+too+many+aromatic+rings+a+liability+in+drug+design%3F&doi=10.1016%2Fj.drudis.2009.07.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of aromatic ring count on compound developability: Are too many aromatic rings a liability in drug design?</span></div><div class="casAuthors">Ritchie, Timothy J.; MacDonald, Simon J. F.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">21/22</span>),
    <span class="NLM_cas:pages">1011-1020</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The impact of arom. ring count (the no. of arom. and heteroarom. rings) in mols. has been analyzed against various developability parameters, aq. soly., lipophilicity, serum albumin binding, CyP450 inhibition and hERG inhibition.  On the basis of this anal., it was concluded that the fewer arom. rings contained in an oral drug candidate, the more developable that candidate is probably to be; in addn., more than three arom. rings in a mol. correlates with poorer compd. developability and, thus, an increased risk of attrition in development.  Data are also presented that demonstrate that even within a defined lipophilicity range, increased arom. ring count leads to decreased aq. soly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2hOeD6TNGUbVg90H21EOLACvtfcHk0lhpaAFeG1T5YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCgt7nP&md5=48454c9809e8225b4336ea76aad3f3ba</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2009.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2009.07.014%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DMacDonald%26aufirst%3DS.%2BJ.%2BF.%26atitle%3DThe%2520impact%2520of%2520aromatic%2520ring%2520count%2520on%2520compound%2520developability%2520-%2520are%2520too%2520many%2520aromatic%2520rings%2520a%2520liability%2520in%2520drug%2520design%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26spage%3D1011%26epage%3D1020%26doi%3D10.1016%2Fj.drudis.2009.07.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Ritchie, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, S. J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickett, S. D.</span><span> </span><span class="NLM_article-title">The impact of aromatic ring count on compound developability: further insights by examiing carbo- and hetero-aromatic and -aliphatic ring types</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span><span class="refDoi"> DOI: 10.1016/j.drudis.2010.11.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1016%2Fj.drudis.2010.11.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=164-171&author=T.+J.+Ritchieauthor=S.+J.+F.+MacDonaldauthor=R.+J.+Youngauthor=S.+D.+Pickett&title=The+impact+of+aromatic+ring+count+on+compound+developability%3A+further+insights+by+examiing+carbo-+and+hetero-aromatic+and+-aliphatic+ring+types&doi=10.1016%2Fj.drudis.2010.11.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DMacDonald%26aufirst%3DS.%2BJ.%2BF.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DPickett%26aufirst%3DS.%2BD.%26atitle%3DThe%2520impact%2520of%2520aromatic%2520ring%2520count%2520on%2520compound%2520developability%253A%2520further%2520insights%2520by%2520examiing%2520carbo-%2520and%2520hetero-aromatic%2520and%2520-aliphatic%2520ring%2520types%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D164%26epage%3D171%26doi%3D10.1016%2Fj.drudis.2010.11.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Lovering, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bikker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span> </span><span class="NLM_article-title">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6752</span><span class="NLM_x">–</span> <span class="NLM_lpage">6756</span><span class="refDoi"> DOI: 10.1021/jm901241e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+Flatland%3A+Increasing+Saturation+as+an+Approach+to+Improving+Clinical+Success&doi=10.1021%2Fjm901241e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0lhPgOqNZBe7dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520Flatland%253A%2520Increasing%2520Saturation%2520as%2520an%2520Approach%2520to%2520Improving%2520Clinical%2520Success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756%26doi%3D10.1021%2Fjm901241e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Peters, W.</span> <span class="citation_source-book">Chemotherapy and Drug Resistance in Malaria</span>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">1987</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1987&author=W.+Peters&title=Chemotherapy+and+Drug+Resistance+in+Malaria"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DW.%26btitle%3DChemotherapy%2520and%2520Drug%2520Resistance%2520in%2520Malaria%26pub%3DAcademic%2520Press%26date%3D1987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Jimenez-Diaz, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulet, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viera, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garuti, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibanez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez-Doval, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shultz, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gargallo-Viola, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo-Barturen, I.</span><span> </span><span class="NLM_article-title">Improved murine model of malaria using <i>Plasmodium falciparum</i> competent strains and non-myelodepleted NOD-scid IL2Rgammanull mice engrafted with human erythrocytes</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4533</span><span class="NLM_x">–</span> <span class="NLM_lpage">4536</span><span class="refDoi"> DOI: 10.1128/AAC.00519-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1128%2FAAC.00519-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=19596869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KkurbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=4533-4536&author=M.+B.+Jimenez-Diazauthor=T.+Muletauthor=S.+Vieraauthor=V.+Gomezauthor=H.+Garutiauthor=J.+Ibanezauthor=A.+Alvarez-Dovalauthor=L.+D.+Shultzauthor=A.+Martinezauthor=D.+Gargallo-Violaauthor=I.+Angulo-Barturen&title=Improved+murine+model+of+malaria+using+Plasmodium+falciparum+competent+strains+and+non-myelodepleted+NOD-scid+IL2Rgammanull+mice+engrafted+with+human+erythrocytes&doi=10.1128%2FAAC.00519-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Improved murine model of malaria using Plasmodium falciparum competent strains and non-myelodepleted NOD-scid IL2Rγnull mice engrafted with human erythrocytes</span></div><div class="casAuthors">Jimenez-Diaz, Maria Belen; Mulet, Teresa; Viera, Sara; Gomez, Vanessa; Garuti, Helen; Ibanez, Javier; Alvarez-Doval, Angela; Shultz, Leonard D.; Martinez, Antonio; Gargallo-Viola, Domingo; Angulo-Barturen, Inigo</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4533-4536</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Murine models of Plasmodium falciparum malaria may become crucial tools in drug discovery.  Here we show that non-myelodepleted NOD-scid IL2Rγnull mice engrafted with human erythrocytes support an infectious burden up to tenfold higher than that supported by engrafted NOD-scid β2microglobulinnull mice.  The new model was validated for drug discovery and was used to assess the therapeutic efficacy of 4-pyridones, selective inhibitors of P. falciparum cytochrome bc1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoGw5NKfthdbVg90H21EOLACvtfcHk0lhPgOqNZBe7dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KkurbO&md5=df25f5f7382b0b422a9e9b2137a66093</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FAAC.00519-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00519-09%26sid%3Dliteratum%253Aachs%26aulast%3DJimenez-Diaz%26aufirst%3DM.%2BB.%26aulast%3DMulet%26aufirst%3DT.%26aulast%3DViera%26aufirst%3DS.%26aulast%3DGomez%26aufirst%3DV.%26aulast%3DGaruti%26aufirst%3DH.%26aulast%3DIbanez%26aufirst%3DJ.%26aulast%3DAlvarez-Doval%26aufirst%3DA.%26aulast%3DShultz%26aufirst%3DL.%2BD.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DGargallo-Viola%26aufirst%3DD.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26atitle%3DImproved%2520murine%2520model%2520of%2520malaria%2520using%2520Plasmodium%2520falciparum%2520competent%2520strains%2520and%2520non-myelodepleted%2520NOD-scid%2520IL2Rgammanull%2520mice%2520engrafted%2520with%2520human%2520erythrocytes%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D4533%26epage%3D4536%26doi%3D10.1128%2FAAC.00519-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Angulo-Barturen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez-Diaz, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulet, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rullas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herreros, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regadera, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bathurst, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompliano, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de las Heras, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gargallo-Viola, D.</span><span> </span><span class="NLM_article-title">A murine model of falciparum-malaria by <i>in vivo</i> selection of competent strains in non-myelodepleted mice engrafted with human erythrocytes</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e2252</span><span class="refDoi"> DOI: 10.1371/journal.pone.0002252</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1371%2Fjournal.pone.0002252" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=18493601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A280%3ADC%252BD1czjtVahsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=e2252&author=I.+Angulo-Barturenauthor=M.+B.+Jimenez-Diazauthor=T.+Muletauthor=J.+Rullasauthor=E.+Herrerosauthor=S.+Ferrerauthor=E.+Jimenezauthor=A.+Mendozaauthor=J.+Regaderaauthor=P.+J.+Rosenthalauthor=I.+Bathurstauthor=D.+L.+Pomplianoauthor=F.+G.+de+las+Herasauthor=D.+Gargallo-Viola&title=A+murine+model+of+falciparum-malaria+by+in+vivo+selection+of+competent+strains+in+non-myelodepleted+mice+engrafted+with+human+erythrocytes&doi=10.1371%2Fjournal.pone.0002252"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A murine model of falciparum-malaria by in vivo selection of competent strains in non-myelodepleted mice engrafted with human erythrocytes</span></div><div class="casAuthors">Angulo-Barturen Inigo; Jimenez-Diaz Maria Belen; Mulet Teresa; Rullas Joaquin; Herreros Esperanza; Ferrer Santiago; Jimenez Elena; Mendoza Alfonso; Regadera Javier; Rosenthal Philip J; Bathurst Ian; Pompliano David L; Gomez de las Heras Federico; Gargallo-Viola Domingo</div><div class="citationInfo"><span class="NLM_cas:title">PloS one</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e2252</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">To counter the global threat caused by Plasmodium falciparum malaria, new drugs and vaccines are urgently needed.  However, there are no practical animal models because P. falciparum infects human erythrocytes almost exclusively.  Here we describe a reliable falciparum murine model of malaria by generating strains of P. falciparum in vivo that can infect immunodeficient mice engrafted with human erythrocytes.  We infected NOD(scid/beta2m-/-) mice engrafted with human erythrocytes with P. falciparum obtained from in vitro cultures.  After apparent clearance, we obtained isolates of P. falciparum able to grow in peripheral blood of engrafted NOD(scid/beta2m-/-) mice.  Of the isolates obtained, we expanded in vivo and established the isolate Pf3D7(0087/N9) as a reference strain for model development.  Pf3D7(0087/N9) caused productive persistent infections in 100% of engrafted mice infected intravenously.  The infection caused a relative anemia due to selective elimination of human erythrocytes by a mechanism dependent on parasite density in peripheral blood.  Using this model, we implemented and validated a reproducible assay of antimalarial activity useful for drug discovery.  Thus, our results demonstrate that P. falciparum contains clones able to grow reproducibly in mice engrafted with human erythrocytes without the use of myeloablative methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSGBUV1EinlYVHFYivNCdPRfW6udTcc2ebtju54alKy9Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czjtVahsg%253D%253D&md5=02f4475ecc0524005f4538e98a0649d8</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0002252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0002252%26sid%3Dliteratum%253Aachs%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DJimenez-Diaz%26aufirst%3DM.%2BB.%26aulast%3DMulet%26aufirst%3DT.%26aulast%3DRullas%26aufirst%3DJ.%26aulast%3DHerreros%26aufirst%3DE.%26aulast%3DFerrer%26aufirst%3DS.%26aulast%3DJimenez%26aufirst%3DE.%26aulast%3DMendoza%26aufirst%3DA.%26aulast%3DRegadera%26aufirst%3DJ.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DBathurst%26aufirst%3DI.%26aulast%3DPompliano%26aufirst%3DD.%2BL.%26aulast%3Dde%2Blas%2BHeras%26aufirst%3DF.%2BG.%26aulast%3DGargallo-Viola%26aufirst%3DD.%26atitle%3DA%2520murine%2520model%2520of%2520falciparum-malaria%2520by%2520in%2520vivo%2520selection%2520of%2520competent%2520strains%2520in%2520non-myelodepleted%2520mice%2520engrafted%2520with%2520human%2520erythrocytes%26jtitle%3DPLoS%2520One%26date%3D2008%26volume%3D3%26spage%3De2252%26doi%3D10.1371%2Fjournal.pone.0002252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Sanz, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De-Cozar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, X. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llergo, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Bustos, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, F. J.</span><span> </span><span class="NLM_article-title"><i>P. falciparum</i> in vitro killing rates allow to discriminate between different antimalarial mode-of-action</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e30949</span><span class="refDoi"> DOI: 10.1371/journal.pone.0030949</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1371%2Fjournal.pone.0030949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=22383983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsFynsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e30949&author=L.+M.+Sanzauthor=B.+Crespoauthor=C.+De-Cozarauthor=X.+C.+Dingauthor=J.+L.+Llergoauthor=J.+N.+Burrowsauthor=J.+F.+Garcia-Bustosauthor=F.+J.+Gamo&title=P.+falciparum+in+vitro+killing+rates+allow+to+discriminate+between+different+antimalarial+mode-of-action&doi=10.1371%2Fjournal.pone.0030949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">P. falciparum in vitro killing rates allow to discriminate between different antimalarial mode-of-action</span></div><div class="casAuthors">Sanz, Laura M.; Crespo, Benigno; De-Cozar, Cristina; Ding, Xavier C.; Llergo, Jose L.; Burrows, Jeremy N.; Garcia-Bustos, Jose F.; Gamo, Francisco-Javier</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e30949</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Chemotherapy is still the cornerstone for malaria control.  Developing drugs against Plasmodium parasites and monitoring their efficacy requires methods to accurately det. the parasite killing rate in response to treatment.  Commonly used techniques essentially measure metabolic activity as a proxy for parasite viability.  However, these approaches are susceptible to artifacts, as viability and metab. are two parameters that are coupled during the parasite life cycle but can be differentially affected in response to drug actions.  Moreover, traditional techniques do not allow to measure the speed-of-action of compds. on parasite viability, which is an essential efficacy determinant.  We present here a comprehensive methodol. to measure in vitro the direct effect of antimalarial compds. over the parasite viability, which is based on limiting serial diln. of treated parasites and re-growth monitoring.  This methodol. allows to precisely det. the killing rate of antimalarial compds., which can be quantified by the parasite redn. ratio and parasite clearance time, which are key mode-of-action parameters.  Importantly, we demonstrate that this technique readily permits to det. compd. killing activities that might be otherwise missed by traditional, metab.-based techniques.  The anal. of a large set of antimalarial drugs reveals that this viability-based assay allows to discriminate compds. based on their antimalarial mode-of-action.  This approach has been adapted to perform medium throughput screening, facilitating the identification of fast-acting antimalarial compds., which are crucially needed for the control and possibly the eradication of malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlaUZufRfYxbVg90H21EOLACvtfcHk0lhxfbLcrfKO2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsFynsLY%253D&md5=65d5d1a24dbe1811301ac5e684c886c5</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0030949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0030949%26sid%3Dliteratum%253Aachs%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DCrespo%26aufirst%3DB.%26aulast%3DDe-Cozar%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DX.%2BC.%26aulast%3DLlergo%26aufirst%3DJ.%2BL.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DGarcia-Bustos%26aufirst%3DJ.%2BF.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26atitle%3DP.%2520falciparum%2520in%2520vitro%2520killing%2520rates%2520allow%2520to%2520discriminate%2520between%2520different%2520antimalarial%2520mode-of-action%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De30949%26doi%3D10.1371%2Fjournal.pone.0030949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Meister, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plouffe, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhen, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonamy, G. M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bopp, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borboa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bright, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dharia, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gagaring, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gettayacamin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groessl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidock, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nam, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richmond, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rottmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Froissard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glynne, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sattabongkot, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuntland, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diagana, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winzeler, E. A.</span><span> </span><span class="NLM_article-title">Imaging of <i>Plasmodium</i> liver stages to drive next-generation antimalarial drug discovery</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">334</span><span class="NLM_x">, </span> <span class="NLM_fpage">1372</span><span class="NLM_x">–</span> <span class="NLM_lpage">1377</span><span class="refDoi"> DOI: 10.1126/science.1211936</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1126%2Fscience.1211936" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=22096101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFOjt7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2011&pages=1372-1377&author=S.+Meisterauthor=D.+M.+Plouffeauthor=K.+L.+Kuhenauthor=G.+M.+C.+Bonamyauthor=T.+Wuauthor=S.+W.+Barnesauthor=S.+E.+Boppauthor=R.+Borboaauthor=A.+T.+Brightauthor=J.+W.+Cheauthor=S.+Cohenauthor=N.+V.+Dhariaauthor=K.+Gagaringauthor=M.+Gettayacaminauthor=P.+Gordonauthor=T.+Groesslauthor=N.+Katoauthor=M.+C.+S.+Leeauthor=C.+W.+McNamaraauthor=D.+A.+Fidockauthor=A.+Nagleauthor=T.+G.+Namauthor=W.+Richmondauthor=J.+Rolandauthor=M.+Rottmannauthor=B.+Zhouauthor=P.+Froissardauthor=R.+J.+Glynneauthor=D.+Mazierauthor=J.+Sattabongkotauthor=P.+G.+Schultzauthor=T.+Tuntlandauthor=J.+R.+Walkerauthor=Y.+Y.+Zhouauthor=A.+Chatterjeeauthor=T.+T.+Diaganaauthor=E.+A.+Winzeler&title=Imaging+of+Plasmodium+liver+stages+to+drive+next-generation+antimalarial+drug+discovery&doi=10.1126%2Fscience.1211936"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery</span></div><div class="casAuthors">Meister, Stephan; Plouffe, David M.; Kuhen, Kelli L.; Bonamy, Ghislain M. C.; Wu, Tao; Barnes, S. Whitney; Bopp, Selina E.; Borboa, Rachel; Bright, A. Taylor; Che, Jianwei; Cohen, Steve; Dharia, Neekesh V.; Gagaring, Kerstin; Gettayacamin, Montip; Gordon, Perry; Groessl, Todd; Kato, Nobutaka; Lee, Marcus C. S.; McNamara, Case W.; Fidock, David A.; Nagle, Advait; Nam, Tae-gyu; Richmond, Wendy; Roland, Jason; Rottmann, Matthias; Zhou, Bin; Froissard, Patrick; Glynne, Richard J.; Mazier, Dominique; Sattabongkot, Jetsumon; Schultz, Peter G.; Tuntland, Tove; Walker, John R.; Zhou, Yingyao; Chatterjee, Arnab; Diagana, Thierry T.; Winzeler, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">6061</span>),
    <span class="NLM_cas:pages">1372-1377</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Most malaria drug development focuses on parasite stages detected in red blood cells, even though, to achieve eradication, next-generation drugs active against both erythrocytic and exo-erythrocytic forms would be preferable.  We applied a multifactorial approach to a set of >4000 com. available compds. with previously demonstrated blood-stage activity (median inhibitory concn. < 1 micromolar) and identified chem. scaffolds with potent activity against both forms.  From this screen, we identified an imidazolopiperazine scaffold series that was highly enriched among compds. active against Plasmodium liver stages.  The orally bioavailable lead imidazolopiperazine confers complete causal prophylactic protection (15 mg/kg) in rodent models of malaria and shows potent in vivo blood-stage therapeutic activity.  The open-source chem. tools resulting from our effort provide starting points for future drug discovery programs, as well as opportunities for researchers to investigate the biol. of exo-erythrocytic forms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyO41naZtcdrVg90H21EOLACvtfcHk0lhxfbLcrfKO2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFOjt7vN&md5=45b2993be36e36eabe1d9280c86c3db2</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1126%2Fscience.1211936&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1211936%26sid%3Dliteratum%253Aachs%26aulast%3DMeister%26aufirst%3DS.%26aulast%3DPlouffe%26aufirst%3DD.%2BM.%26aulast%3DKuhen%26aufirst%3DK.%2BL.%26aulast%3DBonamy%26aufirst%3DG.%2BM.%2BC.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DBarnes%26aufirst%3DS.%2BW.%26aulast%3DBopp%26aufirst%3DS.%2BE.%26aulast%3DBorboa%26aufirst%3DR.%26aulast%3DBright%26aufirst%3DA.%2BT.%26aulast%3DChe%26aufirst%3DJ.%2BW.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DDharia%26aufirst%3DN.%2BV.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DGettayacamin%26aufirst%3DM.%26aulast%3DGordon%26aufirst%3DP.%26aulast%3DGroessl%26aufirst%3DT.%26aulast%3DKato%26aufirst%3DN.%26aulast%3DLee%26aufirst%3DM.%2BC.%2BS.%26aulast%3DMcNamara%26aufirst%3DC.%2BW.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DNam%26aufirst%3DT.%2BG.%26aulast%3DRichmond%26aufirst%3DW.%26aulast%3DRoland%26aufirst%3DJ.%26aulast%3DRottmann%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DB.%26aulast%3DFroissard%26aufirst%3DP.%26aulast%3DGlynne%26aufirst%3DR.%2BJ.%26aulast%3DMazier%26aufirst%3DD.%26aulast%3DSattabongkot%26aufirst%3DJ.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DZhou%26aufirst%3DY.%2BY.%26aulast%3DChatterjee%26aufirst%3DA.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DImaging%2520of%2520Plasmodium%2520liver%2520stages%2520to%2520drive%2520next-generation%2520antimalarial%2520drug%2520discovery%26jtitle%3DScience%26date%3D2011%26volume%3D334%26spage%3D1372%26epage%3D1377%26doi%3D10.1126%2Fscience.1211936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Duffy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, V. M.</span><span> </span><span class="NLM_article-title">Identification of inhibitors of <i>Plasmodium falciparum</i> gametocyte development</span> <span class="citation_source-journal">Malar. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">408</span><span class="refDoi"> DOI: 10.1186/1475-2875-12-408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1186%2F1475-2875-12-408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=24206914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvFehs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=408&author=S.+Duffyauthor=V.+M.+Avery&title=Identification+of+inhibitors+of+Plasmodium+falciparum+gametocyte+development&doi=10.1186%2F1475-2875-12-408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of inhibitors of Plasmodium falciparum gametocyte development</span></div><div class="casAuthors">Duffy, Sandra; Avery, Vicky M.</div><div class="citationInfo"><span class="NLM_cas:title">Malaria Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">408/1-408/15, 15 pp.</span>CODEN:
                <span class="NLM_cas:coden">MJAOAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-2875</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Plasmodium falciparum gametocytes, specifically mature stages, are the only stage in man transmissible to the mosquito vector responsible for malaria transmission.  Anti-malarial drugs capable of killing these forms are considered essential for the eradication of malaria.  The comprehensive profiling of in vitro activity of anti-malarial compds. against both early (I-III) and late (IV-V) stage P. falciparum gametocytes, along with the high throughput screening (HTS) outcomes from the MMV malaria box are described.  Method: Two anti-gametocyte HTS assays based on confocal fluorescence microscopy, utilizing both a gametocyte specific protein (pfs16-Luc-GFP) and a viability marker (MitoTracker Red CM-H2XRos) (MTR), were used for the measurement of anti-gametocytocidal activity.  This combination provided a direct observation of gametocyte no. per assay well, while defining the viability of each gametocyte imaged.  Results: IC50 values were obtained for 36 current anti-malarial compds. for activities against asexual, early and late stage gametocytes.  The MMV malaria box was screened and actives progressed for IC50 evaluation.  Seven % of the "drug-like" and 21% of the "probe-like" compds. from the MMV malaria box demonstrated equiv. activity against both asexual and late stage gametocytes.  Conclusions: The assays described were shown to selectively identify compds. with gametocytocidal activity and have been demonstrated suitable for HTS with the capability of screening in the order of 20,000 compds. per screening campaign, two to three times per seven-day week.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKk3vbc59HXrVg90H21EOLACvtfcHk0lg7TcCJ4SQhaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvFehs7k%253D&md5=5b38ae9bee99e2566f7765099ca7801c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1186%2F1475-2875-12-408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1475-2875-12-408%26sid%3Dliteratum%253Aachs%26aulast%3DDuffy%26aufirst%3DS.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26atitle%3DIdentification%2520of%2520inhibitors%2520of%2520Plasmodium%2520falciparum%2520gametocyte%2520development%26jtitle%3DMalar.%2520J.%26date%3D2013%26volume%3D12%26spage%3D408%26doi%3D10.1186%2F1475-2875-12-408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Slee, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorjani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanier, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueter, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro-Palomino, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gual, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span> </span><span class="NLM_article-title">2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 1. Structure-activity relationships and optimization of heterocyclic substituents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1719</span><span class="NLM_x">–</span> <span class="NLM_lpage">1729</span><span class="refDoi"> DOI: 10.1021/jm701185v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701185v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1719-1729&author=D.+H.+Sleeauthor=Y.+Chenauthor=X.+Zhangauthor=M.+Moorjaniauthor=M.+C.+Lanierauthor=E.+Linauthor=J.+K.+Rueterauthor=J.+P.+Williamsauthor=S.+M.+Lechnerauthor=S.+Markisonauthor=S.+Malanyauthor=M.+Santosauthor=R.+S.+Grossauthor=K.+Jalaliauthor=Y.+Saiauthor=Z.+Zuoauthor=C.+Yangauthor=J.+C.+Castro-Palominoauthor=M.+I.+Crespoauthor=M.+Pratauthor=S.+Gualauthor=J.+L.+Diazauthor=J.+Saunders&title=2-Amino-N-pyrimidin-4-ylacetamides+as+A2A+receptor+antagonists%3A+1.+Structure-activity+relationships+and+optimization+of+heterocyclic+substituents&doi=10.1021%2Fjm701185v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm701185v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701185v%26sid%3Dliteratum%253Aachs%26aulast%3DSlee%26aufirst%3DD.%2BH.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMoorjani%26aufirst%3DM.%26aulast%3DLanier%26aufirst%3DM.%2BC.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DRueter%26aufirst%3DJ.%2BK.%26aulast%3DWilliams%26aufirst%3DJ.%2BP.%26aulast%3DLechner%26aufirst%3DS.%2BM.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DMalany%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DM.%26aulast%3DGross%26aufirst%3DR.%2BS.%26aulast%3DJalali%26aufirst%3DK.%26aulast%3DSai%26aufirst%3DY.%26aulast%3DZuo%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DCastro-Palomino%26aufirst%3DJ.%2BC.%26aulast%3DCrespo%26aufirst%3DM.%2BI.%26aulast%3DPrat%26aufirst%3DM.%26aulast%3DGual%26aufirst%3DS.%26aulast%3DDiaz%26aufirst%3DJ.%2BL.%26aulast%3DSaunders%26aufirst%3DJ.%26atitle%3D2-Amino-N-pyrimidin-4-ylacetamides%2520as%2520A2A%2520receptor%2520antagonists%253A%25201.%2520Structure-activity%2520relationships%2520and%2520optimization%2520of%2520heterocyclic%2520substituents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1719%26epage%3D1729%26doi%3D10.1021%2Fjm701185v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Liebeskind, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srogl, J.</span><span> </span><span class="NLM_article-title">Heteroaromatic thioether-boronic acid cross-coupling under neutral reaction conditions</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">979</span><span class="NLM_x">–</span> <span class="NLM_lpage">981</span><span class="refDoi"> DOI: 10.1021/ol0200091</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol0200091" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A528%3ADC%252BD38Xht1Gktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=979-981&author=L.+S.+Liebeskindauthor=J.+Srogl&title=Heteroaromatic+thioether-boronic+acid+cross-coupling+under+neutral+reaction+conditions&doi=10.1021%2Fol0200091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Heteroaromatic Thioether-Boronic Acid Cross-Coupling under Neutral Reaction Conditions</span></div><div class="casAuthors">Liebeskind, Lanny S.; Srogl, Jiri</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">979-981</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">π-Deficient heteroarom. thioethers undergo efficient palladium-catalyzed cross-coupling with boronic acids, mediated by copper(I) thiophene-2-carboxylate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowmqoxHMYfLbVg90H21EOLACvtfcHk0lg7TcCJ4SQhaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xht1Gktb0%253D&md5=ce42d2952572e0b36f0f60e6037a18f6</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fol0200091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0200091%26sid%3Dliteratum%253Aachs%26aulast%3DLiebeskind%26aufirst%3DL.%2BS.%26aulast%3DSrogl%26aufirst%3DJ.%26atitle%3DHeteroaromatic%2520thioether-boronic%2520acid%2520cross-coupling%2520under%2520neutral%2520reaction%2520conditions%26jtitle%3DOrg.%2520Lett.%26date%3D2002%26volume%3D4%26spage%3D979%26epage%3D981%26doi%3D10.1021%2Fol0200091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Parra, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercader, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agullo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abad-Somovilla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abad-Fuentes, A.</span><span> </span><span class="NLM_article-title">Generation of anti-azoxystrobin monoclonal antibodies from regioisomeric haptens functionalized at selected sites and development of indirect competitive immunoassays</span> <span class="citation_source-journal">Anal. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">715</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span><span class="refDoi"> DOI: 10.1016/j.aca.2011.12.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=10.1016%2Fj.aca.2011.12.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=22244174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsFWhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=715&publication_year=2012&pages=105-112&author=J.+Parraauthor=J.+V.+Mercaderauthor=C.+Agulloauthor=A.+Abad-Somovillaauthor=A.+Abad-Fuentes&title=Generation+of+anti-azoxystrobin+monoclonal+antibodies+from+regioisomeric+haptens+functionalized+at+selected+sites+and+development+of+indirect+competitive+immunoassays&doi=10.1016%2Fj.aca.2011.12.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of anti-azoxystrobin monoclonal antibodies from regioisomeric haptens functionalized at selected sites and development of indirect competitive immunoassays</span></div><div class="casAuthors">Parra, Javier; Mercader, Josep V.; Agullo, Consuelo; Abad-Somovilla, Antonio; Abad-Fuentes, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Analytica Chimica Acta</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">715</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105-112</span>CODEN:
                <span class="NLM_cas:coden">ACACAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2670</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Azoxystrobin is a modern strobilurin fungicide used around the world to combat prime diseases affecting highly valuable crops.  Accordingly, residues of this chem. are frequently found in food, even though mostly under max. tolerated levels.  We herein describe the development of an indirect competitive immunoassay for the detn. of azoxystrobin residues.  A panel of monoclonal antibodies displaying subnanomolar affinity to azoxystrobin was generated using, as immunizing haptens in mice, four functionalized derivs. carrying the same spacer arm located at different rationally chosen positions.  This collection of antibodies was thoroughly characterized with homologous and heterologous antigens, and the immunoassay consisting of monoclonal antibody AZo6#49 and the coating conjugate OVA-AZb6, which displayed an IC50 value of 0.102 μg L-1 and a LOD of 0.017 μg L-1, was eventually optimized.  The response to different pH and ionic strength conditions of the specific assay was studied using a biparametric approach.  In addn., the influence of Tween 20 and org. solvents over the assay parameters was also evaluated.  After optimization, the developed immunochem. assay was applied to the anal. of azoxystrobin in spiked juices of relevant fruits and vegetables, showing excellent recoveries between 2 and 500 μg L-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo75sHlEBpEr7Vg90H21EOLACvtfcHk0lhFafcO1rLM6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsFWhsw%253D%253D&md5=b587cd8acf13f95f6f94ecf0eed6a95c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.aca.2011.12.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.aca.2011.12.014%26sid%3Dliteratum%253Aachs%26aulast%3DParra%26aufirst%3DJ.%26aulast%3DMercader%26aufirst%3DJ.%2BV.%26aulast%3DAgullo%26aufirst%3DC.%26aulast%3DAbad-Somovilla%26aufirst%3DA.%26aulast%3DAbad-Fuentes%26aufirst%3DA.%26atitle%3DGeneration%2520of%2520anti-azoxystrobin%2520monoclonal%2520antibodies%2520from%2520regioisomeric%2520haptens%2520functionalized%2520at%2520selected%2520sites%2520and%2520development%2520of%2520indirect%2520competitive%2520immunoassays%26jtitle%3DAnal.%2520Chim.%2520Acta%26date%3D2012%26volume%3D715%26spage%3D105%26epage%3D112%26doi%3D10.1016%2Fj.aca.2011.12.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i78"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00028">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_26572"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00028">10.1021/acs.jmedchem.6b00028</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Synthetic details for all compounds, supplementary data tables, additional information on ADMET and pharmacology (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00028/suppl_file/jm6b00028_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00028/suppl_file/jm6b00028_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00028/suppl_file/jm6b00028_si_001.pdf">jm6b00028_si_001.pdf (2.01 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00028/suppl_file/jm6b00028_si_002.csv">jm6b00028_si_002.csv (0.78 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00028&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00028%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-13%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00028" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679961acbca2d1cf","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
